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Premature birth, defined as a gestational period less than 37 weeks, occurs in 8% of infants 
born in Canada. These births are associated with a higher risk of developing neurological 
complications. Infants born with very low birth weights (VLBW, < 1500 g) experience 
cognitive or behavioural deficits at a rate of 40-50%, while a further 5-10% develop major 
disorders such as cerebral palsy.  The likelihood of injury increases with a shorter gestational 
period and/or a lower birthweight. Intraventricular hemorrhaging (IVH) occurs in 20-25% of 
VLBW infants, characterized by bleeding in the germinal matrix and surrounding white matter. 
This highly vascularized region is particularly susceptible to bleeds due to underdeveloped 
cerebrovascular structures. Severe IVH causes an inflammatory response and subsequent 
obstruction of cerebrospinal fluid (CSF) drainage, resulting in enlargement of the brain’s 
ventricles, referred to as post-hemorrhagic ventricular dilatation (PHVD). PHVD increases 
intracranial pressure and can result in compression/damage of brain tissue. 
Diagnosis of IVH and PHVD is regularly performed using cranial ultrasound. Clinicians can 
visually assess and grade hemorrhaging/ventricle dilatation. Ultrasound, however, is limited in 
its ability to continuously monitor and only detects irreversible damage. NNeMo (Neonatal 
NeuroMonitor) is a hybrid optical device combining diffuse correlation (DCS) and near-
infrared spectroscopy (NIRS) to simultaneous monitor cerebral blood flow (CBF) and 
metabolism at the bedside. DCS analyzes light scatter from red blood cells to infer their motion 
and calculate CBF while NIRS exploits light absorption properties to quantify changes in 
oxidized cytochrome c oxidase (oxCCO), a direct marker of energy metabolism. System 
validation was presented in a piglet model of neonatal hypoxia-ischemia. Clinical translation 
of NNeMo was demonstrated in PHVD infants during ventricular taps (i.e., CSF drainage). 
Changes in perfusion and metabolism are presented in premature infants at high risk of IVH 
within the first 72 hours of life. Lastly, NNeMo was translated to the cardiac operating room, 
in patients undergoing surgery with cardiopulmonary bypass, to observe metabolic response 
to large intraoperative changes in CBF. Optical measures of perfusion and metabolism show 
potential to act as prognostic markers of injury and could aid clinicians in patient management 
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Summary for Lay Audience 
A full-term pregnancy is approximately 40 weeks in duration. Infants born within 37 weeks 
are defined as premature and often experience inadequate brain growth and underdeveloped 
cerebrovascular structures, which are necessary to maintain an adequate supply of blood and 
oxygen to the brain. As a result, premature infants are at a higher risk of developing a brain 
injury, which further increases with a shorter gestational period or a lower weight at birth. A 
common injury is intraventricular hemorrhaging (IVH), which describes bleeding in and 
around the ventricles of the brain. IVH has been found to occur in up to 25% of infants 
weighing less than 1500 g at birth and 45% in those less than 1000 g, with most cases appearing 
within the first 48 hours of life. Furthermore, severe cases of IVH can result in improper 
draining of cerebrospinal fluid (CSF) from the brain’s ventricles. This leads to increased 
intracranial pressure and ventricle volume, described as post-hemorrhagic ventricular 
dilatation (PHVD), which can compress brain tissue and result in long-term cognitive deficit. 
In today’s neonatal intensive care unit (NICU), brain monitoring is limited to infrequent 
imaging using cranial ultrasound. While ultrasound can accurately diagnose bleeding/ventricle 
enlargement, it cannot continuously monitor and can only image damage that has already 
occurred. This dissertation explores the use of biomedical optics to monitor potential 
physiological markers of brain injury before significant damage occurs. NNeMo (Neonatal 
NeuroMonitor) is a non-invasive optical device developed to continuously monitor cerebral 
blood flow (CBF) and metabolism at the bedside. This was achieved by combining diffuse 
correlation spectroscopy to characterize CBF with broadband near-infrared spectroscopy to 
monitor cerebral metabolism. NNeMo demonstrated changes in CBF and metabolism prior to 
the onset of brain injury in an animal model. The system was translated to the NICU to monitor 
PHVD infants during CSF drainage and preterms at risk of IVH soon after birth. Lastly, the 
relationship between CBF and metabolism as indicators of potential injury was investigated in 
patients undergoing cardiac surgery with cardiopulmonary bypass. Real-time monitoring of 
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Chapter 1  
1 Introduction 
Advancements in the modern neonatal intensive care unit (NICU) have greatly improved 
outcomes of premature infants and those with complications at birth. With increasing 
survival rates across NICU patients, clinical efforts have shifted to quality of life following 
patient discharge. A notable area of focus is in neurodevelopment and 
prevention/mitigation of long-term cognitive deficit. This dissertation explores 
development of optical technologies to aid in the diagnosis and management of premature 
brain injury with the goal of improving clinical outcomes. 
1.1 Clinical Rationale 
1.1.1 Premature Brain Injury 
Premature birth, defined as a gestational period lasting fewer than 37 weeks, is a common 
occurrence with 8% of infants in Canada born prematurely [1]. The shorter the gestational 
age (GA) at birth and the less these infants weigh, the higher the risk of neurological 
complications. Very low birth weight (VLBW; < 1500 g) infants  experience behavioural 
or cognitive deficits at a rate of 25-50%, with a further 5-10% developing major motor 
disorders such as cerebral palsy [2]. These rates are more severe in extremely low birth 
weight (ELBW; < 1000 g) infants, with apparent and significant long-term deficits [3,4]. 
Intraventricular hemorrhaging (IVH), is a common injury following premature birth and is 
characterized by bleeding in the germinal matrix and surrounding white matter. The 
germinal matrix is a highly vascularized region in the brain, comprised of glial and 
neuronal precursor cells, and is particularly susceptible to hemorrhaging within the first 48 
hours following birth [5]. Substantial bleeding in this area can cause a rupture of the 
ependyma (ventricle lining) and result in blood entering the ventricles. IVH has been found 
to occur in 20-25% of VLBW infants [6] and in 45% of ELBW infants [7]. Periventricular 
leukomalacia (PVL) is another common injury characterized by ischemic damage to 
periventricular white matter. PVL has been found in up to 50% of VLBW infants and can 
take the form of a focal cystic injury embodying tissue necrosis or a diffuse non-cystic 
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injury vulnerable to ischemia, with the latter being far more prevalent in preterms [2,8]. In 
severe cases of cerebral hemorrhaging, an inflammatory response, followed by fibrosis, 
can obstruct the drainage of cerebrospinal fluid (CSF) in the brain’s ventricles and lead to 
post-hemorrhagic ventricular dilatation (PHVD) [9,10]. PHVD is a common complication 
of high-grade IVH and can result in CSF accumulation, increased intracranial pressure, and 
compression/damage of brain tissue. 
The pathogenesis of IVH and PVL is multifaceted. The shortened gestation of a premature 
birth prevents adequate development of cerebrovascular structures (i.e., vascularization of 
the germinal matrix). In addition to an immature cerebrovascular system, poor regulation 
of cerebral blood flow (CBF) is believed to contribute to injury as evident by the prevalence 
of impaired cerebral autoregulation (CA; i.e., the ability to maintain CBF despite changes 
in blood pressure) in this population [5,11,12]. In addition, preterms have a significantly 
lower basal CBF compared to adults (<10 ml/100 g/min in preterms versus 
50 ml/100 g/min in adults), and are therefore less tolerant of any disturbance in flow [13].  
1.1.2 Clinical Diagnosis and Neuromonitoring 
Considering the incidence of IVH and PVL following birth increases the risk of long-term 
neurological complications, early characterization of injury is paramount [4]. Many infants 
with brain injury are asymptomatic. Diagnosis is based on screening, most commonly with 
cranial ultrasound (cUS). Cranial US is a non-invasive, bedside imaging technique that can 
detect and grade IVH, identify PVL, and gauge ventricular dilatation [10,14]. Routine 
monitoring with cUS is employed in standard practice in most centers with all infants 
admitted to the NICU receiving a scan within the first week of life and a second at 36-40 
weeks postmenstrual age (PMA) [15]. Imaging with ultrasound has two notable limitations. 
Firstly, cUS cannot provide continuous monitoring, as it only captures a single snapshot of 
the brain. Timely diagnosis, therefore, relies on frequency of imaging. In addition, brain 
injury as observed by cUS is based on structural damage that has already occurred. It is of 
note that magnetic resonance imaging (MRI) can also provide high resolution imaging to 
accurately diagnose injury but, in addition to similar limitations as ultrasound, is costly and 
not deployable at the bedside [16]. At the point of imaging, in both techniques, any damage 
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identified is irreversible and clinical decision making seeks to manage the injury and 
prevent further damage.  
Recent work has looked into physiological precursors of brain injury. More specifically, 
CBF has been measured as a potential marker of damage. The approaches and technologies 
implemented to make this measurement have varied greatly over the years. Early work by 
Volpe et al. in 1983 used positron emission tomography (PET), with oxygen-15 labelled 
water as a radiotracer, to measure CBF in premature infants with IVH [17]. In this study, 
significant reductions in CBF were found in areas of the brain impacted by hemorrhaging. 
The study concluded that a drop in flow was principally responsible for successive 
neurological deficits. In 1986, Greisen implemented a 133-Xenon clearance method to 
measure CBF in premature infants soon after birth [18]. In this study, an arterial injection 
of 133-Xenon was used while monitoring activity over the brain with a sodium-iodide 
crystal detector. A lower-than-expected CBF was found in infants requiring ventilation. 
While PET and 133-Xenon clearance approaches provide a fairly robust measure of CBF, 
the radiation exposure required is a significant drawback.  
Several studies have implemented transcranial Doppler ultrasound (TCD) to measure CBF 
non-invasively. TCD operates by emitting an acoustic wave and monitoring changes in 
frequency of reflected waves scattered from red blood cells (RBC). The difference in 
frequency between incident and reflected wave is referred to as the Doppler shift and is 
directly proportional to RBC velocity [19]. In premature infants, some studies have shown 
strong correlations between TCD-measured CBF and the development of cerebral 
hemorrhages [20]. However, a recent systematic review by Camfferman et al. reports a 
high variability across studies, speculating that measurement frequency may be a limitation 
in correlating flow measurements to the onset of injury [21]. While a continuous measure 
of CBF by TCD is possible, ultrasound equipment is bulky, requiring a transducer 
immediately above the site of interest, and impractical for longitudinal monitoring. Similar 
doppler ultrasound-based techniques have also been implemented to measure CBF 
indirectly via extracerebral feeding arteries. Studies have investigated early changes in 
cerebral blood volume (calculated from CBF) in preterms during the first weeks of life [22] 
and have found strong relationships between superior vena cava flow (measured as a 
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reflection of CBF) and the onset of IVH [23,24]. Additional limitations of TCD include its 
operator dependence, requiring substantial understanding of the underlying 
cerebrovascular structures in order to obtain an adequate measure, and its ability to measure 
only large basal arteries, which describes global changes in flow [19]. 
A further consideration when relying on perfusion monitoring is to understand that CBF is 
not a wholistic marker of cerebral health. Dynamic changes in CBF are generally managed 
by brain homeostasis. So, when do changes in CBF become clinically significant? This 
question can be addressed through a measure of oxygen utilization (i.e., cerebral 
metabolism) as a biomarker of potential injury [25]. When the brain has a limited oxygen 
supply, or is inefficient in metabolizing the oxygen available, there is an impact on energy 
production which can lead to cell death. In the healthy brain, fluctuations in CBF are 
compensated for by changes in the amount of oxygen extracted from the blood, known as 
the oxygen extraction fraction (OEF). Only with extreme changes in flow, at which point 
this compensatory mechanism fails, do changes in metabolism persist (Figure 1.1). 
Metabolism has therefore proven a more direct marker of tissue viability [26]. Approaches 
for monitoring cerebral metabolism in the newborn are limited; disregarding techniques 
that require radiation exposure, magnetic resonance spectroscopy (MRS) is the most 
notable. MRS is capable of directly measuring the concentrations of metabolites in brain 
tissue, which have been shown to correlate with injury in infants with asphyxia [27] and 
hypoxia-ischemia [28]. However, MRS is inconvenient for routine monitoring and poses a 




Figure 1.1: Oxygen extraction and metabolic response to changes in CBF. 
Limited availability of robust and convenient bedside technologies has sparked the 
development of optical techniques to provide a safe, non-invasive approach to 
neuromonitoring. This dissertation describes the technology and clinical translation of 
optical techniques to monitor cerebral tissue saturation, blood flow, and metabolism at the 
bedside. Continuous bedside monitoring of physiological precursors has potential to alter 
patient management and improve clinical outcomes associated with premature brain injury. 
1.2 Near-Infrared Spectroscopy 
Near-infrared spectroscopy (NIRS) is a non-invasive optical technique used to measure the 
concentrations of light-absorbing molecules, termed chromophores, in living tissue. By 
interrogating tissue with non-ionizing light within the near-infrared spectral range, light 
absorption can be characterized and related to the in vivo concentration of chromophores. 
NIRS was introduced by Frans Jöbsis in 1977 who discovered that NIR light could 
penetrate the skull, providing a promising in-situ technique to monitor hemoglobin content 
and oxygen utilization through photo-transmission [29]. Jöbsis observed an optical window 
from 650-950 nm where light absorption from endogenous tissue chromophores is 
relatively small, allowing for deeper photon penetration [30]. The most prevalent 
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chromophores in tissue within this range are oxy-hemoglobin (HbO2), deoxy-hemoglobin 
(Hb), and water. Wavelengths immediately above and below this region are highly 
absorbed by water and Hb, respectively. Similar optical windows of lower absorption also 
exist between 1100–1350 nm and 1600–1870 nm [31]; however, light sources in these 
ranges have traditionally been power inefficient or not cost-effective for bedside 
monitoring. Figure 1.1 shows the absorption spectra of HbO2, Hb, and water in the NIR 
optical window where distinct spectral features between chromophores are apparent.  
 
Figure 1.2: Optical window in the near-infrared. 
By interrogating tissue with light at various wavelengths, the proportion absorbed by each 
chromophore can be determined and related to their respective concentrations. A measure 





This section will elaborate on the analytical basis of NIRS and the principles of converting 
light absorption into chromophore concentrations.  
1.2.1 Physical Principles of NIRS 
Light incident on any media will be attenuated by two primary interactions: absorption and 
scattering. When a photon strikes a medium it is absorbed if the frequency of the incoming 
light is equivalent to the energy required to excite the molecule to a higher energy state. 
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The loss of intensity as light travels through a non-scattering medium was first described 
as absorption by Pierre Bouguer in 1729. Johann Heinrich Lambert, in 1760, expanded this 
idea to describe absorption (A) in a homogenous material as proportional to the length of 
sample through which the light passes: 
 𝐴 = − log (
𝐼
𝐼0
) = 𝜇𝑎𝑙 (1.2) 
where I/I0 is the proportion of light absorbed, µa is the absorption coefficient representing 
the inverse of the average distance that a photon is likely to travel before an absorption 
event, and l is the thickness of a sample. August Beer, in 1852, determined that light 
absorption is proportional to the concentration of the solution in which light is travelling. 
This relationship between absorption and concentration is commonly referred to as the 
Beer-Lambert law: 
 𝐴 = 𝜀𝑐𝑙 (1.3) 
where 𝜀 is the molar extinction coefficient, an intrinsic property specific to each species, 
and c is the concentration of the solution. In a sample consisting of numerous absorbers, 
this law can be expanded to account for all constituents: 
 𝐴 = ∑ 𝜀𝑖𝑐𝑖𝑙𝑖  (1.4) 
The Beer-Lambert law, however, is only satisfied in a non-scattering medium. Within the 
NIR window, light scatter is the most dominant interaction in tissue [32,33]. Rayleigh 
scattering can occur when light interacts with particles smaller than the incident 
wavelength, and Mie scattering when particles are much larger; the latter is more common 
in tissues with the abundance of larger bodies such as nuclei and mitochondria. Scattering 
via Fresnel Reflections is also common, occurring at an index of refraction. To account for 
the influence of scatter, a modified Beer-Lambert law was introduced by Delpy et al. in 
1988 [34]. Firstly, equation 1.3 can be adapted to describe intensity loss due to light 
scattering as follows:  
 𝐼 = 𝐼0𝑒
−𝜇𝑠𝑙 (1.5) 
where µs represents the inverse distance that a photon is likely to travel before it is 
scattered. Similar to absorption, the behaviour of light scatter varies across different media. 
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The Henyey-Greenstein Phase Function, described in 1941, is a probability density 
function which describes the likelihood of light scattering at an angle 𝜃 given the scattering 









where g is intrinsic to the media and describes the likely direction of a scattered photon. 
This metric can range from -1 to 1 as the mean cosine of the scatter angle; a value of 0 
represents isometric scattering. Most tissue types have a g of approximately 0.9, which 
means that light is mostly forward scattered. However, due to the high prevalence of 
scattering events relative to absorption, directionality is quickly lost in tissue and photon 
propagation resembles a photon cloud. As a result, scatter is assumed to be isotropic and 
non-directional. In highly diffuse media such as tissue, scattering is commonly 
characterized by the reduced scattering coefficient, µs′: 
 𝜇𝑠
′ = 𝜇𝑠(1 − 𝑔) (1.7) 
where 1/µs′ describes the average distance that a photon travels before its movement can 
be modelled as a random walk or diffusion-like process. The change in µs′ with respect to 
wavelength can be modelled using a power law:  
 𝜇𝑠






where α is the scattering power and A is the µs′ value at λ0, both of which can be determined 
experimentally. For biological tissue, scattering is a combination of Mie and Rayleigh 
effects with α between 3 and 5.5 [36]. The Beer-Lambert law can be modified to account 
for the effects of scattering: 
 𝐴(𝜆) = 𝐷𝑃(𝜆) ∑ 𝜀𝑖𝑐𝑖 + 𝐺(𝜆)𝑖  (1.9) 
where G is wavelength dependent scalar term, describing the proportion of light not 
detected due to scatter, and the DP is the differential pathlength characterizing the distance 
that light travels following multiple scattering events. In order to quantify chromophore 
concentrations, these scattering dependent metrics must be determined in addition to 




1.2.2 Light Propagation in Tissue 
The behaviour of electromagnetic radiation is governed by Maxwell’s equations; however, 
modelling this becomes exceedingly complex within a highly scattering and heterogeneous 
medium such as tissue. Instead, the radiative transfer equation (RTE) can be used as a 
simplification, describing light as discrete photons which undergo absorption and elastic 






+ ?̂? ⋅ 𝛻 + 𝜇𝑎 + 𝜇𝑠] 𝐿(𝑟, 𝑡, ?̂?) = 𝜇𝑠 ∫ 𝐿(𝑟, 𝑡, ?̂?)𝑃(?̂?, ?̂?
′) ⅆ𝛺′
4𝜋
+ 𝑆(𝑟, 𝑡, ?̂?) (1.10) 
where L(r,t,ŝ) is the radiance at position r in the direction defined by the vector ŝ at time t. 
P(ŝ,ŝ′) is the scattering phase function which describes the probability of scattering to from 
direction ŝ to ŝ′, S(r,t,ŝ) is the source term and 𝑣 is the speed of light in the medium. The 
RTE can be greatly simplified for light propagation through a diffuse medium considering 
the directionality of light quickly becomes isotropic due to the far greater number of 
scattering events compared to absorption. For a source-detector distance (SDD) 







+ 𝛻 ⋅ 𝐽(𝑟, 𝑡) + 𝜇𝑎𝜙(𝑟, 𝑡) = 𝑆(𝑟, 𝑡) (1.11) 
where fluence, 𝛷 = ∫ 𝐿(𝑟, 𝑡, Ω)ⅆΩ and the flux, 𝐽(𝑟, 𝑡) = −𝐷∇𝛷(𝑟, 𝑡). This can be further 






− 𝐷𝛻2 + 𝜇𝑎) 𝜙(𝑟, 𝑡) = 𝑆(𝑟, 𝑡) (1.12) 








Given certain boundary conditions and geometries, analytical solutions to the diffusion 
approximation can be derived, which can be used to determine tissue optical properties 
(i.e., µa and µs′). Section 1.3 elaborates on NIRS techniques that have been developed for 




1.3 In vivo NIRS Techniques 
The fundamental understanding of light interaction with tissue described above is utilized 
in various approaches to quantify chromophore concentrations in vivo for a wide range of 
clinical applications. These methods characterize absorption and scattering effects through 
interrogating an area of interest with NIR light and analyzing changes in light intensity, 
frequency, wavelength, time, and location. This section will describe the different NIRS 
approaches investigated, the technology involved, and touch upon several applications of 
these techniques in neuromonitoring with particular focus on the premature brain. Studies 
involving hybrid/multi-modal devices will be discussed in section 1.5. 
1.3.1 Continuous-wave NIRS 
Continuous-wave (CW) NIRS systems utilize light sources that are constant in intensity 
and implement a minimum of two wavelengths to characterize absorption changes related 
to the concentrations of HbO2 and Hb. These devices are advantageous due to their high 
temporal resolution, cost-effectiveness, and portability [37]. System components include 
light sources, often either laser diodes or light-emitting diodes (LED), optical fibers to 
direct and capture light, and photon detectors which vary across different optical 
techniques. Most detectors rely on the photoelectric effect (PE) where a photon generates 
a charge carrier and electrical current. This can occur ‘externally’, such as in photo-
multiplier tubes (PMT), where an incident photon liberates an electron, is accelerated in an 
electric field, and causes a cascade of electrons ejections resulting in a signal amplification 
[38]. The PE can also occur ‘internally’ as an absorbed photon creates an electron-hole 
pair, produces a photocurrent, and is detected as an electrical signal. An example of the 
internal PE is in the common photodiode, prevalent within CW-NIRS systems, where the 
output voltage is proportional to the power of incident light. Further advances have led to 
the avalanche photodiode (APD) which utilizes the internal PE, as in photodiodes, but 
generates electron cascades to improve signal amplification similar to PMTs [38,39]. The 
portability of sources and detectors, and their ability to effectively shield from ambient 
light, have allowed for bedside monitoring and even wireless/wearable devices [37,40]. 
11 
 
CW-NIRS operates under the assumption that scattering is unchanged over the course of a 
measurement. By analyzing only changes in intensity, without characterizing the optical 
properties, only relative values of hemoglobin and StO2 can be acquired. While relative 
measures can be valuable for tracking longitudinal changes, they are limited for 
establishing clinical thresholds or comparing measures between subjects. Another set-back 
of many CW-NIRS system is depth sensitivity, as they are unable to differentiate between 
brain tissue and extra-cerebral layers (scalp and skull) [41]. This is less of an issue within 
neonatal applications due to the thin skull thickness in the newborn [42]. 
1.3.1.1 Spatially Resolved Spectroscopy 
Spatially resolved spectroscopy traditionally utilizes CW-NIRS techniques while 
quantifying optical properties by implementing multiple light source-detector distances 
(SDD). In 1989 Patterson et al. proposed that the effective attenuation coefficient (µeff) 
could be measured by acquiring intensity information as a function of distance from the 
light source [43]. Equation 1.15 defines µeff, and simplifies it given that µs >> µa:  
𝜇𝑒𝑓𝑓 =  √3𝜇𝑎(𝜇𝑎 + 𝜇𝑠′ )  ≅ √3𝜇𝑎𝜇𝑠′   (1.14) 
Through modelling the diffusion approximation (described in section 1.2.2) for a semi-
infinite geometry, while assuming the SDD, ρ >> 1/µs′, light reflectance can be described 





Taking a natural logarithm, the reflectance can be modelled as a linear equation with µeff 
as the slope:  
 ln(𝜌2𝑅(𝜌)) = −𝜇𝑒𝑓𝑓𝜌 + 𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡 (1.16) 
By acquiring data at multiple distances, µeff can be determined. To quantify µa, an estimate 
of µs′ is required [44]. Some work has utilized calibrated reflectance measurements to solve 
for the intercept of the linear equation and estimate µs′ [45]. SRS was first demonstrated 
by Matcher et al. in 1995 to provide absolute hemoglobin concentrations and saturation 
values comparable to blood-gas analysis [46]. This technique is the basis for most 
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commercially available NIRS devices. Section 1.3.1.2 elaborates on the clinical application 
of commercial CW-NIRS systems implementing SRS technology.  
1.3.1.2 Commercial CW-NIRS Devices 
CW-NIRS has proven extremely useful in brain monitoring studies involving premature 
infants, a very fragile patient population, due to its safe and non-invasive approach. 
Compared to other techniques for examining the brain (described in section 1.1.2), NIRS 
allows for continuous monitoring, requires minimal handling, and can be implemented 
without disrupting clinical care (i.e., x-ray imaging, ventilation equipment, 
electroencephalography (EEG) monitoring, etc.). NIRS was first implemented on 
newborns to monitor cerebral oxygen levels in vivo in 1985 by Brazy et al. [47]. Since 
these preliminary reports, optical neuromonitoring with NIRS has been implemented 
around the world to investigate the developing brain. Numerous commercial systems using 
SRS technology have been developed for neonatal brain monitoring. Several groups have 
compared the robustness of systems available and the clinical relevance of their measures 
[48–52]. Generally, NIRS monitoring of StO2 has proven robust in characterizing trends 
but absolute values have varied depending on the device and sensors used. Saturation 
differences as large as 14% have been reported with neonatal sensors [53]. Notably, work 
by Kleiser et al. compared measurements with five commercially available oximeters on a 
phantom model of a neonatal head. Both system brand and sensor type were determined to 
influence StO2 measures but values were found to be linearly related, allowing for 
comparison across devices [54].  
Despite these differences, the SafeBoosC Phase II randomized clinical trial was 
implemented to determine the benefit of CW-NIRS measures of StO2 in extremely preterm 
infants by developing a treatment guideline to manage deviations from an expected range 
(55–85%) [55]. This study accepted a handful of NIRS devices that produced absolute StO2 
values, allowing only a 5% deviation from the INVOS oximeter (Medtronic) and an 
absolute repeatability of at least than 6% [56]. With these criteria, across 166 preterm 
infants, the trial found that NIRS monitoring resulted in a significantly reduced burden of 
hypoxia within the first 72 hours of life [57]. Without a gold-standard technique to provide 
a robust absolute measure, establishing clinical guidelines for StO2 to gauge brain 
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development or indicate injury remains a challenge. The following sections elaborate on 
advanced NIRS techniques that have been investigated to provide more robust 
measurements or more sensitive biomarkers of development/injury.  
1.3.1.3 Broadband NIRS 
Broadband NIRS (B-NIRS) is a CW-NIRS technique which analyzes absorption as a 
function of wavelength across the entire optical window. An estimate of DP can be derived 
using the absorption spectrum of water, which has distinct spectral features. This approach 
was first reported by Matcher et al. in 1993 who calculated DP as the quotient of the 
apparent water concentration, determined using the measured amplitude at 970 nm, divided 
by an assumed water concentration for brain tissue [58]. Light attenuation is also 
influenced by a DC scattering component (the G term from the modified Beer-Lambert 
law, equation 1.9). By taking the second derivative of the reflectance spectrum, the 
influence of scattering can be considered negligible due to its weak wavelength 
dependence. Derivatives of G can therefore be omitted by assuming wavelength 








𝐶𝑖𝑖  (1.17) 
where terms are defined as in equation 1.9. The water feature can be characterized by 
performing a least-squares fit between the second derivatives of the measured and ground 
truth water absorption spectra. The DP can be determined by scaling this factor by an 
assumed brain water concentration [58]. 
Derivative spectroscopy has since been extended to solve for absolute concentrations of 
hemoglobin by fitting the first and second derivatives of solutions for the diffusion 
approximation to the first and second derivatives of the measured reflectance data 




Figure 1.3: Extinction coefficient, 1st, and 2nd derivatives for HbO2, Hb, and water. 
In this approach, light propagation is modelled via a steady-state solution to the diffusion 


















2  (1.18) 
where r1= [ρ
2 + z0
2]1/2 and r2 = [ρ
2 + (z0 + 2zb)
2]1/2. The effective depth is represented by 
z0 = 1/µs′, while zb = 2D(1+Reff)(1-Reff)
-1 is the extrapolated boundary [63] with 
Reff = 0.493 as the effective reflection coefficient for tissue and air refractive indices [64]. 
The impact of scatter (described by equation 1.8) is characterized by solving for the 
scattering terms A and α using a least-square minimization algorithm. The introduction of 
a derivative analysis has the added benefit of minimizing the influence of DC noise from 
ambient light sources. However, the fitting algorithms involved have proven to be 
computationally heavy and require too much time to allow for real-time monitoring. Recent 
work has combined the derivative approach to quantify chromophores at baseline with 
relative models using the Beer-lambert Law to provide continuous absolute monitoring at 









where the superscript ‘b’ indicated absolute values measured at baseline and variables 
preceded by Δ indicate relative changes [65]. 
In addition to measuring StO2, B-NIRS is capable of monitoring cerebral metabolism. This 
is achieved through the metabolic marker cytochrome c oxidase (CCO), an enzyme in the 
mitochondria’s electron transport chain vital to oxidative phosphorylation. CCO is the final 
electron accepter that becomes oxidized, reducing oxygen to water. This exchange builds 
on an electrochemical gradient which ultimately drives ATP synthesis. A reduction in CCO 
may signal subsequent damage; significant reductions in energy production can lead to cell 
death and tissue damage [66]. To meet high energy demands, the brain has a relatively 
higher concentration of mitochondria compared to the skin and muscle that comprises the 
extra-cerebral layers, making CCO a more brain-sensitive marker of metabolism. Similar 
to hemoglobin, oxygenated and deoxygenated CCO have distinct absorption spectrum in 
the NIR (Figure 1.4).  
 
Figure 1.4: Absorption spectra of oxCCO 
The total concentration of CCO in the brain is stable; however, its oxidization is dynamic 
[67]. A relative change in metabolism can therefore be determined by comparing the 
interchange between oxidation states. This is achieved using B-NIRS by analyzing the 
oxidized-reduced difference spectrum to indicate changes in the oxidized state of CCO 
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(oxCCO). Analytically, a modified Beer-Lambert law (similar to equation 1.9), developed 


















]  (1.20) 
An in vivo measurement of CCO has been sought since the conception of NIRS [29]. With 
a concentration less than 10% of hemoglobin’s, accurate measures of CCO have proven 
challenging and controversial with traditional NIRS technology [68–71]. The more recent 
use of spectral analysis has allowed for robust measures, characterizing oxCCO’s broad 
absorption feature [72,73]. Optical measurements of oxCCO were found consistent with 
metabolic measures from cerebral microdialysis [74] and MRS [75]. To confirm signal 
contribution from cytochrome, equation 1.20 can be solved both with (3-component model) 
and without (2-component model) the inclusion of ΔoxCCO. The resulting concentrations 
can then be used to back-calculate the attenuation from which a residual difference between 
calculated and measured attenuation can be determined. The incorporation of oxCCO as a 
chromophore can be justified by noting that the 2-component residual resembles the 
absorption spectra of oxCCO, suggesting a missing chromophore in the fit, while the 3-
component residual is approximately zero across all wavelengths [67].  
B-NIRS achieves hyperspectral analysis by implementing a ‘white-light’ halogen bulb as 
a source, which emits throughout the NIR, and a spectrometer employing a diffraction 
grating to separate incoming light as a function of wavelength. In the spectrometer, light is 
detected by a charged couple device (CCD) which operates using the internal PE (described 
in section 1.3.1). In comparison to APD or PMT technology, CCDs collect spatial 
information along an array of pixels. B-NIRS systems, in comparison to other advanced 
NIRS approaches (discussed in sections 1.3.2 and 1.3.3), are simple in their design and are 
cost-effective [76]. While B-NIRS is able to acquire metabolic information, it is limited in 
depth sensitivity, similar to traditional CW-NIRS approaches.  
B-NIRS measures of StO2 and oxCCO have been acquired in several relevant animal 
models and neonatal studies. Early work investigating cytochrome using discrete 
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wavelength CW-NIRS systems have reported conflicting and inconsistent measures. Given 
these discrepancies, only recent applications utilizing B-NIRS systems will be discussed 
(for a detailed history of CCO measures see the recent review by Bale et al. [67]). Within 
a piglet model of neonatal hypoxia-ischemia (achieved through reducing inspired oxygen 
and occluding carotid arteries), Bainbridge et al. reported a correlation between oxCCO 
and clinical outcome at 48 hours post-injury [75]. In a similar animal model, measures of 
oxCCO were able to gauge injury severity [77]. In this study, controlled anoxia events prior 
to and following injury were monitored while injury severity was confirmed using MRS. 
In 2014, Bale et al. monitored cerebral saturation and metabolism in six infants with 
neonatal encephalopathy for over 200 hours in the NICU [73]. This work demonstrated the 
feasibility for longitudinal optical monitoring while observing 236 desaturation events. A 
significant similarity between oxCCO and MRS biomarkers of injury severity was 
reported. McLachlan et al. utilized a B-NIRS system to monitor StO2 nine infants with 
PHVD receiving a ventricular tap and demonstrated the potential of optical monitoring in 
gauging intervention efficacy. A significant increase in post-operative StO2 was found 
compared to a control group. In addition, preliminary work in a neonatal piglet model 
manipulated cerebral metabolism through inducing ischemia and using an anaesthetic to 
reduce oxygen demand. This work compared oxCCO and calculated measures of 
metabolism based on oxygen utilization, finding a temporal delay in the latter [78]. Further 
work is required to elucidate the difference between the two metabolic measures. 
1.3.2 Time-resolved NIRS 
Time-resolved NIRS was first introduced in 1988 by Chance et al. and Delpy et al. to 
characterize the DP using time-of-flight information as photons traverse tissue [34,79]. TR-
NIRS utilizes a light source with extremely short laser pulses, on the order of picoseconds. 
High temporal resolution detectors and electronics generate histograms of incoming 
photons as a function of arrival time, referred to as temporal point spread functions (TPSF, 




Figure 1.5: Time-resolved NIRS with pulse of intensity I0(t) is incident on tissue, 
producing a TPSF with intensity I(t). 
By modelling the TPSF by the DA, the optical properties can be quantified and, in turn, 
used to determine absolute chromophore concentrations. The time dependent solution of 
the DA for semi-infinite geometry can be given as follows [80]: 
















Time-of-flight information provides the added benefit of increased depth sensitivity. Later 
arriving photons, depicted by the tail-end of each TPSF, can be separately binned to isolate 
light that has travelled deeper within tissue [81]. Recent studies have demonstrated the 
impact of analyzing these photons to differentiate between signal contribution from the 
brain versus extra-cerebral layers [82]. Depth sensitivity can also be achieved through 
calculating the statistical moments, with higher moments more sensitive to the latter end 
of the histogram representing later arriving photons [83,84].  
To achieve high temporal resolution measures, TR-NIRS systems utilize pulsed lasers 
operating on the order 80 MHz and quick detectors such as PMTs coupled to a photon 
counting module to generate TPSFs. These components are costly and bulky compared to 
other NIRS approaches, making TR-NIRS challenging for bedside monitoring with few 
commercial TR-NIRS systems available, most notably is the TRS device by Hamamatsu 
Photonics, Japan. Many recent studies have worked to minimize the size of TR-NIRS 
equipment and develop portable systems [85,86]. Multi-channel devices have also been 
developed for complete brain mapping and optical tomography [87,88]. The UCL group 
19 
 
has utilized their 32-channel system, dubbed MONSTIR, to generate three-dimensional 
images of the premature brain with IVH. Measured absorption and cerebral blood volume 
(CBV) was consistent with the asymmetry expected from the hemorrhaged area [89]. In 
neonatal animal models, TR-NIRS measurements of venous oxygenation (calculated from 
StO2) were shown to agree with values obtained from directly from sagittal sinus blood 
[90]. However, in a neonatal piglet model of hyper/hypoxia, measures of StO2 with TR- 
and B-NIRS devices produced strong a correlation but discrepancies between absolute 
values persisted, with B-NIRS reporting significantly higher measures [91]. Experiments 
in phantom and animal models have also demonstrated the ability of TR-NIRS to monitor 
deep brain temperature by analyzing shifts in the water absorption peak [92].  
TR-NIRS was first used on newborn infants by Van der Zee et al. in 1992 to characterize 
the DP as a function of depth [93] and similar devices have since been translated to the 
clinic in a number of exploratory studies. In 2005, Ijichi et al. measured optical properties, 
StO2, and CBV as a function of GA in term infants admitted to the NICU [94]. This study 
demonstrated the feasibility for bedside neuromonitoring in the NICU while reporting a 
positive correlation of µs′ and CBV and a negative correlation of StO2 with increasing GA. 
Following this, a number of clinical studies have implemented Hamamatsu’s TRS devices 
in neonatal populations. Using the TRS-10 system, Koyano et al. found significant 
increases in CBV and decreases in StO2 in infants with high Hb levels prior to blood 
transfusion. This work demonstrated the potential of TR-NIRS monitoring to guide the 
decision to transfuse in VLBW infants [95]. Using the TRS-20 system, Ishii et al. reported 
significantly higher StO2 and lower OEF in infants small for their GA compared to infants 
of an appropriate size [96]. In similar measurements, Fujioka et al. compared premature 
infants to those born at term, within the first three days of life, and found similar StO2 
values but significantly increased CBV in the full-term group [97]. 
1.3.3 Frequency-domain NIRS 
Frequency domain NIRS (FD-NIRS) was proposed in 1990 as an alternative approach for 
quantifying tissue optical properties using a radiofrequency modulated light source [98–
100]. By altering the emission-source intensity, light interrogating tissue will reach the 
detector with a change in phase proportional to the distance travelled (Figure 7). By 
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acquiring both the light attenuation and phase shift, the DP and optical properties can be 
determined and used to quantify chromophore concentrations [32]. 
 
Figure 1.6: Frequency domain NIRS, phase modulated light source with intensity I0 
is incident on tissue resulting in an intensity change (I1) and change in phase (𝜱). 
The intensity collected at the detector can be represented by [101]: 
 𝐼 = 𝐼𝐷𝐶 + 𝐼𝐴𝐶 𝑠𝑖𝑛(2𝜋𝑣𝑡 − 𝜙) (1.22) 
where IDC is the average detected intensity, IAC is the amplitude of the frequency dependent 
intensity, v is the modulating frequency, and 𝛷 is the phase shift. The DP can then be 
calculated as 𝐷𝑃 = 𝛷c𝑣/2π𝑣𝑛𝑡 [101]. By assuming the modulating frequency is 
significantly smaller than frequency of scattering events, a solution to the diffusion 
approximation exists for a semi-infinite homogeneous medium. In 1993, Fishkin and 
Gratton [102] derived expressions for the measured phase (F 𝛷), AC (FAC), and DC (FDC) 
signals which can be summarized as follows [103]: 
 𝐹𝜑(𝜑, 𝜌, 𝜔, 𝜇𝑎, 𝜇𝑠
′ ) = 𝑆𝜑(𝜔, 𝜇𝑎, 𝜇𝑠
′ )𝜌 + 𝐾𝜑−𝑆𝑜𝑢𝑟𝑐𝑒 + 𝐾𝜑−𝐷𝑒𝑡𝑒𝑐𝑡𝑜𝑟 (1.23) 
 𝐹𝐴𝐶(𝐷𝐶, 𝜌, 𝜔, 𝜇𝑎, 𝜇𝑠
′ ) = 𝑆𝐴𝐶(𝜔, 𝜇𝑎, 𝜇𝑠
′ )𝜌 + 𝐾𝐴𝐶−𝑆𝑜𝑢𝑟𝑐𝑒 + 𝐾𝐴𝐶−𝐷𝑒𝑡𝑒𝑐𝑡𝑜𝑟 (1.24) 
 𝐹𝐷𝐶(𝐷𝐶, 𝜌, 𝜇𝑎, 𝜇𝑠
′ ) = 𝑆𝐷𝐶(𝜇𝑎, 𝜇𝑠
′ )𝜌 + 𝐾𝐷𝐶−𝑆𝑜𝑢𝑟𝑐𝑒 + 𝐾𝐷𝐶−𝐷𝑒𝑡𝑒𝑐𝑡𝑜𝑟 (1.25) 
where ρ represents the SDD and ω is the angular modulation frequency of the source. SDC, 
SAC, and Sφ represent the slopes of these linear functions and the K terms embody 
instrumental factors intrinsic to the source and detector [103]. While the latter terms are 
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unknown, SRS techniques can be used to acquire measurements at multiple distances and 



















− 𝜇𝑎 (1.27) 
where S denotes the slope for equations 1.24-1.26. With data acquired from a minimum of 
two wavelengths, absolute concentrations of Hb and HbO2 can be determined [101]. 
Single-distance approaches to quantify FD-NIRS measures has also been achieved by using 
a calibration phantom with known optical properties to determine K terms (in equations 
1.23-1.25) or by using a multi-frequency measurement with the modulation frequency (ω) 
as the independent variable opposed to the SDD (ρ) [103]. 
While FD-NIRS systems are more complex than CW-NIRS techniques, they are simpler 
and more cost-effective compared to TR-NIRS. Sources often exist as laser diodes 
alternately driven at frequencies on the order of 100 MHz and fast detectors, such as PMTs, 
operating in heterodyne mode. Compared to TR-NIRS devices, FD-NIRS requires multi-
distance or multi-frequency measurements to quantify tissue chromophores. Alternatively, 
FD-NIRS requires the inclusion of a calibration measurement, prior to monitoring, in order 
to characterize the power of different sources and gains of detectors [104]. Despite the 
ability of FD-NIRS to characterize the DP, a study by Binzoni et al. compared the depth 
sensitivity between FD and CW-NIRS approaches and reported a similarity when 
modulation frequencies were < 200 MHz [105]. A study by Dehaes et al. found a major 
source of error with FD-NIRS measures, determined through Monte Carlo simulations, to 
be the significant curvature of the neonatal head relative to the typical source-detector 
distance since FD-NIRS are typically calibrated assuming a planar geometry. In this study 
optical absorption in the neonatal brain was retrieved with an error of 8–24% [106]. 
FD-NIRS was first implemented on newborn infants in 1995 by Duncan et al. to 
characterize optical pathlength [107], and in 1998 ISS Inc. (Champaign, IL) developed 
Oxiplex, the first commercial FD-NIRS system. Today it remains as one of the few 
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commercially available devices. In 2007, Franceschini et al. implemented FD-NIRS to 
monitor early brain development [108]. Here, StO2, CBV, and CMRO2 were calculated 
from measurements of hemoglobin concentrations and agreed with previously described 
developmental milestones from PET and EEG studies. A strong correlation was also found 
between changes in CBV/CMRO2 measures and neonatal brain injury [109]. Recent work 
by van Essen et al. compared StO2 measurements acquired using the Oxiplex FD-NIRS 
and the INVOS CW-NIRS (Medtronic) systems in premature infants within the first 15-
minutes of life [110]. Significantly higher saturation values resulted using the Oxiplex 
system, suggesting persistent inconsistencies between optical techniques. Comparing 
preterm to term infants, Arri et al. found no significant difference between mean StO2 
values, similar to the study by Fujioka et al. using TR-NIRS [97], but reported 
measurement precision greater in infants at term due to changes in tissue homogeneity with 
development [33]. Roche-Labarbe et al. acquired optical measures of CBV and StO2 using 
FD-NIRS in combination with CBF from TCD to calculate CMRO2 in premature infants 
within six weeks following birth [111]. CBV was found to increase with GA, similar to 
reports using TR-NIRS [94]; however, no change in StO2 was noted. This study found a 
significant discrepancy between CMRO2 calculated using estimated and direct measures 
of CBF and emphasized the benefit of combining NIRS approaches with CBF monitoring. 
Section 1.4 describes optical techniques to measure CBF and section 1.5 elaborates on the 
development of hybrid systems. 
1.4 Optical Blood Flow Monitoring 
NIRS measurements of StO2 have been used to describe oxygen content in the newborn 
brain during various stages and abnormalities. This metric has acted as a surrogate marker 
of cerebral hemodynamics and metabolism, due to a lack of adequate technology to provide 
more direct measures, but has proven limited in indicating adverse cerebral events or in 
predicting clinical outcomes [49,50,112]. Emerging optical techniques have proven 
capable of measuring blood flow in cerebral macro and microvasculature. This section will 




1.4.1 Dynamic Contrast-Enhanced NIRS 
NIRS is capable of quantifying blood flow using both endogenous [113,114] and 
exogenous [115–117] contrast agents. The former approach is based on the Fick principle 
and work by Kety and Schmidt who, in 1945, utilized nitrous oxide gas inhalation and brain 
uptake to provide the first quantitative measure of cerebral perfusion in humans [118]. 
NIRS can similarly use light absorption from HbO2 as a flow tracer and has demonstrated 
comparable CBF measures with 133Xe clearance techniques in premature infants [119,120]. 
Dynamic contrast-enhanced (DCE) NIRS instead utilizes an intravenous injection of the 
light absorbing dye indocyanine green (ICG) to act as an intravascular contrast agent. This 
exogenous tracer has a stronger and more distinct absorption peak in the NIR. DCE-NIRS 
can quantify CBF through a tracer kinetics model [121–123]: 
 𝐶𝑏(𝑡) = 𝐶𝐵𝐹 ∙ 𝑅(𝑡) ∗ 𝐶𝑎(𝑡) (1.28) 
where Cb is the ICG concentration in brain tissue measured using NIRS and Ca is the 
arterial concentration acquired using a dye densitometer. R(t) is the impulse residue 
function which describes the fraction of dye in the tissue at time t following a bolus 
injection at t = 0. CBF can be solved by deconvolution since R(0) ≡ 1. Absolute measures 
of CBF have been validated in piglets against measurements obtained with computed 
tomography (CT) perfusion [115,124] and in adults against arterial spin labelling (ASL) 
MRI [125]. DCE-NIRS has shown strong agreement when using both CW- and TR-NIRS 
techniques [116]. In addition, multi-distance NIRS has allowed for depth-resolved flow 
measurements [126,127]. The use of ICG to monitor CBF was demonstrated in infants by 
Patel et al. in 1998 who found good agreement with NIRS measures of flow using HbO2 
as an endogenous marker [128]. DCE-NIRS measures of CBF have been combined with 
StO2 from standalone NIRS to calculate CMRO2 in piglet models of neonatal hypoxia 
ischemia [129,130] and in infants with patent ductus arteriosus [131] and post-hemorrhagic 
hydrocephalus [132]. The development and clinical translation of hybrid systems to acquire 
metabolic information is the focus of section 1.5. Due to the need for a contrast agent, 
DCE-NIRS is a minimally invasive technique but is only able to provide discrete 
measurements of CBF. More recent advancements in optical technology have provided a 
means of continuous non-invasive monitoring of CBF at the bedside. 
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1.4.2 Diffuse Correlation Spectroscopy 
Diffuse correlation spectroscopy (DCS) is a technique gaining significant popularity in 
recent literature which can continuously acquire microvascular CBF without the use of 
contrast. DCS, similarly to NIRS, utilizes light in the NIR range, but focuses on 
characterizing scattering events caused by red blood cells (RBC). When interrogating a 
region with light, constructive and destructive interference of light electric fields will be 
apparent at the site of the detection fiber as dynamic bright and dark spots; this is referred 
to as a speckle pattern. Speckle intensity analysis was originally investigated to determine 
the size and structure of large molecules [133] and, under various names, has shown 
potential in flow monitoring [134,135]. More recently, Boas et al. set the ground work in 
developing DCS as a potential tool for measuring cerebral perfusion [136,137]. Since RBC 
are the primary moving light scatterers in tissue [138], the faster they move in vasculature 
the quicker the speckle intensity will fluctuate. By analyzing these temporal fluctuations 
with an autocorrelation, RBC motion can be related to correlation decay and, in turn, to 
blood flow. For an electromagnetic field in a highly scattering medium, the field 
autocorrelation function G1(𝜌,𝑡) can be given by: 
 𝐺1(𝜌, 𝜏) = 〈𝐸(𝜌, 𝜏) ∙ 𝐸(𝜌, 𝑡 + 𝜏)〉 (1.29) 
where E(𝜌,𝑡) is the electric field at SSD (𝜌) and time (t), 𝜏 is the delay time, and angle 
brackets denote temporal averages. The normalized field autocorrelation function can then 
be represented as: 




DCS monitors speckle light intensity at high temporal resolutions, from which a 
normalized intensity autocorrelation function can be determined: 




where I(ρ,t) is the detected light intensity at an SDD ρ and time t. The normalized intensity 
and electric field autocorrelation function are related via the Siegert relationship [139]: 




where β is the coherence factor dictated by the number of speckles detected and laser 
properties (i.e., coherence length and stability). G1 satisfies the diffusion equation and, 
assuming a point source and semi-infinite homogenous geometry, can be solved for using 
the correlation diffusion equation (CDE) [137]. Similar to the RTE (Equation 1.10) which 
assumes energy conservation with photon scatter, the CDE describes a transfer of 
correlation, in that it accumulates a correlation decay with scattering events. The DA 
(equation 1.12), simplified from the RTE, can instead be modelled as the CDE [136]:  
 [𝐷(𝑟, 𝑡)𝛻2 − 𝑣𝜇𝑎(𝑟, 𝑡) − 𝑘𝐷
2 (𝜏)] ⋅ 𝐺1(𝑟, 𝑡) = −𝑣𝑆(𝑟) (1.33) 
where D is the diffusion coefficient (equation 1.13) and kD
2 represents a correlation decay 
caused by the motion of scatterers. 
 𝑘𝐷
2 (𝜏) = 3𝜇′𝑠𝜇𝑎 + 𝛼𝜇′𝑠
2𝑘0
2〈𝑟2(𝜏)〉 (1.34) 
where alpha is the ratio of moving scatterers to all scatterers, 𝑘0 = 2𝜋𝑛/𝜆  is the light 
wavenumber (with λ as the wavelength and n as the refractive index), and <Δr2(τ)> is the 
mean-square displacement of the scatterers over delay time τ. To model flow in 
vasculature, the Brownian diffusion model assumes incoherent motion and is given by: 
 〈∆𝑟2(𝜏)〉 = 6𝐷𝐵𝜏 (1.35) 




2 = 3𝜇′𝑠𝜇𝑎 + 6𝜇′𝑠
2𝑘0
2𝛼𝐷𝐵𝜏 (1.36) 
where the collective term αDB (in units cm
2/s) represents an index of blood flow (BFI) 
[140,141]. To solve for aDB, G1 must first be calculated, which is achieved through an 
analytical solution to the CDE (equation 1.33) [62,142]: 












2]1/2 and r2 = [ρ
2 + (z0 + 2zb)
2]1/2.. The effective depth is represented by 
z0 = 1/µs′, while zb = 2D(1+Reff)(1-Reff)
-1 is the extrapolated boundary [63] with 




Figure 1.7: Normalized intensity autocorrelation function showing correlation decay 
at varying flowrates 
To isolate speckle intensity fluctuations from RBC motion, DCS employs a continuous-
wave long-coherence laser. A coherence length (>5 m) significantly larger than the photon 
pathlength (<1 m) is required to ensure that the light interrogating tissue remains in-phase 
despite the large pathlength travelled. Any decay in the correlation can then be attributed 
to the movement of scatterers opposed to fluctuations from the source itself. Most 
commonly, DCS utilizes a laser within the first optical window (e.g. 785 nm). Recent work 
has shown that longer wavelengths (>1000 nm) have SNR advantages [143]. When 
collecting light, implementing a single-mode detection fiber (core radius ~2-8 µm) 
improves speckle contrast by allowing only a single scattered electric field component. 
However, the small amount of light collected from the small core greatly reduces SNR. 
The use of few-mode fibers has been shown to improve upon this by increasing the number 
of photons collected while suffering only a slight decrease in speckle contrast [144–146]. 
To monitor CBF at high temporal resolutions, single-photon avalanche photodiode (SPAD) 
detectors are utilized. Coupled with a counting board, these detectors can achieve a high 
SNR. To calculate an autocorrelation curve, incoming photons are binned as a function of 
time. Traditionally, this is achieved using a multi-tau hardware correlator board with set 
delay times, ranging from µs to s. Improving upon this, Baker et al. found a selection of 
delay times to increase temporal resolution and SNR [147]. Modifying delay times also has 
potential to improve depth sensitivity, as fitting earlier delay times represents longer photon 
27 
 
pathlengths and increased brain signal contribution [148]. Further, Wang et al. showed the 
development of a software correlator to digitally bin photons for calculation of the 
autocorrelation curve, allowing increased selectivity of the delay time range [149]. High 
temporal resolution flow measurements achieved using software correlators have proven 
capable of monitoring CBF pulsatility [149,150]. In comparison to NIRS, DCS has 
improved depth sensitivity, showing a three-fold increase in brain-to-scalp signal 
contribution, making it ideal for bedside neuromonitoring [148]. Multi-layer models have 
been implemented to differentiate between scalp and brain flow in both animals and 
humans [147,151]. Signal contribution from the brain has been further investigated with 
the development of time-domain (TD) DCS systems. Similar to TR-NIRS approaches, TD-
DCS acquires a temporal point spread function, while simultaneously measuring the 
autocorrelation function, and through time-gating can differentiate photon pathlengths and 
ultimately depth penetration [152]. 
A large number of studies in animal models, adults, and neonates have reported strong 
correlations of BFI (measured in cm2/s) with CBF (measured in traditional units of 
mL/min/100 g) using numerous techniques including Doppler ultrasound [153], DCE-
ultrasound [154], TCD [155], Xenon-CT [156], DCE-NIRS [60,157], phase-contrast MRI 
[158], and ASL-MRI [140,159–162]. DCS has generally been used to track relative 
measures of CBF, as quantification requires measuring the optical properties 
[157,163,164]. BFI’s relative measure of flow has been implemented alongside DCE-NIRS 
techniques to quantify CBF [157,165]. Recently, a stand-alone DCS system was shown to 
capable of providing absolute CBF through multi-distance DCE measurements, finding a 
strong correlation with DCE-NIRS measures of flow [141].  
DCS systems have been implemented to monitor the premature brain in a number of studies 
and are often combined with other NIRS techniques to provide both perfusion and 
metabolic information. Section 1.5 outlines the benefits of hybrid optical systems in 
acquiring these metrics and elaborates on the clinical applications of both CBF and 
metabolic neuromonitoring in the NICU. 
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1.5 Hybrid Optical Systems 
Limitations in the clinical relevance of StO2 alone, and the more recent emergence of DCS 
measures of flow, has prompted the development of hybrid NIRS/DCS devices to acquire 
both cerebral perfusion and metabolism concurrently [25]. A bedside measure of 
metabolism has potential in providing a more direct marker of injury. It can provide context 
to fluctuations in CBF and indicate when changes are significant enough to impact oxygen 
utilization. When cells are not sufficiently metabolizing oxygen to create energy, it can 
result in cell death and subsequent brain damage. Metabolism is most commonly calculated 
as CMRO2, a conservation equation based on the Fick principle, which determines oxygen 
consumption in units of O2/100 g/min by measuring cerebral blood flow and the 
arteriovenous oxygen difference [90,118,140]:  
 𝐶𝑀𝑅𝑂2 = 𝐾 × 𝑡𝐻𝑏 × 𝐶𝐵𝐹 × (𝑆𝑎𝑂2 − 𝑆𝑣𝑂2) (1.38) 
where K is the oxygen carrying capacity of hemoglobin (1.39 mL of O2 per g of Hb [166]), 
tHb is the total hemoglobin concentration, SaO2 is the arterial oxygen saturation, and SvO2 
is the venous oxygen saturation. When applied to NIRS, SvO2 is determined from StO2 by 










× (𝑆𝑎𝑂2 − 𝑆𝑡𝑂2) (1.40) 
By combining NIRS measures of StO2 and DCS measures of CBF, CMRO2 can be 
determined. This combination was first demonstrated by Cheung et al. in 2001 and has 
since evolved in highly sophisticated and commercially available devices [142]. This 
section elaborates on the development of systems combining the NIRS techniques 
described in section 1.3 with DCS to monitor the newborn brain. 
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1.5.1 Frequency-domain NIRS and DCS 
The first hybrid system presented by Cheung et al. utilized multi-distance FD-NIRS and 
DCS technology to collect optical data from four different positions on a rat’s brain [142]. 
The system was adapted to monitor CBF and CMRO2 during ischemia in a similar animal 
model [168] and soon after in the adult brain [169]. This device acquired FD-NIRS and 
DCS information in succession and reported a 2.5-minute temporal resolution for a full 
data set. Since this work, significant improvements have been made to system SNR, 
temporal resolution, and depth sensitivity. Advancements have allowed for robust 
monitoring and translation of technology to the NICU to monitor perfusion and metabolism 
at the bedside [104]. A notable milestone was the development of the MetaOx described 
by Carp et al. in 2017, the first commercially available FD-NIRS/DCS device [170]. This 
system can acquire data at 10 Hz, enabling pulsatile measurements, and can analyze 
collected data in real-time. By implementing a short-pass filter to block DCS light from 
FD-NIRS PMT detectors, it allows for a truly simultaneous measure of perfusion and 
metabolism. Validation of the system demonstrated similar results to stand-alone devices. 
Recent work has also introduced motion correction algorithms for CBF and CMRO2 
measures [171]. 
Both research and commercial FD-NIRS/DCS systems have been translated to the NICU 
to investigate perfusion and metabolic change during early stages of brain development. In 
2010, Roche-Labarbe et al. monitored CBF and CMRO2 in preterm infants during the first 
six weeks of life. In this study StO2 measures steadily decreased during this period, while 
CBF and CMRO2 increased, with the latter increasing 40% [111]. This group also observed 
changes in CBF and CMRO2 as a function of brain development, finding both to positively 
correlate with post-menstrual age [172]. Recent work has also found correlations between 
CBF and malnutrition impeding adequate development [173]. Significantly reduced CBF 
and CMRO2 values have been reported in extremely low GA (24-28 weeks gestation) 
infants with IVH compared to those without hemorrhages [174]. Regional changes in CBF 
and CMRO2 in both preterm and term infants have also been investigated, finding 
significantly increased values in the right hemisphere [175,176]. In age-matched groups, 
males were found to have higher CBF in most regions, a higher CMRO2 in the frontal 
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region, and more prominent hemispheric asymmetry [104,176]. Such a discrepancy was 
expected since newborn males are generally more susceptible to white matter injury, 
hypoxic-ischemic injury, and cerebral palsy than females [177,178].  
Similar FD-NIRS/DCS systems have been utilized to investigate a wide range of neonatal 
brain injuries. Several studies have monitored CBF and CMRO2 in infants with complex 
congenital heart disease (CHD). Durduran et al. investigated cerebrovascular reactivity 
(i.e., changes in CBF in response to change in partial pressure of CO2), which has been 
associated with adverse neurodevelopment, finding minimal influence of hypercapnia on 
flow/metabolic measures in term infants [179] while differences in CBF and CMRO2 were 
found in CHD patients compared with controls [180]. Severe forms of CHD were found to 
produce CBF and CMRO2 values similar to expected values for preterms and showed a 
strong correlation to MRI-measured values when infants were at rest and hypercapnic 
[161]. In infants with ventricle lesions undergoing neonatal cardiac surgery, no correlation 
was found between changes in CBF/CMRO2 and duration of deep hypothermic circulatory 
arrest [181]. In infants with hypoxic-ischemic encephalopathy decreases in both metrics 
were found when undergoing therapeutic hypothermia [182]. Optical measures of 
perfusion and metabolism have also been used as a marker of functional activation in 
preterm infants [183]. 
1.5.2 Time-resolved NIRS and DCS 
Similar to devices described in section 1.5.1, hybrid systems combining TR-NIRS and DCS 
techniques offer continuous and robust measurements of CBF and CMRO2. Due to the 
complexity of TR-NIRS devices (as described in section 1.3.2) studies combining these 
approaches are limited. In 2010, Diop et al. first utilized TR-NIRS in conjunction with 
DCS to quantify the relative measures of CBF using a DCE-NIRS approach [157]. The 
device’s ability to monitor flow and metabolic information was demonstrated in a neonatal 
piglet model of brain injury by manipulating metabolism using anaesthetics and sodium 
cyanide [90]. The system’s ability to accurately monitor optical properties and CBF was 
demonstrated in a phantom model along with the depth sensitivity of acquired measures 
[184]. Recent iterations of this device employed optical filters to allow NIRS and DCS 
technique to run truly simultaneously [185]. 
31 
 
More recent work by Giovannella et al. presented a commercial-grade hybrid TR-
NIRS/DCS device called the BabyLux [186]. This system also utilizes optical filters to 
acquire simultaneous NIRS and DCS data at a temporal resolution of 1 s, while avoiding 
crosstalk between signals. System stability was demonstrated, and in-vivo measurements 
were conducted on the adult brain. The accuracy and precision of this device was described 
using phantoms and piglet models in comparison to expected values from simulated data 
[187]. Concurrent measures of cerebral oxygenation and blood flow were demonstrated in 
healthy term infants, reporting an improved intra-subject variability in oxygenation values 
compared to commercial NIRS devices [188]. 
1.5.3 Broadband NIRS and DCS 
While hybrid systems using FD- and TR-NIRS can provide concurrent measures of CBF 
and CMRO2, the latter is a calculated metric based on the former. As such, any error in the 
CBF measure is also reflected in CMRO2. As discussed in section 1.3.1.3, B-NIRS has the 
advantage of acquiring a measure of oxCCO, a direct marker of cerebral metabolism, in 
addition to CMRO2. While a comparison between oxCCO and CMRO2 is limited, 
preliminary work reports a slight discrepancy [78]. Compared to other NIRS approaches, 
B-NIRS devices have the added benefit of simplicity and cost, requiring only a halogen 
bulb and spectrometer. A study utilizing both B-NIRS and DCS was presented, but 
continuous measurements of both techniques had not been achieved. In premature infants 
receiving an indomethacin infusion (a vasoconstrictor) as treatment for patent ductus 
arteriosus, Diop et al. monitored CBF and CMRO2 surrounding the intervention using B-
NIRS and DCS [60]. This study reported a significant reduction in StO2 and CBF, with no 
change in CMRO2. Measurements in this work were non-continuous, and simultaneous 
acquisitions of oxCCO and CBF had yet to be reported. 
1.6 Research Objectives 
The goals of my doctoral research were to develop a hybrid optical system to provide a 
continuous measure of cerebral perfusion and metabolism, via the marker oxCCO, in 
infants at risk of brain injury. A non-invasive technique to characterize these metrics has 
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potential to aid in early detection and clinical management of IVH and PHVD. These goals 
have been addressed through the following aims: 
1. Develop and validate a hybrid B-NIRS and DCS neuromonitor to simultaneously 
acquire CBF and oxCCO at the bedside. 
2. Assess system feasibility in PHVD infants in the neonatal intensive care unit. 
3. Investigate cerebral perfusion and metabolic stability during early brain 
development in premature infants soon after following birth. 
4. Investigate the impact of significant changes in CBF on cerebral energy 
metabolism. 
Chapters two through five address these goals in order. 
1.7 Thesis Outline 
This dissertation includes six chapters. Chapters two to four were adapted from published 
work. Chapter five presents the first application of CBF and oxCCO measures in premature 
infants immediately following birth. Chapter 7 summarizes the advancements presented in 
this body of work. 
1.7.1 Development of a hybrid broadband NIRS and DCS device for 
concurrent measurements of cerebral perfusion and 
cytochrome c oxidase (Chapter 2) 
The development of a novel system combining B-NIRS and DCS is described. The 
system’s ability to acquire oxCCO and CBF is demonstrated in a piglet model of neonatal 
hypoxia-ischemia. This chapter is based on a publication titled “Simultaneous monitoring 
of cerebral perfusion and cytochrome c oxidase by combining broadband near-infrared 
spectroscopy and diffuse correlation spectroscopy,” published in Biomedical Optics 
Express in 2018 by Ajay Rajaram, Gemma Bale, Matthew Kewin, Laura B. Morrison, Ilias 
Tachtsidis, Keith St. Lawrence, and Mamadou Diop [65]. 
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1.7.2 Monitoring changes in cerebral blood flow and metabolism in 
infants with post-hemorrhagic ventricular dilatation during 
ventricular taps (Chapter 3) 
NNeMo (Neonatal Neuromonitor) a clinical B-NIRS/DCS system is presented. System 
feasibility is demonstrated in infants with post-hemorrhagic ventricular dilatation (PHVD) 
to monitor hemodynamics and metabolism during the surgical removal of cerebrospinal 
fluid. This chapter is based on a publication titled “Perfusion and metabolic 
neuromonitoring during ventricular taps in infants with post-hemorrhagic ventricular 
dilatation,” published in Brain Sciences in 2020 by Ajay Rajaram, Lawrence C. M. Yip, 
Daniel Milej, Marianne Suwalski, Matthew Kewin, Marcus Lo, Jeffrey J. L. Carson, Victor 
Han, Soume Bhattacharya, Mamadou Diop, Sandrine de Ribaupierre, and Keith St. 
Lawrence [189]. 
1.7.3 Monitoring cerebral hemodynamic, oxygenation and 
metabolic stability in premature infants following birth using a 
hybrid broadband NIRS/DCS optical brain monitor (Chapter 
4) 
NNeMo was utilized to monitor premature infants with the first 72 hours of life, starting 
soon after birth. Spontaneous and dynamic changes in CBF and metabolism are reported 
during this early period. A publication titled “Monitoring cerebral hemodynamic and 
metabolic stability in premature infants following birth using NNeMo (Neonatal 
NeuroMonitor) a hybrid broadband NIRS/DCS optical brain monitor,” which elaborates 
on the data presented in this section is in preparation by Ajay Rajaram, Daniel Milej, Lilian 
Kebaya, Matthew Kewin, Lawrence C. M. Yip, Marianne Suwalski, Sandrine de 
Ribaupierre, Soume Bhattacharya, Mamadou Diop, and Keith St. Lawrence.  
1.7.4 Changes in cerebral blood flow and metabolism in response 
to hypoperfusion events in adults during surgery with 
cardiopulmonary bypass (Chapter 5) 
Successful preliminary results in the NICU prompted translation of NNeMo to monitor 
CBF and metabolism in adults undergoing surgery with cardiopulmonary bypass. While 
this study investigates a very different patient population, the underlying pathophysiology 
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and development of brain injury is similar. The relationship between cerebral perfusion 
and metabolism is demonstrated during extreme hypoperfusion events and transitions 
on/off cardiopulmonary bypass. This chapter is based on a publication titled “Optical 
monitoring of cerebral perfusion and metabolism in adults during cardiac surgery with 
cardiopulmonary bypass,” published in Biomedical Optics Express in 2020 by Ajay 
Rajaram, Daniel Milej, Marianne Suwalski, Lawrence C. M. Yip, Linrui R. Guo, Michael 
W. A. Chu, Jason Chui, Mamadou Diop, John M. Murkin, and Keith St. Lawrence [150]. 
1.7.5 Conclusion and Future Directions (Chapter 6) 
This section summarizes the main findings of all work presented and elaborates on future 
directions for optical neuromonitoring in the newborn. Final conclusions and closing 
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Chapter 2  
2 Simultaneous monitoring of cerebral perfusion and 
cytochrome c oxidase by combining broadband near-
infrared spectroscopy and diffuse correlation 
spectroscopy 
This chapter has been adapted from the publication titled “Simultaneous monitoring of 
cerebral perfusion and cytochrome c oxidase by combining broadband near-infrared 
spectroscopy and diffuse correlation spectroscopy” published in the journal Biomedical 
Optics Express in 2018 by Ajay Rajaram, Gemma Bale, Matthew Kewin, Laura B. 
Morrison, Ilias Tachtsidis, Keith St. Lawrence, and Mamadou Diop, volume 9, issue 6. 
2.1 Abstract 
Preterm infants born with very low birth weights are at a high risk of brain injury, in part 
because the premature brain is believed to be prone to periods of low cerebral blood flow 
(CBF). Tissue damage is likely to occur if reduction in CBF is sufficient to impair cerebral 
energy metabolism for extended periods. Therefore, a neuromonitoring method that can 
detect reductions in CBF, large enough to affect metabolism, could alert the neonatal 
intensive care team before injury occurs. In this report, we present the development of an 
optical system that combines diffuse correlation spectroscopy (DCS) for monitoring CBF 
and broadband near-infrared spectroscopy (B-NIRS) for monitoring the oxidation state of 
cytochrome c oxidase (oxCCO) – a key biomarker of oxidative metabolism. The hybrid 
instrument includes a multiplexing system to enable concomitant DCS and B-NIRS 
measurements while avoiding crosstalk between the two subsystems. The ability of the 
instrument to monitor dynamic changes in CBF and oxCCO was demonstrated in a piglet 
model of neonatal hypoxia-ischemia (HI). Experiments conducted in eight animals, 
including two controls, showed that oxCCO exhibited a delayed response to ischemia while 
CBF and tissue oxygenation (StO2) responses were instantaneous. These findings suggest 
that simultaneous neuromonitoring of perfusion and metabolism could provide critical 





An estimated 15 million babies are born prematurely each year and those with very low 
birth weights (VLBW < 1500 g) are at a high risk of neurodevelopmental impairment [1]. 
Among the 63,000 VLBW infants born annually in the United States, 5-10% develop major 
disabilities such as cerebral palsy and 25-50% show other cognitive and behavioural 
deficits [2,3]. Although other factors contribute to perinatal brain injury, alterations in 
cerebral blood flow (CBF) are believed to play a significant role due to the immaturity of 
the cerebral vascular system and complications associated with premature birth, such as 
poor cardiac and lung function, which can impede blood flow and oxygenation [4]. In 
addition, changes in brain tissue metabolism are likely to precede structural abnormalities 
associated with injury [5]. In term infants, metabolite ratios measured by magnetic 
resonance (MR) spectroscopy have shown high accuracy in predicting adverse 
neurodevelopmental outcome [6,7] and have potential in guiding clinical management. 
Despite this, applications of MR methods for routine brain monitoring are clearly 
impractical. Cranial ultrasound remains the first-line option in the neonatal intensive care 
unit (NICU), particularly for monitoring intraventricular haemorrhage. However, 
ultrasound is used to detect brain damage that has already occurred, rather than detecting 
pathophysiological events that are indicative of oncoming injury. This speaks to the need 
for bedside methods capable of detecting CBF and metabolic fluctuations which could act 
as prognostic markers of brain injury.  
Advancements in biomedical optics have provided cost-effective alternatives for 
monitoring the brain with the aim of detecting hemodynamic/metabolic events that may 
precede brain injury. In particular, near-infrared spectroscopy (NIRS) – a safe, quantitative, 
and portable technology – is widely used to obtain estimates of cerebral oxygen saturation 
(StO2), which has been used as a surrogate marker of CBF in the clinic [8]. NIRS can also 
directly measure CBF, either by dynamic contrast-enhanced (DCE) methods [9,10], or by 
diffuse correlation spectroscopy (DCS). DCS has been extensively validated against other 
perfusion techniques and it has the advantage of providing continuous monitoring [11].  
The combination of NIRS and DCS has the potential to further enhance brain monitoring 
by combining flow and oxygenation measurements to determine the cerebral metabolic 
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rate of oxygen (CMRO2) [8,12–15], which is a more sensitive marker of tissue viability 
[16]. Consequently, monitoring CMRO2 could help identify clinically significant changes 
in CBF considering the fact that only flow reductions large enough to exhaust the 
compensatory increase in oxygen extraction will have an impact on energy metabolism [9]. 
However, a potential challenge with continuous monitoring of CMRO2 is that it requires 
the combination of a number of parameters: CBF, StO2, and arterial oxygen saturation 
(SaO2) – which have proven challenging to measure during asphyxia [16]. Furthermore, 
CMRO2 computation relies on assuming a fixed arteriovenous blood volume ratio, which 
may vary under pathological conditions [17–19].  
A direct measure of cerebral energy metabolism can be obtained by measuring changes in 
the oxidation state of cytochrome c oxidase (CCO) – a key element in oxidative metabolism 
– which is directly related to mitochondrial ATP production [20]. CCO is the terminal 
electron acceptor in the electron transport chain (ETC): the final stage of oxidative 
metabolism. A unique copper dimer (Copper A) in the enzyme has an absorption peak 
around 835 nm in its oxidized form (oxCCO), but not in its reduced state. A change in the 
redox state represents a change in oxidative cellular metabolism. To accurately resolve 
changes in oxCCO, many wavelengths (broadband) are required as the concentration of 
CCO is 10% of the in vivo hemoglobin concentration. Previous studies have shown that 
broadband NIRS (B-NIRS) measured oxCCO changes are associated with acute changes 
in metabolism following hypoxia-ischemia (see Bale et al. for a detailed review [20]). As 
well, changes in oxCCO measured by B-NIRS showed strong correlation with measures of 
cellular metabolism from magnetic resonance spectroscopy [21] and microdialysis [22]. 
Simultaneous monitoring of perfusion and oxygen metabolism, through combining DCS 
and B-NIRS, could therefore provide a valuable tool for neuromonitoring in the NICU. 
This report presents the development a hybrid B-NIRS/DCS system for real-time 
monitoring of StO2, CBF, and ΔoxCCO. The ability of the instrument to capture dynamic 
oxygenation, blood flow, and metabolic changes was demonstrated in an animal model of 
neonatal hypoxia-ischemia that has been shown to cause rapid reductions in cerebral blood 





The light source of the B-NIRS subsystem, a 20 W halogen lamp (Ocean Optics Hl-2000-
HP), was high-pass filtered at 500 nm to remove ultraviolet light and directed towards the 
tissue by an optical fiber bundle (3.5 mm active diameter, 30-μm core, 0.55 numerical 
aperture). Light diffusely reflected from the tissue was collected with an identical fiber 
bundle, placed at 30 mm away from the emission probe (see Fig. 1), and directed to a 
custom-made spectrometer (iDus Andor camera, Oxford Instruments; 548-1085 nm 
bandwidth; 1.65 nm resolution; P&P Optica, ON, Canada). The light source of the DCS 
was a long coherence length, continuous-wave laser emitting at 785 nm (DL785-100s, 
CrystaLaser, NV) and was coupled into a 400-μm diameter fiber. Light from the tissue was 
collected with a few-mode fiber (SMF-28e+, 8 µm core; few-mode at 785 nm) placed 20 
mm from the DCS emission probe and coupled to a single-photon counting module 
(SPCM-AQR4C, Excelitas, QC, Canada). The output of the SPCM was fed into a correlator 
board (Flex033LQ-1, Correlator.com, NJ) to generate normalized intensity autocorrelation 
curves. Note that in some of the phantom experiments, a single-mode fiber (S630 Nufern, 
6 µm core) was used instead of the few-mode fiber. 
Operating the two subsystems simultaneously would result in significant crosstalk since 
the DCS laser is powerful enough to saturate the spectrometer’s CCD detector. As well, 
the presence of incoherent light from the broadband light source alters the autocorrelation 
curves acquired while the B-NIRS light is on. To avoid crosstalk, a shutter-based 
multiplexing approach was used to alternatively collect measurements from each 
subsystem (i.e., B-NIRS and DCS). Fig. 2.1 shows a schematic of the hybrid B-NIRS/DCS 
device. 
Optical fibers were discontinuous on the NIRS emission and detection ends, with shutters 
placed at these junctions. Signal loss was minimized by securing the probes in close 
proximity to the shutter, using an optical breadboard. A shutter was also placed in front of 
the DCS laser, and another in front of the single-photon counting module. The latter was 
equipped with a light collimator and a coupling lens to maximize the signal-to-noise ratio 
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(SNR). A dual DC power supply was used to operate the multiplexer: a high voltage (24 V) 
was sent to rapidly open the shutter, immediately followed by a lower voltage (10 V) to 
maintain the open state. These voltage values were chosen to minimize shutter blade 
transition time and digital modules (NI 9477, National Instruments, TX) were utilized to 
cycle between the voltage outputs. Opening and closing of the shutters were alternated to 
allow for sequential acquisition and were controlled using a field programmable gate array 
(FPGA) card (PCI-7811R, National Instruments). Digital modules (NI 9401, NI) were also 
used to control and monitor shutter states, which were synchronized by in-house software 
written in LabVIEW FPGA, as detailed in [23]. B-NIRS and DCS measurements were 
analyzed using a customized MATLAB script to yield cerebral oxygen saturation, 
perfusion, and metabolism. 
 
Figure 2.1: Simplified schematic of B-NIRS/DCS system with the shutter-based 
multiplexer. Red dots: B-NIRS emission and detection probes; blue dots: DCS 
emission and detection fibers. 
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2.3.2 System demonstration 
2.3.2.1 Phantom Experiments 
To investigate the potential impact of the B-NIRS light on the DCS measurements, 
autocorrelation curves were acquired while the broadband light source remained on. Data 
were collected on a liquid phantom consisting of a mixture of Intralipid and India ink that 
provided a reduced scattering coefficient of 1.0 mm-1 and an absorption coefficient of 0.01 
mm-1; values were chosen to mimic tissue based on previous reports [24]. In the first set of 
measurements, the emission probe of the B-NIRS was positioned 30 mm away from the 
detection fiber of the DCS system, and the level of light contamination experienced by the 
DCS was varied by modulating the intensity of the B-NIRS light using its built-in aperture. 
This test was repeated with a 10-mm distance between the B-NIRS emission probe and 
DCS detection fiber to further increase the intensity of B-NIRS light collected by the DCS 
system. 
2.3.2.2 Hypoxia-ischemia Model 
The ability of the hybrid B-NIRS/DCS device to monitor dynamic changes in CBF and 
oxCCO was demonstrated in an animal model of hypoxia-ischemia (HI) involving newborn 
piglets aged 10-40 hours. This model was chosen because it results in rapid changes in 
blood flow and oxygen supply to the brain [15]. Piglets were anesthetized under 3% 
isoflurane during preparatory surgery (2% post-surgery), tracheotomized, and 
mechanically ventilated on an oxygen-medical air mixture. Incisions were made lateral to 
the trachea and vascular occluders (In Vivo Metric, CA) were placed around the carotid 
arteries posterior to the clavicle. Catheters were inserted into an ear vein for injections and 
into a femoral artery to monitor vitals (SurgiVet, Smiths Medical, MN), as well as to collect 
arterial blood samples for gas and glucose analyses. Arterial oxygen saturation (SaO2) was 
measured via a pulse oximeter attached to the piglet’s right forelimb. Piglets were placed 
in the prone position and the B-NIRS and DCS probes were secured to the left side of the 
head, avoiding the sagittal sinus, using an in-house 3D-printed probe holder. 
HI insult was induced by first inflating the occluders around the carotid arteries, followed 
by reducing the inspired oxygen from 21% to 8%. B-NIRS and DCS data were acquired 
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continuously throughout the insult, starting 5 minutes prior to carotid clamping to acquire 
baseline measurements. The real-time DCS blood flow index was used to confirm 
successful clamping, i.e., an immediate drop in CBF. Following this confirmation, inspired 
oxygen concentration was reduced and the HI insult was maintained for a minimum 
duration of 10 minutes once the blood flow index reached its nadir. At the end of the HI 
insult, recovery was initiated by deflating the carotid occluders and returning oxygen 
supply to baseline levels. Two control animals experienced identical procedures, excluding 
inflation of the occluders and reduction in inspired oxygen, to confirm the stability of the 
optical measurements during the experiment. 
The continuous recording of B-NIRS and DCS data were set on a 14-s cycle. That is, 12 B-
NIRS spectra were acquired over 3 s, followed by 2 DCS measurements over the following 
10 s, with a 0.5-s delay both preceding and following each technique. Data were 
continuously saved and imported into MATLAB for real-time update of the DCS blood 
flow index and relative oxCCO. The final step in the experiment was to calibrate the DCS 
data by measuring absolute CBF with DCE-NIRS following the 90-minute recovery (i.e., 
post HI insult) period [25]. The DCE-NIRS protocol consisted of a bolus injection of 
indocyanine green (ICG, 0.1 mg/kg) into a cannulated vein. The passage of ICG through 
the brain was captured by continuously recording B-NIRS data at a temporal resolution of 
400 ms. The time-varying arterial ICG concentration was concomitantly measured by a 
dye densitometer (DDG 2001, Nihon Kohden, Japan) attached to a front paw.  
This study was approved by the Animal Use Subcommittee of the Canadian Council on 
Animal Care at Western University (London, Ontario). 
2.3.3 Data Processing 
2.3.3.1 Quantification of Tissue Chromophore Concentrations and 
StO2 
2.3.3.1.1 Broadband Fitting for Absolute Concentrations 
Before the start of each study, the spectrometer was wavelength calibrated using a neon 
light source and a dark-noise signal was also acquired. Thereafter, a reference spectrum 
was acquired – using a pinhole attenuator, which provided uniform attenuation while 
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avoiding detector saturation – to account for the spectral properties of the light source and 
the spectrometer. A de-noising algorithm was subsequently applied to the data to reduce 
the measurement noise as described previously [26]. The baseline reflectance spectrum 
R(λ) was then computed from the spectrum measured on the piglet’s head, the dark-noise 
signal of the spectrometer, and the reference spectrum as follows: 




The 1st and 2nd derivative of R(λ) was fit to the 1st and 2nd derivatives of the solution to the 
diffusion approximation for a semi-infinite homogenous medium (i.e., the theoretical 
model) [10], characterized by the reduced scattering (µs′) and absorption (µa) coefficients, 
described respectively in equations (2.2) and (2.3) [27]: 
 𝜇𝑠






where α is the scattering power, characterizing the wavelength dependence of the µs′, and 
A is the µs′ value at a wavelength λ= 800 nm (in our analysis, but can be any wavelength 
in the range where Eq. 2.2 is valid). 
 𝜇𝑎(𝜆) = 𝑊𝐹 ∙ 𝜀𝐻2𝑂(𝜆) + 𝐻𝑏
𝑏 ∙ 𝜀𝐻𝑏(𝜆) + 𝐻𝑏𝑂2
𝑏 ∙ 𝜀𝐻𝑏𝑂2(𝜆) (2.3) 
where WF is the tissue water fraction, ε is the extinction coefficient of the corresponding 
chromophore, and Hbb and HbO2
b are respectively the baseline concentrations of 
deoxyhemoglobin and oxyhemoglobin in µM. CCO was not included in the baseline 
analysis due to its relatively small concentration and lack of features in the derivative 
spectra.  
The baseline reflectance spectrum was analyzed using a three-step, multi-parameter fitting 
algorithm, based on a constrained least-square minimization algorithm built with a custom 
MATLAB function (fminsearchbnd) [10]. Firstly, the second-derivative of the reflectance 
spectrum R(λ) was fit to the 2nd derivative of the theoretical model between 815 and 845 
nm to obtain the tissue water fraction (WF). Although the fitting yielded estimates for all 
the parameters listed in Table 2.1, we only consider WF to be reliably estimated from this 
step because it has been previously shown that the 2nd derivative of the scattering 
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coefficient and the other tissue chromophores do not have significant contribution in this 
wavelength range [28]. Using the value of WF obtained in the first step as a known 
parameter, the 2nd derivative fit was performed from 680 to 800 nm to obtain Hbb. The 
WF and Hbb values were then used as known parameters in the fitting of the first derivative 
of R(λ) from 680 to 845 nm to determine HbO2
b, A, and α [10,26,28]. The upper and lower 
bounds, as well as the initial values of the parameters used in the fitting routine are given 
in Table 2.1. 
Table 2-1: Initial values, lower and upper bounds of the fitting parameters. 





WF 0.8 0.6 0.95 
Hbb(g/dL) 10 0 60 
HbO2
b(g/dL) 40 0 80 
A (mm-1) 1 0 1.3 
 2.7 0.6 4.0 
Baseline tissue oxygen saturation (StO2








2.3.3.1.2 Derivative Spectroscopy for Differential Concentrations 
Once the baseline StO2 was quantified, a modified Beer-Lambert Law approach was used 
to analyze the complete set of B-NIRS spectra as it is considerably faster than the derivative 
fitting which takes 84 ± 17 s per spectrum on an i7-4700MQ 2.40 GHz processor. The 
UCLn algorithm was used to quantify changes in Hb, HbO2, and oxCCO concentrations 
(units: µM) from changes in attenuation across 770-900 nm [29], using a dynamic 
pathlength calculated by fitting the 2nd derivative of R(λ) to the second derivative of the 
water absorption spectra [28] and correcting for the wavelength dependence of the 
pathlength [30]. Tissue oxygen saturation at each time point was determined by combining 
the relative changes derived from the values obtained with the UCLn algorithm with the 









where ΔHbO2 and ΔHb represent the relative changes in oxy/deoxy-hemoglobin. 
2.3.3.2 Quantifying CBF 
DCS data were analyzed by fitting the measured electric field autocorrelation function to a 
solution to the diffusion approximation for a semi-infinite homogeneous medium [10]. 
Fitting was performed using the known source-detector distance (20 mm) and values of µa 
and µs′ at 785 nm obtained from the B-NIRS analysis. Time varying changes in µa were 
used along with the baseline µs′ [25] to fit the dynamic data. The fitting of the 
autocorrelation curves yielded the correlation factor (β) and the blood flow index (BFi) 
[25].  
For the DCE-NIRS analysis, CBF was quantified by relating the time-varying arterial 
concentration of ICG, Ca(t), to the corresponding brain concentration curve, Cb(t), using 
the following equation [31]: 
 𝐶𝑏(𝑡) = 𝐶𝐵𝐹 ∙ 𝑅(𝑡) ∗ 𝐶𝑎(𝑡) (2.6) 
where R(t) is the impulse residue function and * refers to the convolution operation. The 
product CBF • R(t) was extracted using a deconvolution algorithm [32], from which CBF 
was determined by the initial value since R(t) by definition begins at a value of one. The 
CBF measurement was then used to convert the DCS BFi time series into physiological 
blood flow units (i.e., ml/100g/min) [25]. 
2.3.4 Error Analysis 
Monte Carlo simulations were conducted to assess the accuracy of the 3-step, multi-
parameter fitting approach. Simulated spectra were generated using the semi-infinite 
solution to the diffusion approximation with values of Hbb and HbO2
b that corresponded to 
an StO2 = 75.5% (all input parameters are given in Table 2.2). Poisson noise was added at 
each wavelength, and the fitting routine used to obtain best-fit estimates of the 
5 parameters. The same initial values and boundary conditions given in Table 2.1 were 
used. Simulations were run 500 times to generate a distribution of estimates for each fitting 
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parameter. As well, the entire analysis was repeated by averaging spectra over 8 to 512 
repetitions to estimate the precision of the fitting parameters over a range of SNR.   
2.3.5 Statistical Analysis 
For the tissue phantom experiments, the influence of the NIRS broadband source on the 
estimated diffusion coefficients was tested using a Student’s t-test.  
For the HI experiments, individual CBF time series, from each animal, were normalized to 
their corresponding baseline values. Thereafter, ten CBF values were extracted by dividing 
the normalized time series into bins of successive 10% reductions in flow and averaging 
within these bins. The corresponding oxCCO concentration changes were obtained for each 
CBF interval. A multivariate ANOVA was conducted to determine which oxCCO values 
were significantly different from baseline. The same approach was also applied to 
investigate the relationship between CBF and StO2 during HI. 
2.4 Results 
2.4.1 Instrumentation 
The experiments conducted with the tissue-mimicking phantoms showed a significant 
effect of the broadband light source on the autocorrelation curves. Fig. 2.2 presents curves 
acquired with the B-NIRS emission probe at 10 mm away from the DCS detection, along 
with the corresponding best fit to the diffusion approximation. Note that a single-mode 
fiber was used in this test to provide a wide dynamic range for the correlation factor, β. 




Figure 2.2: Autocorrelation functions (blue symbols) acquired with (a) DCS alone, 
and (b) DCS in the presence of light from the B-NIRS source (10 mm). The red lines 
in both figures are the best fit to the diffusion approximation. 
As expected at this short distance between the B-NIRS emission and DCS detection, the 
high intensity of incoherent light from the broadband source significantly reduced the SNR 
of the acquired autocorrelation functions and the correlation factor β (y-intercept). The use 
of a few-mode fiber in this test would produce even lower β values, by allowing the 
propagation of more modes of light. A significant difference in the derived diffusion 
coefficient was found between the two curves: 1.56 ± 0.05×10-8 cm2/s (DCS alone) and 
1.82 ± 0.30×10-8 cm2/s (with broadband light source on) (p < 0.01). The broadband light 
source also affected the estimated β value when using a few-mode fiber with a distance of 
30 mm as shown in Fig. 2.3, A. However, in contrast to the data acquired at 10 mm, the 
broadband light contamination did not significantly affect the values of the derived 
diffusion coefficient when the B-NIRS emission probe was 30 mm away from DCS 




Figure 2.3: (A) DCS autocorrelation curves with B-NIRS light (30 mm from DCS 
detection) at varying intensities, (B) diffusion coefficient values without (blue) and 
with (red) the B-NIRS light; data were averaged over 10 acquisitions, error bars 
represent standard deviation. 
To demonstrate the robustness of the B-NIRS multi-parameter fitting, the algorithm 
described was used to estimate the 5 fitting parameters from spectra of varying SNR 
(obtained by averaging a varying number of spectra). The parameters obtained by fitting a 
low SNR spectrum (obtained from one simulated spectrum with added Poisson noise, as 
described above) and one high SNR spectrum (obtained by averaging 512 spectra low SNR 
spectra) are displayed in Table 2.2, along with the resulting StO2 value. Note that the mean 
and standard deviation displayed in Table 2. 2 were obtained by repeating the simulations 
500 times (i.e., Monte Carlo type approach). 
Table 2-2: Monte Carlo simulation of B-NIRS fitting algorithm. 
Simulation parameter Input Values 1 acquisition 512 averages 
WF 0.8 0.71 ± 0.13 0.80 ± 0.04 
Hbb(g/dL) 13 12.0 ± 3.3 12.9 ± 0.6 
HbO2
b(g/dL) 40 36.2 ± 9.4 39.8 ± 1.7 
A (mm-1) 0.8 0.93 ± 0.23 0.81 ± 0.04 
 2.6 2.6 ± 0.3 2.6 ± 0.03 
StO2 (%) 75.5 75.0 ± 3.9 75.5 ± 0.2 
StO2 values obtained by using a varying number of averaged spectra are displayed in Fig. 




Figure 2.4: Estimation of StO2 from simulated spectra of varying SNR (obtained by 
varying the number of averaged spectra). The circles represent the mean and the 
error bars are the standard deviation over 500 repetitions for each set of averaged 
spectra. 
2.4.2 Hypoxia-ischemia Insult 
Experiments were conducted on eight piglets (2 female, mean age = 25 ± 10 h, 
weight = 1.6 ± 0.3 kg). Of these, control experiments involving no HI insult were 
conducted on two animals. Table 3 displays the average baseline values across all animals 
for all 5 fitting parameters, cerebral oxygen saturation, and perfusion. 
Table 2-3: Baseline fitting parameters, StO2, and CBF. 
Parameter Baseline value 
WF 0.78 ± 0.02 
Hbb(g/dL) 18 ± 3 
HbO2
b(g/dL) 35 ± 13 
A (mm-1) 0.35 ± 0.11 
 3.3 ± 0.5 
StO2 (%) 64 ± 13 
CBF (ml/100g/min) 28 ± 7 
B-NIRS spectra recorded at baseline and during the peak of HI insult are shown in 
Fig. 2.5, A). An attenuation difference, calculated as the log of the ratio between these 
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spectra, is displayed in black in Fig. 2.5 B. The fit of the attenuation by the concentrations 
recovered from the Beer-Lambert algorithm are shown in blue and red. The blue curve 
represents the fit of HbO2 and Hb (2-component model), while the red line represents the 
fit of HbO2, Hb, and oxCCO (3-component model). It is clear that the addition of oxCCO 
to the model improved the fitting; this is further demonstrated in Fig. 5, C which shows 
residuals between measured and modelled attenuation. The 3-component model has a 
smaller residual, randomly distributed around 0, whereas, the 2-component model had a 
residual centered on a peak around 820 nm. This suggests that there is a missing 
chromophore in the model with a peak at 820 nm, which is very similar to the oxCCO 
difference spectrum [20]. 
 
Figure 2.5: Broadband NIRS analysis showing (A) raw intensity measurements at 
baseline and during HI insult, (B) attenuation and best fit of the 2- (Hb and HbO2) 
and 3-component models (Hb, HbO2, and oxCCO), and (C) and residuals between 




A 5-s DCS acquisition period provided sufficient SNR with adequate temporal resolution 
to discern physiological changes caused by HI. Specifically, various DCS acquisition times 
were tested at baseline, and there was no statistically significant difference between the 
BFi obtained at 5 and 15 s acquisitions over 30 cycles (difference = 3.2%, p=0.42). DCS 
autocorrelation curves acquired at baseline, during HI insult, and following recovery are 
displayed in Fig. 2.6. The CBF values derived by calibrating each BFi were 35.2 ± 0.8 
ml/100g/min, 2.6 ± 0.1 ml/100g/min, and 32.5 ± 0.8 ml/100g/min respectively. 
 
Figure 2.6: DCS autocorrelation curves measured in one piglet during (A) baseline 
(CBF = 35.2 ± 0.8 ml/100g/min), (B) HI insult (CBF = 2.6 ± 0.1 ml/100g/min), and 
(C) following insult recovery (CBF = 32.5 ± 0.8 ml/100g/min). The red lines 
represent best fit to the diffusion approximation. 
Fig. 2.7 presents StO2, CBF, and oxCCO time courses for three HI piglets and one control. 
Region (i) in each graph corresponds to the brief period between inflating the carotid 
occluders and reducing the inspired oxygen content. The combination of both components 
of HI is represented by region (ii). For the controls, no significant changes in the any of the 
parameters were detected. While StO2 and CBF responded immediately to occluder 
inflation, oxCCO displayed a delayed response. As well, a continual reduction in oxCCO 





Figure 2.7: Simultaneous monitoring of StO2, absolute CBF, and oxCCO in 3 
hypoxia-ischemia (HI) animals (A, B, C) and a control piglet (D). The HI insult 
began with clamping the carotid arteries (region (i)), followed by inducing hypoxia 
by reducing the inspired oxygen fraction to 8% (region (ii)). 
To further investigate the temporal relationship between CBF and metabolism during HI, 
oxCCO and StO2 were separately correlated to incremental changes in CBF as described 
in section 2.3.5. Data presented in Fig. 2.8(A) and Fig. 2.8(B) show oxCCO and StO2, 
respectively, averaged across all animals and plotted against averaged changes in CBF 
normalized to baseline values. Due to the rapid and large initial reduction in CBF caused 
by carotid occlusion, the initial drop in CBF was greater than 40% in some experiments. 
Consequently, CBF intervals with mean values of 0.62 and 0.76 show only data from two 




Figure 2.8: Correlation plots of a) oxCCO vs CBF, and b) StO2 vs CBF; * indicates a 
significant change in either oxCCO or StO2 from baseline (p<0.05). Error bars 
represent the standard error of the mean. CBF intervals with mean values of 0.62 
and 0.76 show only data from two and one animals, respectively. 
2.5 Discussion 
In this article, we report on the development of a hybrid diffuse correlation spectroscopy 
(DCS) and broadband near-infrared spectroscopy (B-NIRS) instrument capable of 
simultaneous monitoring of cerebral blood flow (CBF) and changes in the oxidation state 
of cytochrome c oxidase (oxCCO). This was achieved using a simple shutter-based 
multiplexing method that allowed acquisition of DCS and B-NIRS measurements in quick 
succession, thereby avoiding crosstalk between the two subsystems.  
Although the importance of monitoring both CBF and metabolism has been long 
recognized, StO2 is still the most widely used marker of cerebral health in the clinic, despite 
its limited sensitivity to brain injury [8]. The lower sensitivity of StO2 is believed to be 
related, in part, to the inability to separate blood flow and metabolic effects [8,33]. 
Hemoglobin difference (Δ[HbDiff] = Δ[HbO2] - Δ[Hb]) has been used as a surrogate 
marker of CBF, but its relationship to flow also depends on oxygen metabolism [33]. 
Recent advancements have enabled direct CBF monitoring by DCS; however, monitoring 
CBF alone may not be sufficient to capture the interplay between substrate delivery and 
demand. To assess clinically significant changes in CBF, which could impact tissue 
viability, measures of metabolism have been recently investigated. Conversely, monitoring 
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CBF could help determine if metabolic reductions are due to limited oxygen delivery as 
opposed to changes in demand.  
The multiplexing approach presented here was necessary to avoid crosstalk between the B-
NIRS and DCS techniques as the DCS laser would saturate the B-NIRS detector if they are 
operated simultaneously. As well, when the broadband source is used concurrently with 
DCS measurements, the autocorrelation curves are altered, particularly at short distances 
between the B-NIRS emission probe and DCS detection fiber. Even when a single-mode 
DCS detection fiber was used, to maximize the dynamic range of the correlation factor, we 
found that with a 10 mm distance between the B-NIRS source and the DCS detection, 
incoherent light excited additional modes in the DCS fiber. This manifested as a much 
lower β value in the autocorrelation curves (Fig. 2.2) and resulted in a significantly 
different diffusion coefficient (p < 0.01), warranting the use of shutters. Fig. 2.3 A shows 
that increasing the B-NIRS light intensity decreases the correlation factor (y-intercept). 
However, the values of diffusion coefficients obtained by fitting the measured 
autocorrelation curves in Fig. 2.3 A with the solution to the diffusion equation for a semi-
infinite homogeneous medium [34] did not significantly differ, as shown in Fig. 2.3 B. This 
shows that at larger distances, the B-NIRS light affects the correlation factors of the 
autocorrelation curves but has no significant effect on the diffusion coefficient.  
The SNR can be further increased by reducing the sampling rate; lengthening the shutter 
cycle times allows for measures to be averaged over more acquisitions, but this would 
increase the time between successive measurements. In its current configuration, the hybrid 
B-NIRS/DCS device provided StO2, CBF, and oxCCO measurements every 14 s. This 
sampling rate could likely be increased to every 3-5 s using new technologies such as the 
DCS software correlator [35]. However, the speed of the current system was sufficient to 
capture the dynamics of the CBF and oxCCO responses to HI, and therefore will likely be 
sufficient for cerebral monitoring in the NICU.  
StO2 was monitored by a combination of a spectral derivative fitting approach to determine 
baseline StO2 and a faster linear algorithm based on the Beer-Lambert law to track 
subsequent changes in HbO2 and Hb concentrations. The reproducibility of the baseline 
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optical properties derived from the former was tested by conducting an error analysis 
involving Monte Carlo simulations. Fig. 2.4 and Table 2-2 demonstrate the ability of the 
fitting technique to extract parameter estimates with good precision and accuracy. These 
estimates were found to be insensitive to the boundary conditions and initial values used 
by the fitting routine (Table 2-1). Furthermore, the average baseline StO2 (64±13%) was 
in good agreement with a previous study (StO2 = 69±2%) involving the same animal model 
but using time-resolved NIRS to measure the optical properties [12]. Further validation 
studies are on-going to assess the accuracy of this technique over a wide range of StO2 
[36]; however, it is important to realize that the computational efficiency of the UCLn 
algorithm is extremely valuable for real-time monitoring in clinical applications.  
Source-detector distances of 3 cm for B-NIRS and 2 cm for DCS were chosen to probe the 
piglet brain because it has been shown that in reflectance geometry, the penetration depth 
is approximately the square root of the source-detector distance [37]. Considering that the 
thickness of the extra-cerebral layers in newborn piglets is 2-3 mm [23], the brain can be 
reliably probed using a source-detector distance of 2 cm or greater. Note that this approach 
has been previously validated against CT perfusion measurements in a neonatal piglet 
model [23]. In addition, the probe geometry depicted in Fig. 2.1 was designed to ensure 
that DCS and B-NIRS probed overlapping brain regions. It is important to note that the HI 
model causes global changes in cerebral blood flow and metabolism. Therefore, it is 
expected that small differences in the tissue volumes interrogated by the two instruments 
will not alter the relationship between the measured hemodynamic and metabolic changes. 
There have been a number of previous studies combining B-NIRS and DCS [38–40]; in 
particular Lee et al. recently presented a compact device for dual monitoring of tissue flaps. 
However, the greater source-detector distances required for brain monitoring limits the 
applicability of many of these approaches. Furthermore, a key novelty of our method is the 
ability to continuously monitor StO2, absolute blood flow, and oxCCO, which has not been 
previously reported. In terms of brain monitoring, a similar concept combining frequency-
domain NIRS (FD-NIRS) and DCS [41] was recently reported. This device is capable of 
simultaneous monitoring of StO2, CBF, and CMRO2, and has been used to investigate 
neonatal hemodynamics. Instead of a 785-nm laser, a DCS laser emitting at 850 nm was 
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used along with optical filters to prevent crosstalk between the two systems. An 850-nm 
laser is outside of the spectral range used for broadband analysis of hemoglobin 
concentration (680 to 845 nm), but more critically it is within the range of the CCO feature 
(780 to 900 nm). Although there are long coherence lasers operating at wavelengths lower 
than 680 nm, it is noteworthy that they have significantly lower power outputs. As well, 
above 900 nm, SPCM detectors commonly used in DCS systems have lower quantum 
efficiencies; both factors would reduce SNR. These limitations of current technology 
restrict the feasibility of using optical filters for concurrent monitoring of CBF and oxCCO. 
The HI piglet model produced rapid and dynamic changes in StO2, CBF, and oxCCO. More 
importantly, the experimental results clearly demonstrated the unique individual responses 
in oxygenation, flow, and metabolism (Fig. 2.7 and 2.8). These differences warrant the 
inclusion of all three measures in order to understand the broader physiological impact of 
HI. That is, StO2 and hemoglobin concentrations allow for monitoring of hypoxia, CBF 
dynamics indicate ischemia, and changes in oxCCO relate to metabolic stress. Together, 
these different perspectives describe the hemodynamic and metabolic environment that 
surrounds and precedes brain injury.  
In the 6 animals with HI injury, the decrease of oxCCO was delayed in comparison to CBF 
and continued to decline even after CBF and StO2 reached their nadirs. A similar biphasic 
relationship between oxCCO and HbDiff was found in piglets experiencing anoxia [42]. 
Group averages of time courses are not shown due to the temporal variability between 
clamping carotid arteries and reducing oxygen content. The timing of the latter varied 
because it was only executed once occluders were shown to produce a noticeable decrease 
in CBF. Nevertheless, time courses across all experiments showed the direct effect of 
decreased CBF on StO2 and a delayed oxCCO response. Reduced blood flow is likely met 
by increased oxygen extraction in order to maintain oxidative metabolism, which is 
consistent with previous reports between CBF and CMRO2 in piglets [33] and infants [9].  
This compensatory mechanism may explain the delayed oxCCO response. However, the 
relationship between oxidative metabolism and oxCCO is complex. Further investigation 
into the interrelationship between these values and their physiological significance in 




This article reports on the development of a novel optical system that combines DCS and 
B-NIRS to enable continuous monitoring of absolute cerebral blood flow and changes in 
the oxidation state of cytochrome c oxidase – two sensitive biomarkers of brain health. The 
combination of the two subsystems was achieved through the use of a simple multiplexing 
approach based on electromechanical shutters and can be easily implemented elsewhere. 
In addition, the ability to simultaneously monitor CBF and oxCCO has led to a key finding; 
that is, the response of cerebral oxygen metabolism is delayed in hypoxia-ischemia while 
the CBF response is instantaneous. We anticipate that real-time monitoring of absolute 
CBF and oxCCO will provide greater insights into hemodynamic events that precede brain 
injury and could become valuable for guiding therapeutic interventions. Furthermore, 
because the hybrid B-NIRS/DCS system is safe and portable, it could be easily deployed 
in the NICU to monitor cerebral perfusion and metabolism at the bedside in early stages 
following birth, with the goal of detecting significant hemodynamic events before brain 
injury occurs. 
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Chapter 3  
3 Perfusion and metabolic neuromonitoring during 
ventricular taps in infants with post-hemorrhagic 
ventricular dilatation 
This chapter has been adapted from the publication titled “Perfusion and metabolic 
neuromonitoring during ventricular taps in infants with post-hemorrhagic ventricular 
dilatation” published in Brain Sciences in 2020 by Ajay Rajaram, Lawrence C. M. Yip, 
Daniel Milej, Marianne Suwalski, Matthew Kewin, Marcus Lo, Jeffrey J. L. Carson, Victor 
Han, Soume Bhattacharya, Mamadou Diop, Sandrine de Ribaupierre, and Keith St. 
Lawrence, volume 10, issue 7. 
3.1 Abstract 
Post-hemorrhagic ventricular dilatation (PHVD) is characterized by a build-up of 
cerebrospinal fluid (CSF) in the ventricles, which increases intracranial pressure and 
compresses brain tissue. Clinical interventions (i.e., ventricular taps, VT) work to mitigate 
these complications through CSF drainage; however, the timing of these procedures 
remains imprecise. This study presents Neonatal NeuroMonitor (NNeMo), a portable 
optical device that combines broadband near-infrared spectroscopy (B-NIRS) and diffuse 
correlation spectroscopy (DCS) to provide simultaneous assessments of cerebral blood 
flow (CBF), tissue saturation (StO2), and the oxidation state of cytochrome c oxidase 
(oxCCO). In this study, NNeMo was used to monitor cerebral hemodynamics and 
metabolism in PHVD patients selected for a VT. Across multiple VTs in four patients, no 
significant changes were found in any of the three parameters: CBF increased by 14.6 ± 
37.6% (p = 0.09), StO2 by 1.9 ± 4.9% (p = 0.2), and oxCCO by 0.4 ± 0.6 µM (p = 0.09). 
However, removing outliers resulted in significant, but small, increases in CBF (6.0 ± 
7.7%) and oxCCO (0.1 ± 0.1 µM). The results of this study demonstrate NNeMo’s ability 
to provide safe, non-invasive measurements of cerebral perfusion and metabolism for 




Premature birth, defined as a gestational period less than 37 weeks, occurs in 8% of infants 
in Canada [1]. Those born with lower birthweights (<1500 g) are at an increased risk of 
neurological complications, including deficits in cognition and behaviour as well as a 
higher incidence of major motor disorders (e.g., cerebral palsy) [2]. The largest contributor 
to preterm brain injury is intraventricular hemorrhaging (IVH). The pathogenesis of IVH 
involves the combination of an immature cerebral vascular anatomy (i.e., a highly 
vascularized germinal matrix) and poor cerebral blood flow (CBF) regulation [3,4]. It is 
believed that IVH elicits an inflammatory response, followed by fibrosis and subsequent 
obstruction of cerebrospinal fluid (CSF) drainage [5]. This can lead to accumulation of 
CSF, increased intracranial pressure (ICP), and dilatation of the entire ventricular system, 
referred to as post-hemorrhagic ventricular dilatation (PHVD). 
PHVD is a major complication in severe cases of IVH (Grade III and higher), where more 
than 50% of the lateral ventricles are experiencing a bleed [6,7]. Due to a progressively 
increasing ICP, any delay in treatment can result in white matter atrophy and neurologic 
deterioration [4,8]. Cranial ultrasound (cUS) is the current gold standard in diagnosing and 
monitoring the progression of PHVD through ventricular measurements such as the 
ventricular index, anterior horn width, and thalamo-occipital distance [9]. Given these 
measures, there is still some debate over the timing of clinical intervention [10]. An early 
approach used by many European centres relies on ventricular measurements before 
patients are symptomatic. Intervention consists of a variety of techniques to drain CSF, 
including external ventricular drains (EVD), lumbar punctures (LP), and ventricular taps 
(VT), among others. [11]. In comparison, many North American centres employ a later 
approach where treatment is initiated depending on the ventricular index and clinical signs 
(e.g., increased ICP, head circumference, ventricle size, tense fontanelle, etc.) [12,13]; 
similar techniques are then implemented to drain CSF. 
The discrepancy in the timing of clinical intervention is largely due to a lack of adequate 
monitoring techniques to quantify PHVD progression and treatment efficacy. Recent work 
has elucidated the benefits of hemodynamic and metabolic neuromonitoring surrounding 
the development of PHVD [14,15]. These metrics have shown potential to act as prognostic 
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markers of PHVD symptoms and could better indicate when to implement CSF drainage 
strategies. Measurements of CBF by transcranial doppler (TCD) have proven robust in 
premature infants; however, continuous monitoring is not ideal as TCD is operator-
dependent and only measures macrovascular changes in blood flow [16,17]. Biomedical 
optics instead provide a safe, non-invasive technique ideal for longitudinal brain 
monitoring at the bedside [3,18–20]. 
This study presents an in-house built brain monitoring system referred to as NNeMo 
(Neonatal NeuroMonitor) that is capable of simultaneous measurement of cerebral 
perfusion, tissue saturation, and oxygen metabolism at the bedside through combining two 
optical techniques. Broadband near-infrared spectroscopy (B-NIRS) uses near-infrared 
light to measure absorption properties of tissue that can be used to estimate the 
concentrations of oxy and deoxyhemoglobin, from which the cerebral tissue saturation 
(StO2) can be calculated [21]. B-NIRS can also provide a direct measurement of cerebral 
metabolism by monitoring absorption changes in the oxidation state of cytochrome c 
oxidase (oxCCO), which is directly related to mitochondrial ATP production in the electron 
transport chain [22]. Diffuse correlation spectroscopy (DCS) is an emerging technique that 
provides continuous monitoring of CBF by analyzing dynamic light scatter from red blood 
cells [23]. DCS has been validated against multiple modalities, including dynamic contrast-
enhanced NIRS, Positron Emission Tomography with oxygen-15 (15O) labelled water, and 
Arterial spin labelling MRI [24–26]. NNeMo combines B-NIRS and DCS technology to 
simultaneously monitor CBF, StO2, and oxCCO. 
This study presents the clinical translation of NNeMo to monitor PHVD infants in the 
neonatal intensive care unit (NICU) undergoing CSF drainage via ventricular taps. 
Previous work using contrast-enhanced NIRS reported a small increase in CBF after the 
VT, but with no concurrent change in cerebral energy metabolism [14]. However, only 
single time-point measurements before and after the procedure were acquired due to the 
need to inject a contrast agent (indocyanine green). Here, we present continuous bedside 
monitoring of cerebral perfusion and metabolism in PHVD patients undergoing a VT, with 
the goal of assessing any potential treatment-related changes in CBF and oxCCO. Based 
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on the magnitude of CBF changes previously reported [14], it was hypothesized that CSF 
drainage would lead to a modest increase in CBF, but with minimal impact on oxCCO. 
3.3 Materials and Methods 
3.3.1 Patient Population 
This study was approved by the Western University Health Sciences Research Ethics 
Board (Project Identification Code: 17828), which adheres to the guidelines of the 
Canadian Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. 
Patients with PHVD were enrolled after obtaining parental consent. The initial IVH was 
diagnosed by cranial ultrasound (cUS) and graded according to the Papile scale [5]. The 
decision to perform a ventricular tap was based on standard of care, including clinical 
evidence (apnea, bradycardia, full fontanelles) and increased ventricle size as measured by 
cUS. 
3.3.2 Study Design 
Infants receiving a VT were monitored throughout the procedure with NNeMo 
(Figure 3.1 a). Prior to surgical setup, optical probes were placed on the infant’s scalp 
above the frontoparietal cortex and held in place by a custom-built probe holder 
(Figure 3.1b). Two optical probes (one for the B-NIRS and one for the DCS) delivered 
light to the scalp. Source power levels were maintained within ANSI standards for skin 
exposure. A common detection fiber bundle was used to collect diffusely reflected light 
that had propagated through the head. The DCS and B-NIRS systems collected light at 
source-detector distances (SDD) of 2 and 3 cm, respectively, to ensure adequate brain 
interrogation (Figure 3.1 c). As an additional precaution, a phototherapy eye shield was 









Figure 3.1: (a) Neonatal NeuroMonitor (NNeMo) combining broadband near-
infrared spectroscopy (B-NIRS) and diffuse correlation spectroscopy (DCS) 
techniques. (b) Optical fibers affixed to an infant’s head using a 3D-printed probe 
holder. A phototherapy eye shield was used as a safety precaution. (c) Optical fiber 
schematic showing two optical sources and a common detection fiber  
(SDD: DCS 2 cm; B-NIRS 3 cm). 
Following sterilization of the surgical site, a VT was performed by a pediatric 
neurosurgeon. A needle was inserted into the lateral ventricles (Figure 3.2 a) to allow for 
CSF drainage (Figure 3.2 b). Following sufficient CSF removal, as determined by the 
clinician, the needle was removed and gentle pressure was applied to the needle insertion 
site. Optical data were collected throughout the VT, extending a minimum of 10 min prior 
to and following the procedure. B-NIRS and DCS data were acquired sequentially at a 
sampling rate of 250 ms and each dataset was averaged to achieve a final temporal 







Figure 3.2: (a) Pediatric neurosurgeon inserting a needle into the ventricle and (b) 
draining cerebrospinal fluid (CSF) from the patient. Optical probes were affixed to 
the patient’s head throughout the procedure. 
3.3.3 Instrumentation 
NNeMo was constructed by combining B-NIRS and DCS modalities using a multiplexing 
shutter system controlled by custom software developed in LabView (2017 SP1, National 
Instruments, Austin, TX, USA) and MATLAB (R2018b, MathWorks, Natick, MI, USA) 
[27]. The acquisition times of both the B-NIRS and DCS were set to 250 ms (4 Hz). The 
shutter system cycled between the two subsystems in 3 s intervals. A total of 12 data points 
were acquired in each interval and averaged for both B-NIRS and DCS measurements. A 
0.5-s delay was added between the intervals to account for shutter transition times and to 
avoid overlap between the B-NIRS and DCS data. 
The B-NIRS light source was a 20-W halogen bulb (Hl-2000-HP, Ocean Optics, Delay 
Beach, FL, USA) that was filtered from 600 to 1000 nm and coupled into a custom optical 
fiber bundle (2.4 mm diameter, 30 µM core, 0.55 numerical aperture ((NA), Loptek, 
Berlin, Germany) that directed the light to the head. Light from the interrogated tissue was 
collected by 3 fiber bundles (2 mm diameter, 30 µm core, 0.55 NA, Loptek, Berlin, 
Germany) that were linearly aligned at the entrance of the spectrometer (iDus 420, Andor, 
Oxford Instruments, Abingdon, UK; 548–1085 nm bandwidth; 1.65 nm resolution; P&P 
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Optica, Waterloo, ON, Canada). For DCS, light from a long coherence laser (DL785-100s, 
CrystaLaser, Reno, NV, USA) was coupled into a fiber bundle (4 × 200 µm core diameter, 
0.22 NA, Loptek, Berlin, Germany) and directed towards the head. Light was collected by 
4 single-mode fibers (8 µm core diameter, 0.12 NA, Loptek, Berlin, Germany) and coupled 
to a four-channel single photon counting module (SPCM-AQR-15-FC, Excelitas 
Technologies, Montreal, QC, Canada). The output from each detector was fed into an edge-
detecting counter on a PCIe-6612 counter/timer data acquisition board (National 
Instruments) [28]. Photon counts were recorded and processed using in-house developed 
software (LabVIEW, MATLAB) [29]. For each detector, the software generated intensity 
autocorrelation curves at 50 delay times ranging from 1 µs to 1 ms. 
For use in the NICU, the optical fibers were designed to be lightweight and flexible, with 
a 90°bend at the patient end to further minimize weight on the infant. A 3D-printed fiber 
probe holder (5 × 2 × 1 cm; Flexible Resin, Form 2, Formlabs, Somerville, MA, USA) was 
designed to secure the three optical probes (2 emission, 1 detection) to the patient’s 
forehead using a soft and flexible base material with a non-abrasive strap (Figure 1 b). 
3.3.4 Data processing 
3.3.4.1 NIRS Analysis: Quantifying StO2 and Changes in oxCCO 
Concentration 
Prior to clinical measurements, a reference spectrum was acquired using a pinhole 
attenuator to characterize the spectral properties of the optical system. In addition, a 
measurement of the dark noise was acquired to characterize ambient light conditions. For 
the clinical NIRS data, each reflectance spectrum, R(λ), was corrected for the reference 
and dark count spectra as follows: 




where spectrum λ refers to the clinical measurement at wavelength λ. 
To quantify chromophore concentrations, while accounting for the contribution of light 
scatter, a derivative approach was utilized [18,30,31]. First and second derivatives of R(λ) 
were calculated and fit to the solution of the diffusion approximation for a semi-infinite 
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homogeneous medium [19]. Light absorption (Equation (3.2)) and scattering (Equation 
(3.3)) parameters were input into the solution as follows [30]: 
 𝜇𝑎(𝜆) = 𝑊𝐹 ∙ 𝜀𝐻2𝑂(𝜆) + 𝐻𝑏
𝑏 ∙ 𝜀𝐻𝑏(𝜆) + 𝐻𝑏𝑂2
𝑏 ∙ 𝜀𝐻𝑏𝑂2(𝜆) (3.2) 
where WF is the tissue water fraction, Hbb and HbO2
b are baseline concentrations of 
deoxyhemoglobin and oxyhemoglobin in µM, and ε refers to the unique extinction 
coefficient for each chromophore. 
 𝜇𝑠






where α is the scattering power and A is the μs′ value at λ = 800 nm. Reflectance spectra 
measured at baseline were analyzed with a multi-parameter fitting algorithm based on a 
constrained least-square minimization using a custom MATLAB function 
(fminsearchbnd). Briefly, second derivative R(λ) spectra were fit by the model between 
815 and 845 nm to obtain WF. The WF value was incorporated into the second derivative 
fit from 680 to 800 nm to determine Hbb. Lastly, WF and Hbb were used in the analysis of 
the first derivative spectrum. The fitting procedure extended from 680 to 845 nm to obtain 
an estimate of HbO2
b [30]. 
Following baseline analysis, a modified Beer–Lambert law based on the UCLn algorithm 
(Equation (4)) was used to calculate changes in hemoglobin and oxCCO concentrations 



















where ΔHbO2, ΔHb, and ΔoxCCO are relative changes from baseline in oxy-hemoglobin, 
deoxy-hemoglobin, and the oxidation state of cytochrome c oxidase. The differential 
pathlength (DP) was set to 4.39 based on previous literature [32,33] and corrected for the 
wavelength dependency of the pathlength [34]. ΔA represents the measured change in 
attenuation. Relative and baseline measures of hemoglobin were combined to determine 









3.3.4.2 DCS Analysis: Relative Measure of CBF 
Acquired normalized intensity autocorrelation data were converted to electric field 
autocorrelation data following the Siegert relation [35,36]: 





where g2(ρ,𝜏) is the measured normalized intensity autocorrelation, β is the coherence 
factor, G1(ρ,𝜏) is the electric field autocorrelation function, and <I(ρ,𝜏)> is the averaged 
detected intensity. The parameter ρ refers to the SDD and 𝜏 is the correlation time. G1 was 
modeled using the solution to the diffusion approximation for a semi-infinite homogenous 
medium and assuming the motion of light scatterers can be characterized by a pseudo-
Brownian motion [35,37,38]. Fitting was conducted for ρ = 2 cm and using the dynamic 
µa measurements obtained by B-NIRS. A constant value for μs′ of 8 cm−1 was used in 
accordance with recent literature [39]. Fitting each autocorrelation curve provided an index 
of cerebral blood flow (CBFi). 
3.3.5 Statistical Analysis 
All data are presented as mean ± standard deviation (range) unless otherwise noted. Since 
the tapping duration varied between procedures, the perfusion, oxygen saturation, and 
metabolic data collected for each VT were temporally normalized to the average tap 
duration to obtain mean time courses. For pre- and post-VT statistics, data were limited to 
two minutes prior to needle insertion and following needle removal to avoid motion 
artifacts. To assess the overall change in CBFi, StO2, and oxCCO due to a VT, a one-tailed 
paired t-test was used to compare pre- and post-VT measurements. Potential outliers were 
identified as points greater than q3 + w × (q3 − q1) or less than q1 – w × (q3 − q1) in the 
box plots, where w represents the whisker length and q indicates the quartile number. 
Statistics were repeated excluding any outliers. A matched pairs power analysis was 
conducted using the G*Power 3 software (v3.1.9.7, Düsseldorf, Germany) to calculate the 
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total sample size required to achieve significance [40]. Statistical significance was based 
on a p-value < 0.05; power was set to 0.8. 
3.4 Results 
Optical measurements were acquired during 14 ventricular taps across four patients (one 
female, three males, gestational age 25.0 to 37.6 weeks, mean = 29.2 ± 5.6 weeks). Data 
from four events were excluded due to excessive patient motion. A further three B-NIRS 
datasets were excluded due to ambient light contamination. DCS data acquired during these 
periods were not impacted and remained in the analysis. A total of 10 ventricular taps were 
analyzed for CBFi, and seven for StO2 and oxCCO. Clinical parameters are displayed in 
Table 3.1. 
Table 3-1: Clinical parameters for post-hemorrhagic ventricular dilatation (PHDV) 
patients. 
Gestational age at birth (weeks) 29.2 ± 5.6 (25–37 4/7) 
Birth weight (g) 1259.0 ± 746.7 (810–2376) 
Sex (n) F = 1, M = 3 
Apgar 1 min 3.8 (1–8) 
Number of VT performed (n) 7.8 (5–10) 
Age at first VT (weeks) 3.8 ± 2.1 (2.3–7) 
EVD (n) 2 
VP shunt (n) 3 
IVH Grade: Bilateral III 2 
IVH Grade: III (R)/ IV (L) 1 
IVH Grade: Bilateral IV 1 
EVD, external ventricular drain; VP ventriculoperitoneal; IVH, intraventricular hemorrhage. 
Infants were monitored continuously throughout the ventricular tap, spanning needle 
insertion and CSF drainage. Ventricular tap duration varied across the interventions with 
an average duration of 16.1 ± 7.7 min (range: 8.75 to 29.25 min). Average time courses of 
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CBFi, StO2, and oxCCO during the tapping procedure are displayed in Figure 3.3. 
 
Figure 3.3: Change in cerebral blood flow index (ΔCBFi, n = 10), tissue saturation 
(StO2, n = 7), and change in oxidation state of cytochrome c oxidase (ΔoxCCO, 
n = 7) averaged across multiple trials over the course of ventricular taps (VT). Data 
were temporally normalized to the averaged tap duration (16 min) and aligned to 
VT start and end points. Each time course is displayed with its standard error 
(shaded background). 
The grey shaded regions in Figure 3.3 surrounding the CSF drainage period represent the 
intervals used to calculate average pre- and post-VT values. Figure 3.4 presents the changes 
in CBFi and oxCCO relative to baseline and pre- and post-VT StO2 values. The outliers 
indicated on the plot borders corresponded to ΔCBFi changes of 122.0% and −25.0%, and 
ΔoxCCO of 1.7 µM. Averaged values are displayed in Table 3-2 along with t-test and 
power analysis results. Significance was not met for any of the parameters. Power analysis 
99 
 
indicated that sample sizes of 29 and 18 for ΔCBFi and ΔoxCCO, respectively, would be 
required to achieve significance. A significant increase was found for both ΔCBFi and 
ΔoxCCO if outliers were excluded. 
 
Figure 3.4: Boxplots showing changes in CBFi (a) and oxCCO (c) following 
ventricular tap and StO2 (b) before and after the tap. Results are based on the 
difference between pre- and post-VT measurements that were averaged over 2-min 
periods. Individual data points are displayed; outliers are indicated by the crosses 
on the borders and represent ΔCBFi values of 122% and −25% and ΔoxCCO of 1.7 
µM. 
Table 3-2: Average changes following VT relative to baseline, t-test, and power 
analysis. 
Statistical parameter ΔCBFi (%) ΔStO2 (%) ΔoxCCO (µM) 
Average change 14.6 ± 37.6 1.9 ± 4.9 0.4 ± 0.6 
p-value 0.09 0.20 0.09 
Required sample size for significance1 29 45 18 
Average change excluding outliers 6.0 ± 7.7 - 0.1 ± 0.1 
p-value excluding outliers 0.05 - 0.02 
3.5 Discussion 
The purpose of this study was to implement the recently developed Neonatal NeuroMonitor 
(NNeMo) to assess cerebral hemodynamics and metabolism during ventricular taps in 
patients with post-hemorrhagic ventricular dilatation. Compared with commercial NIRS 
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devices that focus on monitoring StO2, the goal of implementing NNeMo was to assess the 
direct impact of a VT on CBF, as measured by DCS, and cerebral oxygen metabolism, as 
determined by monitoring oxCCO with B-NIRS. Both methods provide continuous 
recordings, which enabled CBFi and oxCCO to be monitored throughout the tapping 
procedure (Figure 3.3). 
In hydrocephalus, decreases in cerebral perfusion are expected to precede changes in 
metabolism and clinical symptoms [41]. In agreement with this concept, reductions in CBF 
have been shown to impact metabolism only when CBF drops below a certain threshold 
[27,42]. During a VT, as the ventricle volume and ICP decrease, perfusion is expected to 
improve. The possibility of concurrent changes in metabolism would therefore depend on 
the extent to which CBF is improved by the VT. A large increase in oxCCO following a 
VT would suggest that the mitochondria were oxygen-limited prior to the procedure, 
implying that the intervention could have been performed earlier [43]. In this study, it was 
anticipated that a VT would improve CBF, but the magnitude of the perfusion increase 
would likely not be sufficient to have an effect on oxCCO. Following 10 VTs, a non-
significant increase was found in ΔCBFi (14.6 ± 37.6%, p = 0.09) and ΔoxCCO 
(0.4 ± 0.6 µM, p = 0.09), while little change was observed in ΔStO2 (1.9 ± 4.9%, p = 0.2). 
Power analysis indicated that achieving significance for these relatively small increases 
would require a sample size of 29 for ΔCBFi and 18 for ΔoxCCO. Removing the outliers 
in the ΔCBFi (n = 2) and ΔoxCCO (n = 1) datasets did result in significant increases in 
both parameters; however, the average changes remained small (6.0 ± 7.7% for ΔCBFi and 
0.1 ± 0.1 µM for ΔoxCCO). 
Several studies have investigated the potential impact of CSF drainage on cerebral 
hemodynamics in PHVD patients. An increase in CBF velocity was found by Doppler 
ultrasound across seven patients [44], and stable oxCCO, as measured by NIRS, in 
23 infants receiving a VT or lumbar puncture (LP) [45]. In an earlier study, Casaer et al. 
reported that oxCCO increased in infants with grade 3 or 4 IVH who received an LP if 
patients had clinical signs of elevated ICP (i.e., increased head circumference, bulged 
fontanel, n = 4), but not if these symptoms were absent (n = 4) [46,47]. Similarly, elevated 
cerebral oxygenation has been reported during cerebrospinal fluid removal, which was 
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interpreted as evidence of increased CBF [45,48,49]. Previous work by our group measured 
absolute CBF and the cerebral metabolic rate of oxygen (CMRO2) before and following a 
VT using dynamic contrast-enhanced NIRS [14]. A significant increase in CBF (15.6%) 
across 20 VTs was found with no change in CMRO2. In general, evidence of increased 
CBF following CSF removal has been consistent across studies. The lack of a metabolic 
response can be explained by the modest perfusion increase, indicating that the reduction 
in CBF prior to the VT was not sufficient to impede oxygen delivery [18,31]. The results 
of the current study complement these findings as the average increases in CBFi and 
oxCCO were small and only reached significance after removing outliers. It is important 
to note that the technologies used across studies to monitor cerebral perfusion and oxygen 
metabolism are quite different, yet the findings are similar. 
Compared with McLachlan et al. [14], the use of the hybrid B-NIRS/DCS system had the 
advantages of not requiring an injection of an exogenous contrast agent to assess cerebral 
perfusion and metabolism and providing continuous monitoring of these parameters 
throughout the tapping procedure. The combination of B-NIRS and DCS in NNeMo was 
achieved using a multiplexing shutter system to prevent crosstalk between the two 
techniques. The intensity of the light from the DCS laser is large enough to easily saturate 
the B-NIRS spectrometer, which impedes its ability to detect the relatively small spectral 
features of oxCCO. Conversely, broadband light from the B-NIRS light source is highly 
incoherent, which can degrade the temporal correlation of dynamic light scattering used by 
DCS to measure CBFi [50]. These issues can be overcome by cycling data acquisition 
between the two techniques. In this study, a sample rate of 4 Hz for both systems with an 
overall cycling time of 7 s was considered sufficient, given the procedure was between 10 
to 30 min in duration. It should be noted, however, that the multiplexing shutter system has 
the flexibility to achieve higher temporal resolutions if required. Both systems are capable 
of sampling rates up to 10 Hz, which could be used for instance to capture blood flow 
pulsatility [28]. The minimum cycling time would be on the order of 300 ms, accounting 
for shutter opening and closing times of less than 50 ms [51]. Alternately, truly 
simultaneous measurements could be achieved using optical filters to selectively block B-
NIRS and DCS light sources from the opposing detectors. Recent works describing hybrid 
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B-NIRS/DCS and time-resolved NIRS/DCS systems utilizing bandpass and notch filters 
have been proposed [50,52,53]. 
In this clinical application, the two major sources of signal contamination were motion 
artifacts and ambient light. Maintaining adequate probe contact with the scalp was 
challenging on infants with PHVD as the head is distended due to the enlarged ventricles. 
As CSF is drained during a VT, head circumference decreases, which can loosen the straps 
holding the probes to the head. To mitigate this issue, the probes were placed on the 
forehead above the frontoparietal cortex, where there is minimal change in head 
circumference. In addition, the elastic property of the strap used to hold the probes in place 
helped maintain good contact throughout the procedure. To minimize motion artifacts, an 
NICU nurse gently restrained the patient’s head during the VT. Other sources of motion 
were the repositioning of the infant in the cot for needle insertion and the application of 
pressure to the head after the needle was retracted (Figure 3.2). As a result, data analysis 
was limited to 2-min windows immediately prior to and following the VT. This short period 
prevented monitoring for possible long-term changes after the VT, despite NNeMo’s 
measurement stability over extended durations [27]. In three experiments, subjects were 
located in an environment with excessive ambient light, as reflected by greater dark count 
measurements acquired by B-NIRS. Since oxCCO only contributes approximately 10% of 
the total spectral signal [22], it was necessary to remove B-NIRS datasets in which the dark 
count was deemed excessive. In contrast, ambient light did not have the same impact on 
the DCS measurements due to the stronger intensity of the laser and therefore these datasets 
were included in the analysis. 
Another potential source of error with optical neuromonitoring methods is the effect of 
scalp contamination. The influence of the scalp is considerably less in infants compared 
with adults, and within this study its effects were mitigated using appropriate source-
detector distances for B-NIRS (SDD = 3 cm) and DCS (SDD = 2 cm) [54]. An additional 
source of signal contamination unique to hydrocephalus is possible light loss in the 
enlarged ventricle as the cortical mantle becomes increasingly thin. Our group 
demonstrated that this effect could distort absorption spectra as the thickness of the cortical 
mantle approaches 1 cm [14]. This likely did not have a significant effect on the CBFi 
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measurements since the SDD was 2 cm. The NIRS spectra were, however, acquired with 
SDD = 3 cm, which would increase the chance of light loss in the ventricles. The excellent 
agreement in mean baseline StO2 values from the current and previous study – 58.4 ± 9.7% 
compared to 58.9 ± 2.7% from reference [14] – indicates that cortical thickness did not 
have a significant effect. 
Future work will investigate a potential correlation of hemodynamic changes with 
subsequent markers of brain injury. Comparison to clinical outcomes has the potential to 
establish clinical thresholds of perfusion/metabolic change and could aid in describing VT 
efficacy or in gauging brain injury severity during the progression of PHVD. 
3.6 Conclusion 
In summary, this feasibility study presents an optical system capable of providing real-time 
monitoring of cerebral perfusion and oxygen metabolism in the NICU. In this application, 
cerebral blood flow and metabolic changes monitored throughout VTs were small and only 
reached significance after removing outliers. These results are in good agreement with 
previous studies. Considering that the hybrid optical system is portable and completely 
non-invasive, it is well suited for neuromonitoring in PHVD patients who may be suspected 
of larger cerebral hemodynamic changes based on clinical symptoms. 
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Chapter 4  
4 Monitoring cerebral hemodynamic, oxygenation and 
metabolic stability in premature infants following birth 
using a hybrid broadband NIRS/DCS optical brain 
monitor 
This chapter features unpublished work in preparation for submission by Ajay Rajaram, 
Daniel Milej, Lilian Kebaya, Matthew Kewin, Lawrence C. M. Yip, Marianne Suwalski, 
Sandrine de Ribaupierre, Soume Bhattacharya, Mamadou Diop, and Keith St. Lawrence. 
4.1 Introduction 
As the perinatal period is a time of rapid neurodevelopment, a shortened gestation leaves 
an immature and fragile cerebrovascular system vulnerable to damage that can lead to long-
term cognitive dysfunction or life-long disability [1]. Premature birth is defined as a 
gestational age (GA) less than 37 weeks and has shown to strongly correlate with the 
development of adverse neurological outcomes, such as cognitive and behavioural deficits, 
and more severe disorders, such as cerebral palsy. [2–4]. The duration of gestation and an 
infant’s weight at birth are factors that influence the likelihood of adverse effects. Clinical 
management (e.g. thermoregulation, respiratory management, etc.) during the first few 
days following birth have proven critical in improving short and long-term outcome [5,6]. 
A common brain injury associated with preterm birth is intraventricular hemorrhaging 
(IVH), which is characterized by bleeding in the germinal matrix and surrounding white 
matter. IVH has been found to occur in 20-25% of preterms born with very low birth 
weights (VLBW, <1500 g) and most commonly appears within the first 72 hours following 
birth [7]. The pathogenesis behind IVH is multifactorial. However, contributing factors 
include an unstable cerebral blood flow (CBF), resulting from an underdeveloped 
cerebrovascular system, and having a limited ability to adequately perfuse distal white-
matter regions [8]. This is exacerbated by the absence of intact cerebral autoregulation 
(CA; i.e., the ability to maintain constant CBF during changes in blood pressure). In 
addition, the premature brain likely has a minimal tolerance to reductions in CBF due to 
the lower basal values compared to adults [9]. Diagnosis of IVH is achieved through 
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imaging with cranial ultrasound (cUS) to visually assess and grade cerebral hemorrhages 
at the bedside. In most centers, standard practice calls for imaging within the first week of 
life and again within the first month [10]. A major drawback is that cUS is not a prognostic 
technique as it can only indicate damage that has already occurred.  
Recent work has demonstrated the value of optical devices to non-invasively monitor 
physiological precursors of brain injury. Near-infrared spectroscopy (NIRS) utilizes light 
in the near-infrared spectral range to determine cerebral tissue saturation (StO2) by 
quantifying hemoglobin concentrations. Commercial NIRS devices have been utilized to 
demonstrate the value of StO2 as a biomarker of cerebral hemodynamic stability in the 
premature brain [11–14]. Notably, the SafeBoosC Phase II randomized clinical trial found 
that neuromonitoring using NIRS within the first 72 hours resulted in a significantly 
reduced burden of hypoxia [15]. While StO2 has become an accessible and robust marker 
of cerebral oxygenation, the development of diffuse correlation spectroscopy (DCS) offers 
a non-invasive approach to directly monitor CBF [16]. The index of cerebral blood flow 
(CBFi) obtained by DCS has been validated against numerous gold-standard techniques, 
such as arterial spin labelling MRI [17–21] and transcranial doppler ultrasound [22], and it 
has proven useful in monitoring neonatal populations during various developmental stages 
and clinical interventions. For example, CBF has been monitored in preterm infants during 
the first six weeks of life and has shown to positively correlate with postmenstrual age 
[23,24].  
A measure of cerebral hemodynamics alone is likely insufficient for describing the risk of 
injury since sufficient oxygen delivery can be maintained despite fluctuations in CBF due 
to compensatory changes in the oxygen extraction fraction (OEF) [25,26]. If changes in 
CBF are significant or persistent enough to exceed this compensatory mechanism, the 
cerebral energy metabolism will be negatively impacted. Substantial drops in metabolism 
often lead to cell death and subsequent tissue damage [27]. Recent work using broadband 
NIRS (B-NIRS) to quantify light absorption over the NIR spectrum has allowed for robust 
measurements of cytochrome c oxidase (CCO), a direct marker of cerebral oxidative 
metabolism [28]. CCO is an enzyme in the mitochondria’s electron transport chain vital to 
cellular energy production through oxidative phosphorylation. In the final step of this 
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process, CCO becomes oxidized, which contributes to an electrochemical gradient driving 
energy production. Similar to hemoglobin, changes in light absorption from the oxidation 
state of CCO (oxCCO) can be quantified by B-NIRS. Changes in oxCCO during anoxia 
events have shown to correlate severity of injury in animal models [29] and, in term infants 
with hypoxic-ischemic encephalopathy, oxCCO has shown indicative of outcome [30]. 
NNeMo (Neonatal NeuroMonitor) is an in-house built hybrid B-NIRS/DCS device capable 
of continuous bedside monitoring of cerebral perfusion and metabolism, via the marker 
oxCCO. With a concurrent measure of metabolism, more physiological context can be 
given to CBF monitoring by describing both oxygen supply and its impact on utilization. 
This study aims to demonstrate NNeMo’s ability to characterize CBF and metabolic 
stability within the first 72 hours of life in infants with an increased risk of developing IVH 
(i.e., < 32 weeks GA and/or weighing < 1500 g). It is hypothesized that only significant 
changes in CBF will impact metabolism. With a simultaneous acquisition of perfusion and 
metabolism, the interrelationship of these metrics can be investigated and could provide 
insight on hemodynamic instability during early brain development, the presence/absence 
of CA, and potential links to the onset of IVH. 
4.2 Materials and Methods 
4.2.1 Patient Population 
This study was approved by the Western University Health Sciences Research Ethics 
Board, which adheres to the guidelines of the Canadian Tri-Council Policy Statement: 
Ethical Conduct for Research Involving Humans. Subjects recruitment for this study was 
conducted in the neonatal intensive care unit at the Children’s Hospital, London Health 
Sciences Center. Following parental consent, infants born less than 32 weeks GA and/or 
weighing less than 1500 g were enrolled in the study and monitored for two six-hour 
periods within the first 72-hours of life. The first period was conducted as soon as clinically 
feasible following birth and resuscitation and the second at 48 hours post-natal age (PNA). 
During each monitoring period, cUS was performed to diagnose cerebral hemorrhaging, 
which was graded according to the Papile scale [31]. 
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4.2.2 Study Design 
Once transferred to the NICU from the birthing suite, following acquisition of vitals by 
nursing staff, the optical probes were secured to the scalp above the frontoparietal cortex 
using a 3-D printed probe holder and adjustable strap (Figure 4.1, A). The optical fibers 
were bent 90° at the point of contact on the head for ease of use, and the optical prober 
holder was designed to be light, flexible and non-abrasive (Figure 4.1, B; 5×2×1 cm; 
Flexible Resin, Form 2, Formlabs, Somerville, MA, USA). The design of the probe holder 
enabled it to be used with infants requiring ventilation with continuous positive airway 
pressure (CPAP) as it could be positioned under the CPAP cap and tube. The infant’s eyes 
were shielded using phototherapy eye goggles as a precaution. Two optical fibers (B-NIRS 
and DCS sources) directed light to the head, while a third (common detection) collected 
diffusely reflected light. The source-detector distance (SDD) was 3 cm for B-NIRS and 
2 cm for DCS. A smaller distance was chosen for DCS as it is inherently more sensitive to 
the brain [32]. Light source power levels and spot size incident on the scalp were adjusted 
to meet ANSI standards for skin exposure. Following the monitoring period, the probe 
holder was removed and the skin immediately under was assessed for redness or irritation. 
This workflow was repeated for the second day monitoring session. 
 
Figure 4.1: A) Premature infant with optical probes secured to the forehead and 
phototherapy eye shield, B) schematic of probe holder with NIRS (3-cm SDD) and 
DCS (2-cm SDD) optical fibers with the common detection fiber shaded; probe 




NNeMo is a multimodal optical device that combines B-NIRS and DCS. It incorporates a 
multiplexing shuttering system to cycle between acquisitions from the two subsystems; the 
details are described elsewhere [33,34]. For this study, NIRS and DCS data were each 
acquired at sampling frequency of 4 Hz in consecutive 3-s intervals, resulting in full data 
sets every 7 s (with a 0.5-s dead-time between techniques). For B-NIRS, a 20-W halogen 
bulb (Hl-2000-HP, Ocean Optics, Delay Beach, FL, USA), filtered from 600 to 1000 nm, 
and a spectrometer (iDus 420, Andor, Oxford Instruments, Abingdon, UK; 548–1085 nm 
bandwidth; 1.65 nm resolution; P&P Optica, Waterloo, ON, Canada) were employed. An 
optical fiber bundle (2.4 mm diameter, 30 µM core, 0.55 numerical aperture (NA), Loptek, 
Berlin, Germany) directed light towards the subject, while a second set of fibers (three 
linearly aligned 2 mm diameter fibers, 30 µm core, 0.55 NA, Loptek, Berlin, Germany) 
collected light interrogating tissue. The DCS light source was a long-coherence laser 
(DL785-100s, CrystaLaser, Reno, NV, USA) and a four-channel single-photon counting 
module (SPCM-AQR-15-FC, Excelitas Technologies, Montreal, QC, Canada) was used 
for detection. A DCS emission fiber (4 × 200 µm core diameter, 0.22 NA, Loptek, Berlin, 
Germany) and a single-mode detection fiber (8 µm core diameter, 0.12 NA, Loptek, Berlin, 
Germany) directed light towards and collected light from the scalp. A PCIe-6612 data 
acquisition board collected the SPCM output which was processed using in-house 
developed software (LabVIEW, MATLAB) [35,36]. 
4.2.4 Data Analysis 
4.2.4.1 Quantifying StO2 and ΔoxCCO by B-NIRS 
Each monitoring period began by measuring a dark signal, which was determined by taking 
a measurement with the emission source turned off. A reference measurement was 
collected prior to monitoring to characterize the spectral properties of the instrumentation. 
The reference spectrum and the dark signal measurement were incorporated into the 
analysis of measured light reflectance spectra. A derivative spectroscopy approach was 
applied to reflectance spectra to quantify hemoglobin and water concentrations, while 
accounting for light scatter contributions [26,37]. The first and second derivatives of 
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reflectance spectra were fit to a solution of the diffusion approximation for a semi-infinite 
homogeneous medium. A multi-parameter minimization fitting algorithm was utilized to 
estimate the tissue water fraction, hemoglobin concentrations (oxy-, HbO2, and deoxy-
hemoglobin, Hb), and optical properties [38]. Baseline cerebral tissue oxygen saturation 
(StO2







A modified Beer-Lambert Law approach based on the UCLn algorithm was utilized to 
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where Δ denotes a change relative to baseline concentration, DP is the differential 
pathlength (set to 4.9 based on previous literature [39,40]), ε is the molar extinction 
coefficient of each chromophore, and A is the measured change in attenuation. Changes in 
hemoglobin were calibrated using absolute values measured at baseline with the derivative 
approach to provide continuous quantification of StO2. Metabolic changes were 
represented by absolute changes in the concentration of oxCCO. 
4.2.4.2 Monitoring CBF by DCS 
To determine the cerebral blood flow index (CBFi), measured normalized intensity 
autocorrelation data were converted to electric field autocorrelation data using the Siegert 
relation [16,41]: 





where g2(ρ,τ) represents the measured normalized intensity autocorrelation as a function 
of SDD and time (ρ,τ), G1(ρ,τ) is the electric field autocorrelation function, <I(ρ,τ)> is the 
average intensity, and β is the coherence factor. G1 was fit with the solution to the diffusion 
approximation for a semi-infinite homogenous medium while assuming pseudo-Brownian 
motion of light scatterers [42,43]. The fitting was performed by incorporating changes in 
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the absorption coefficient determined by B-NIRS and a constant scattering coefficient of 
8 cm-1 [44]. All CBFi estimates were normalized to their respective baseline value to 
generate a time series of relative changes in CBF. 
4.2.5 Data Post-processing and Statistical Analysis 
Time courses of StO2, CBFi, and oxCCO were filtered as a function of frequency using an 
inverse wavelet transform with a Morlet wavelet (cwt MATLAB function) [45–47]. This 
approach has been applied for time-frequency analysis of similar patient populations 
[48,49]. To isolate relevant physiological frequencies, high (f > 0.01 Hz) and low 
(f < 0.001 Hz) frequencies were removed. Next, time courses for each parameter were 
corrected for motion artifacts using an algorithm utilizing a moving standard deviation and 
spline interpolation [50,51].  
Absolute StO2 measures as well as the standard deviation of CBFi and oxCCO values were 
compared across day one and day three monitoring periods. The relationship between 
saturation and perfusion was investigated to assess differences between these metabolic 
markers. Both StO2 and CBFi were also compared to oxCCO measures to characterize the 
impact of hemodynamic changes on metabolism. Comparisons were made by analyzing 
correlations between CBFi/StO2, CBFi/oxCCO, and StO2/oxCCO and calculating 
coherence and semblance across the frequency range (0.001-0.01 Hz). A measure of 
coherence characterizes the strength of the relationship between variables, ranging from 
0 to 1, while semblance describes the phase difference, ranging from -1 (antiphase) to 1 (in 
phase) [48]. Coherence and semblance for all three combinations of optical measures were 
compared across patients for both monitoring periods.  
For data displayed in boxplots, statistical outliers were determined as points greater than 
q3 + w × (q3 − q1) or less than q1 – w × (q3 − q1) where q is the quartile number and w is 
the whisker length. All data are presented as mean ± standard deviation (range) unless 
otherwise noted. Statistical analyses were conducted using a statistical toolbox (MATLAB) 
and significance was defined as p < 0.05. A paired t-test was used to investigate differences 
in measurements across days. In addition, regression analysis was conducted to assess the 
relationships between CBFi, StO2 and oxCCO within a single day. A one-way repeated-
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measures analysis of variance was used to investigate differences in average coherence and 
semblance values obtained from data measured in each subject across both monitoring 
periods. 
4.3 Results 
Optical data were acquired in nine infants on the first and third days of life (6 male, 
3 female, GA 28 ± 2 weeks, range: 24 weeks, 5 days to 31 weeks, one day). The first 
monitoring period began on average at 5.9 ± 6.2 hours after birth (range: 1 to 18 hours) and 
the second at 53.8 ± 8.2 hours (range: 44.5 to 61 hours). Data from the first subject were 
excluded due to excessive ambient light that resulted in substantial signal artifacts. For 
subsequent acquisitions, the optical probes were covered at the site of contact using a thin 
blanket to reduce signal from ambient light. This was confirmed by quantifying the 
spectrometer’s intensity output with the light source turned off. Data from the remaining 
eight infants are reported in this work. Optical data acquired during significant patient 
handling (e.g. vital signs, patient repositioning) or clinical intervention (e.g. x-ray, US 
imaging) were omitted to avoid motion artifacts. On average, 233 ± 68 minutes 
(range: 145 to 340 minutes) of data were analyzed on day one and 254 ± 36 minutes 
(range: 210 to 290 minutes) on day three. Clinical parameters of patients enrolled are 
displayed in Table 4-1. 
Table 4-1: Patient demographics and clinical metrics. 
Gestational age at birth (weeks + days) 28 ± 2 (24+5 – 31+1) 
Birth weight (g) 1123 ± 344 
Sex (n) 5 M; 3 F 
Apgar score 5 min 6.4 ± 3.2 (1 – 9) 
Apgar score 10 min 8.3 ± 1.0 (7 – 9) 
Monitoring start time on day 1 (hours) 5.9 ± 6.2 (1 – 18) 
IVH diagnosis (n, grade) 1, Grade II right/Grade I left 
Optical parameters (StO2, ΔCBFi, and ΔoxCCO) were analyzed over the duration of the 
monitoring period. An example of time courses obtained from one patient are displayed in 
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Figure 4.2. In this dataset, a clear discrepancy is noted between CBFi values during the 
first and third day of life. Large fluctuations in ΔCBFi were found during the first 
monitoring period compared to the second. For StO2 and ΔoxCCO time courses, smaller 
differences were observed across days. 
 
Figure 4.2: Cerebral tissue saturation (StO2), change in cerebral blood flow index 
(ΔCBFi), and change in oxidation state of cytochrome c oxidase (ΔoxCCO) of a 
subject on the first (A) and third (B) day of life. 
To illustrate the stability of time courses obtained in all subjects, absolute StO2 and the 
standard deviation of ΔCBFi and ΔoxCCO across both days are presented in Figure 4.3. 
Mean StO2 was 73.9 ± 11.6% on the first day of life and 79.7 ± 5.9% on the third day. For 
relative ΔCBFi and ΔoxCCO measures, the standard deviation of time courses across 
monitoring periods were found to decrease from 11.5 to 7.9% and 0.7 to 0.5 µM, 
respectively; however, these changes were not statistically significant. While a trend is 
apparent in StO2 and σCBFi values across days, much smaller changes were observed in 
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σoxCCO. As oxCCO is measured as an absolute change, it is necessary to provide context 
to characterize the extent of these fluctuations. 
 
Figure 4.3: StO2, standard deviation of ΔCBFi , and standard deviation of ΔoxCCO 
during day 1 and day 3; statistical outliers are indicated by +. 
For each subject, time courses of optical metrics were analyzed using an inverse wavelet 
transform to describe prevalent frequencies over the monitoring period. Figure 4.4 depicts 
the heat maps for the same infant featured in Figure 4.2. A notable frequency band around 
0.004 Hz was apparent in the CBFi data on day 1 and is highlighted for illustration 
purposes only. By day 3, this oscillation was no longer present. A similar but less 
pronounced effect was observed in the StO2 data that also dissipated by day 3. No 
oscillations were evident in the corresponding oxCCO data. 
Figures 4.5 and 4.6 display the coherence and semblance between optical parameters for 
the same subject featured above. In both cases, there was notable coherence and semblance 





Figure 4.4: Frequency analysis of cerebral tissue saturation (StO2), cerebral blood 
flow index (CBFi), and oxidation state of cytochrome c oxidase (oxCCO) on the first 
(A) and third (B) day of life for one subject. The highlighted region isolates a 
notable frequency band. 
 
Figure 4.5: Coherence of cerebral tissue saturation (StO2), cerebral blood flow index 
(CBFi), and oxidation state of cytochrome c oxidase (oxCCO) on the first (A) and 




Figure 4.6: Semblance of cerebral tissue saturation (StO2), cerebral blood flow index 
(CBFi), and oxidation state of cytochrome c oxidase (oxCCO) on the first (A) and 
third (B) day of life for one subject. 
Coherence and semblance measurements across all subjects are depicted in boxplots in 
Figure 4.7. A significant difference was found between coherence of CBFi/StO2 compared 
to coherence of CBFi/oxCCO on day 1. Semblance of CBFi/StO2 was significantly 
different from the two semblances that included the metabolic marker oxCCO (i.e., 




Figure 4.7: Boxplot showing coherence and semblance in all parameters across both 
measurement days; statistical outliers are indicated by +. 
4.4 Discussion 
This study demonstrated the ability to monitor cerebral perfusion and metabolism 
concurrently in preterms infants within the first critical 72 h of life. Numerous practical 
challenges exist in monitoring premature infants so soon after birth. First, many births that 
occur at this gestation are sudden or emergencies, which poses a challenge for patient 
recruitment and obtaining consent. Clinical and research teams must communicate closely 
to identify potential study participants and commence monitoring. Infants admitted to the 
NICU are not only at risk of adverse neurological development, many have complications 
with respiration, circulation, temperature control, or a number of other potential ailments, 
which all require some form of intervention. As such, the period immediately following 
birth has many events likely to produce artifacts in optical data from ambient light or 
motion (e.g. phototherapy, imaging, patient handling). While each infant in this study was 
monitored for 6 hours at a time, only 65% and 70% of the data sets on average were usable 
on days one and three, respectively.  
NNeMo provided continuous measures of StO2, CBFi, and oxCCO. These metrics each 
provide a different perspective in terms of characterizing early brain development. Work 
by Kissak et al. monitored OEF using NIRS in VLBW infants during the first three post-
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natal days and reported significant fluctuations in OEF in infants with IVH [52]. However, 
NIRS measurements of StO2 and OEF alone have shown limited use as surrogate markers 
of cerebral metabolism [53]. For example, a study monitoring premature infants following 
administration of indomethacin (vasoconstrictor) for treatment of patent ductus arteriosus 
found statistically significant decreases in CBF and corresponding significant increases in 
the OEF. Despite these changes, no notable difference in cerebral metabolism was reported 
[25]. It is therefore more useful to combine NIRS measures of oxygen content with CBF 
and metabolic information to provide a more wholistic understanding of hemodynamic 
fluctuations and their impact on energy production. A study by Noori et al monitored StO2 
using NIRS and CBF with Doppler ultrasound in extremely premature infants during the 
first three days of life [54]. This work reported a lower StO2 and an increased OEF in 
infants who developed IVH compared to those who did not. The IVH group also 
experienced a notable difference in cerebral hemodynamics; a fluctuating CBF was 
observed and attributed to a hypoperfusion-reperfusion cycle that preceded the onset of 
hemorrhaging. By adding a measure of metabolism, the impact of these fluctuations in CBF 
could be further investigated and related to tissue viability and potential injury. 
In our study, a large range of StO2 values as well as an increased standard deviation of 
CBFi was found during the first day of life compared to the third (Figure 4.3). Much 
smaller changes were observed in the standard deviation of oxCCO across the monitoring 
periods. This implies that hemodynamic fluctuations were not significant enough to impede 
energy metabolism. To place the oxCCO measure in context, animal experiments 
conducted in adult rats estimate that the absolute concentration of CCO to be between 
4.5 and 5.5 µM [27,55]. As metabolism in this animal model is higher than in humans, this 
value should be considered an upper limit [28]. Furthermore, the total concentration of 
CCO in neonates is likely less than the adult brain. Compared to the 0.7 µM standard 
deviation in oxCCO observed on day much larger changes in oxCCO have been observed 
in animal models prior to hypoxic ischemic injury [34] and following seizures in term 
infants [56].  
Frequency analysis using an inverse wavelet transform was implemented to characterize 
the stability of optical parameters. Frequencies were limited between 0.001 – 0.01 Hz to 
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isolate physiologically relevant signals [48,49]. Figure 4.4 illustrates the data from one 
patient. For this infant, a consistent oscillation in CBFi and StO2 was observed only on day 
one. By day three, a change in frequency components in this signal (i.e., a more balanced 
distribution of fast and slow frequencies) left no disenable pattern. No prevailing frequency 
was observed for metabolic measures. This observation was made for several subjects in 
the study, as reflected in Figure 4.3. 
To compare the interrelationship between saturation, perfusion, and metabolism, the 
coherence and semblance for each pair was calculated. Figures 4.5 and 4.6 depict these 
relationships for the same subject featured in Figure 4.2. Analyzing these metrics over all 
subjects resulted in a significantly different coherence of CBFi/StO2 (Figure 4.7, A) from 
CBFi/oxCCO on day one. Similarly, CBFi/StO2 semblance was significantly higher than 
CBFi/oxCCO and StO2/oxCCO relationships on both monitoring periods (Figure 4.7, B). 
In the healthy brain, a distinction between CBF and metabolic measures is expected, as 
metabolism is heavily regulated and is largely independent [57]. A measure of metabolic 
reactivity therefore has the potential to better characterize the impact of impaired CA on 
the preterm brain. This relationship was shown to predict outcome in term infants with 
hypoxic-ischemic encephalopathy as validated by metabolic measures of Lac/NAA levels, 
using magnetic resonance spectroscopy, and a one-year neurodevelopmental outcome 
check [48]. Within premature infants, CA is known to be frequently impaired; however, in 
this work no significant relationship between metabolism and other optical measures was 
observed, implying sufficient energy production. Fluctuations in StO2 and CBF had a 
negligible influence on oxCCO measures.  
In this study, only one subject was diagnosed with IVH and this scan took place prior to 
optical monitoring on day 1. Due to this timing and the small sample size, no distinction 
could be made between hemodynamic/metabolic instability and the onset of a bleed. In 
addition, this study is limited in the amount of time monitored. Data from approximately 
four hours was compared on the first and third day of life. Since CBFi is a relative measure 
and oxCCO represents a change in concentration, trends in flow and metabolism could not 
be compared across monitoring periods. Instead, data analysis focused on comparing the 
standard deviations, as a marker of stability, within each monitoring period. Future work 
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seeks to monitor changes continuously for the first 72 hours of life to better characterize 
changes over this entire period. While frequency analysis provided valuable insight to the 
relationship between hemodynamics and metabolism, a larger cohort is required to 
determine if changes in oxCCO can be linked to IVH. Furthermore, NNeMo does not 
provide any spatial resolution, having only a single B-NIRS/DCS interrogation site, and 
therefore can only infer local changes. The one subject diagnosed with IVH experienced a 
bilateral bleed (Grade II, right, Grade I, left). With the current system, discerning any 
difference in hemodynamics across these two sites is not possible. Additional source-
detector pairs could allow for hemispheric/regional monitoring. 
4.5 Conclusion 
This study demonstrates the feasibility of simultaneous bedside monitoring of cerebral 
perfusion and metabolism following premature birth using a hybrid optical system 
combining broadband-NIRS and DCS. Perfusion and metabolic stability on the first and 
third day of life was demonstrated using frequency analysis with an inverse wavelet 
transform. Prevalent oscillations in StO2 and ΔCBFi present on day one diminished by day 
three. No accompanying changes were noted in ΔoxCCO. Coherence and semblance 
analysis of optical parameters found a notable relationship between CBFi/StO2 only on the 
first day while measures of metabolism were independent. Monitoring dynamic changes in 
cerebral perfusion and its potential influence on metabolism could provide a clearer 
indication of the impact of autoregulation in the newborn brain, sufficient energy 
production, and tissue viability. Optical measures have potential as prognostic markers of 
tissue damage and timely detection of injury could allow for corrective patient management 
and improved clinical outcome. 
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Chapter 5  
5 Optical monitoring of cerebral perfusion and metabolism 
in adults during cardiac surgery with cardiopulmonary 
bypass 
This chapter has been adapted from the publication titled “Optical monitoring of cerebral 
perfusion and metabolism in adults during cardiac surgery with cardiopulmonary bypass” 
published in Biomedical Optics Express in 2020 by Ajay Rajaram, Daniel Milej, Marianne 
Suwalski, Lawrence C. M. Yip, Linrui R. Guo, Michael W. A. Chu, Jason Chui, Mamadou 
Diop, John M. Murkin, and Keith St. Lawrence, volume 11, issue 10. 
5.1 Abstract 
During cardiac surgery with cardiopulmonary bypass (CPB), adequate maintenance of 
cerebral blood flow (CBF) is vital in preventing postoperative neurological injury – i.e., 
stroke, delirium, cognitive impairment. Reductions in CBF large enough to impact cerebral 
energy metabolism can lead to tissue damage and subsequent brain injury. Current methods 
for neuromonitoring during surgery are limited. This study presents the clinical translation 
of a hybrid optical neuromonitor for continuous intraoperative monitoring of cerebral 
perfusion and metabolism in ten patients undergoing non-emergent cardiac surgery with 
non-pulsatile CPB. The optical system combines broadband near-infrared spectroscopy (B-
NIRS) to measure changes in the oxidation state of cytochrome c oxidase (oxCCO) – a 
direct marker of cellular energy metabolism – and diffuse correlation spectroscopy (DCS) 
to provide an index of cerebral blood flow (CBFi). As the heart was arrested and the CPB-
pump started, increases in CBFi (88.5 ± 125.7%) and significant decreases in oxCCO 
(−0.5 ± 0.2 µM) were observed; no changes were noted during transitions off CPB. Fifteen 
hypoperfusion events, defined as large and sustained reductions in CPB-pump flow rate, 
were identified across all patients and resulted in significant decreases in perfusion and 
metabolism when mean arterial pressure dropped to 30 mmHg or below. The maximum 
reduction in cerebral blood flow preceded the corresponding metabolic reduction by 
18.2 ± 15.0 s. Optical neuromonitoring provides a safe and non-invasive approach to 
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assessing intraoperative perfusion and metabolism and has potential in guiding patient 
management to prevent adverse clinical outcome. 
5.2 Introduction 
Cardiopulmonary bypass (CPB) has become a cornerstone of cardiac surgery since its 
introduction in the 1950s. By taking over the physiological functions of the heart and lungs, 
CPB provides surgeons with an operating field unobstructed by blood and free of cardiac 
motion; however, there are numerous postoperative neurological complications associated, 
including cognitive dysfunction [1–3], delirium, and stroke [4–6]. During CPB, procedural 
changes in pump flow rate and unplanned fluctuations in cardiac output can produce 
variations in cerebral blood flow (CBF) [7]. Given the high metabolic demands of the brain 
and its reliance on a continuous supply of oxygen, changes in CBF that are large enough 
to impact cerebral metabolism could lead to tissue damage and subsequent brain injury.  
There is currently no established method for intraoperative monitoring of CBF and cerebral 
metabolism during CPB. Traditionally, CBF was measured using Xenon-133, a 
discontinuous method that requires an invasive injection via the arterial circulation [8]. 
Transcranial Doppler (TCD) ultrasound has also been used to measure CBF in major 
cerebral arteries [9]; however, TCD embodies numerous drawbacks, including space 
limitations when utilizing a large transducer probe, inconsistent acoustic windows due to 
variations in thickness and porosity of the skull [10], and signal contamination from 
electrocautery used during surgery [11]. Optical techniques are becoming more prevalent 
for real-time monitoring due to their safety, low-cost, and ease of implementation [12]. 
Cerebral oximetry can continuously measure cerebral tissue saturation (StO2) during 
surgery and provides valuable insight into cerebral hemodynamics but has proven 
insufficient for monitoring oxygen utilization [13–15]. More advanced optical methods of 
neuromonitoring have demonstrated the ability to measure microcirculatory blood flow and 
cerebral metabolism continuously and noninvasively [16,17]. Broadband near-infrared 
spectroscopy (B-NIRS) provides a means of directly monitoring cerebral energy 
metabolism by measuring the oxidation state of cytochrome c oxidase (oxCCO). This 
enzyme is involved in the electron transport chain and is vital to energy production via 
oxidative phosphorylation [18]. In addition, diffuse correlation spectroscopy (DCS) 
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provides continuous CBF monitoring by tracking the temporal correlation of light scatter 
from red blood cells in the cerebral microvasculature [19–22]. 
This manuscript reports the clinical translation of a hybrid B-NIRS/DCS optical 
neuromonitor to provide non-invasive and continuous monitoring of CBF and oxCCO 
throughout cardiac surgery with CPB. The goal was to assess the system’s ability to 
identify fluctuations in perfusion and metabolism, while determining the efficacy of CPB 
in maintaining adequate oxygen supply and utilization. It was hypothesized that transitions 
on and off CPB would impact CBF, based on the CPB-pump flowrate (FRCPB) chosen, but 
fluctuations in flow would be insufficient to impact cerebral metabolism. It was also 
expected that significant operational changes in FRCPB, while patients were fully reliant on 
CPB, would directly influence cerebral hemodynamics, with large and sustained drops 
leading to metabolic change. 
5.3 Methods 
5.3.1 Patient Population 
This study was approved by the Western University Health Sciences Research Ethics 
Board, which adheres to the guidelines of the Tri-Council Policy Statement: Ethical 
Conduct for Research Involving Humans (REB #113650). After obtaining consent, patients 
admitted to University Hospital’s Cardiac Surgical Unit in London, Ontario, were 
monitored during non-emergent cardiac surgery with the use of non-pulsatile CPB. 
5.3.2 Clinical Monitoring 
Optical monitoring was conducted throughout surgery with CPB. Vital parameters were 
recorded with a clinical unit (Intellivue MX800, Philips Healthcare, MA, USA) and 
exported to the optical system. In accordance with clinical protocol, patients presenting 
with an increased risk of postoperative cognitive effects were monitored with EEG and a 
cerebral oximeter (SedLine®, Masimo, CA, USA). The optical probes were placed on the 
right temporal region of the forehead following anesthetic induction, endotracheal 
intubation, and placement of arterial and venous lines, but prior to skin incision. The probes 
were secured using a 3D-printed probe holder (Fig. 5.1a) and medical tape. Two optical 
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fibers delivered light from the DCS and B-NIRS sources onto the patient’s scalp. Diffusely 
reflected light was collected from a common detection fiber bundle that corresponded to 
source-detector distances (SDD) of 2 and 3 cm for DCS and B-NIRS, respectively (Fig. 
5.1b), to ensure adequate brain interrogation. Prior to monitoring, broadband light spectra 
were assessed to ensure negligible contamination from ambient light and the Masimo 
oximeter (< 5% signal contribution). Optical source power levels were maintained within 
ANSI limits for skin exposure. 
B-NIRS and DCS measurements were acquired sequentially in a period of 3 s each. Within 
each period, the integration time was 250 ms. A transition delay of 0.5 s was incorporated 
between techniques to account for shutter transition times, achieving a cycle time of 7 s. 
Data were continuously acquired during the entire surgical procedure, spanning the 
transition on and off the CPB machine. Prior to and following CPB, DCS data were 
acquired for a minimum of 10 seconds at an increased sampling rate (20 Hz) to capture 
pulsatile waveforms. 
 
Figure 5.1: A) Optical fiber probes and 3D-printed probe holder (5 × 2 × 1 cm) B) 
Schematic of the probe holder showing near-infrared spectroscopy (NIRS, 3-cm 
SDD) and diffuse correlation spectroscopy (DCS, 2-cm SDD) emission probes with a 
common detection probe 
5.3.3 Instrumentation 
The development of a hybrid B-NIRS/DCS system has been previously reported and 
demonstrated continuous monitoring of cerebral blood flow, cerebral oxygen saturation, 
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and metabolism in both animal models and infants in the neonatal intensive care unit [16-
17]. 
The system was constructed by combining B-NIRS and DCS modalities using a 
multiplexing shuttering system. The B-NIRS source (Hl-2000-HP, Ocean Optics, FL, 
USA) was coupled into a custom optical fiber bundle (2.4 mm diameter active area, 30 µM 
core, 0.55 numerical aperture (NA), Loptek, Germany) to guide light to the subject’s head. 
Light that interrogated the head was collected by a detection fiber bundle (2 mm diameter 
active area, 30 µm core, 0.55 NA, Loptek, Germany), and led to a custom-made 
spectrometer (548 to 1085 nm bandwidth; 1.65 nm resolution; P&P Optica, ON, Canada). 
Light from the DCS laser (DL785-100s, CrystaLaser, NV, USA) was similarly coupled 
into a fiber bundle (4 × 200 µm core diameter, 0.22 NA, Loptek, Germany) and directed 
towards the head. Diffusely reflected DCS light was collected with a bundle of four single-
mode fibers (8 µm core diameter, 0.12 NA, Loptek, Germany) coupled to a four-channel 
single-photon counting module (SPCM-AQR-15-FC, Excelitas Technologies, QC, 
Canada). The output of the detectors was sent to a data acquisition board (PCIe-6612, 
National Instruments, TX, USA) and processed by in-house developed software 
(LabVIEW, National Instruments, TX, USA; MATLAB, MathWorks, MI, USA) [23,24]. 
Intensity autocorrelation curves at 50 delay times, ranging from 1 μs to 1 ms, were 
generated for each detector. 
For use in the operating room, the fibers were shielded to prevent ambient light 
contamination from the bright surgical environment. The tips of the optical probes, in 
contact with the scalp, were bent 90 degrees to maintain a low profile and held in placed 
by a 3D-printed holder constructed from a lightweight, flexible material (5 × 2 × 1 cm; 
Flexible Resin, Form 2, Formlabs, MA, USA). 
5.3.4 Data Processing 
5.3.4.1 B-NIRS Quantification of Baseline StO2 
Prior to clinical monitoring, the spectral profile of the optical system was characterized by 
acquiring a reference measurement. Once the probes were positioned on the scalp, a dark 
count measurement was acquired while the light sources of the optical system were off. A 
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reflectance measurement R(λ) was determined by correcting for both reference and dark 
count measures as follows: 




where spectrumλ refers to the measured light intensity at wavelength λ. Reflectance data 
were analyzed by fitting the first and second derivatives of R(λ) to solutions of the diffusion 
approximation for a semi-infinite homogeneous medium [12,25,26]. As previously 
reported, the tissue water fraction, oxy- and deoxy-hemoglobin (HbO2, Hb) concentrations, 
and scattering parameters were estimated using a three-step multi-parameter fitting with a 
constrained minimization algorithm based on the MATLAB function fminsearchbnd 
[12,16,17]. Baseline tissue oxygen saturation (StO2








where the superscript b denotes baseline values. 
5.3.4.2 Monitoring StO2 and Absolute Change in Oxidative State of 
Cytochrome c oxidase 
Following a minimum five-minute baseline measurement, a modified Beer-Lambert Law 
based on the UCLn algorithm (Equation 3) was used to calculate changes in Hb, HbO2, 



















where ΔHbO2, ΔHb, and ΔoxCCO are the relative changes from baseline in oxy-
hemoglobin, deoxy-hemoglobin, and the oxidation state of cytochrome c oxidase, 
respectively. DP is the differential pathlength and ΔA is the measured change in 
attenuation. DP was set to 6.26, based on previous literature representing measurements in 
the adult head [27], and corrected for the wavelength dependency of the pathlength [28]. 
Relative measures determined by the modified Beer-Lambert approach were utilized in 
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conjunction with absolute baseline values from the derivative approach. This method 
provided absolute saturation values at faster computational speeds, allowing for real-time 







5.3.4.3 CBF Monitoring 
Acquired DCS intensity data were normalized, autocorrelated, and converted to electric 
field autocorrelation data following the Siegert relation [29,30]. Each autocorrelation 
function was fit with the solution to the diffusion approximation for a semi-infinite 
homogenous medium for SDD = 2 cm, dynamic µa measurements obtained by B-NIRS, 
and a constant value for μs
′ of 8 cm-1 [22]. Fitting resulted in an estimate of the cerebral 
blood flow index (CBFi). CBFi data were normalized to baseline values to represent 
relative changes [31]. 
5.3.5 Statistical Analysis 
All data are presented as mean ± standard deviation and statistical significance is defined 
as p < 0.05. CPB transition periods were defined as the minimum time to increase the CPB-
pump flow rate (FRCPB) from zero to values sustained throughout the procedure, and vice-
versa. To characterize this impact, data were averaged over 5-minute periods immediately 
surrounding CPB transitions and displayed in boxplots. An additional 5-minute period was 
analyzed 15 minutes into CPB and compared to baseline values. Outliers were defined as 
points greater than q3 + w × (q3 – q1) or less than q1 – w × (q3 – q1), where w represents 
the whisker length and q indicates quartile number. A two-tailed paired t-test was 
conducted to determine significance following the onset/end of CPB. Intraoperative 
hypoperfusion events were identified, defined as sudden and large decreases in FRCPB 
lasting a minimum of 30 s. Changes in optical parameters during these events were binned 
into 10-mmHg MAP intervals and plotted. A multivariate ANOVA was used to determine 
statistical significance in optical parameters compared to baseline values. For each 




Optical measurements were acquired in ten adult patients (nine male, one female, aged 
34 to 76 years, mean age = 58.1 ± 13.8 years). Data from the first three patients had to be 
excluded due to excessive ambient light from the bright surgical environment. Additional 
shielding, in the form of an optical blackout cloth (Thorlabs, NJ, USA), was implemented 
following these subjects to minimize artifacts from external light sources (< 5% signal 
contribution). Data from the fourth and seventh patients were limited to hypoperfusion 
events due to excessive motion during CPB transitions. The fourth subject experienced the 
onset of a bleed in the chest cavity resulting in a severely deteriorating condition and 
ultimately death. Remaining data sets were analyzed for changes in CBFi, StO2, and 
oxCCO. Table 5-1 displays patient demographics. 
Table 5-1: Demographic and procedural variables. 
Sex (n) F = 1, M= 6 
Age (year) 58.1 ± 13.8 
Duration of surgery (min) 409.4 ± 191.4 
Duration of CPB (min) 191.9 ± 177.3  
Procedure (n)  
- CABG  3 
- CABG + AVR  1 
- Aortic arch repair 1 
- Bentall 1 
- Bentall + MVR 1 
Patient death (n) 1 
CABG: Coronary artery bypass graft; AVR: Aortic valve replacement; MVR: Mitral 
valve replacement. Values are represented as mean ± standard deviation. 
Fig. 5.2 displays time courses from one patient during the transition on (Fig. 5.2 A) and off 
(Fig. 5.2 B) CPB; the FRCPB, mean arterial pressure (MAP), and optical measurements – 
ΔCBFi, StO2, and ΔoxCCO – are displayed. The FRCPB was measured by the CPB machine 




Figure 5.2: Cerebral hemodynamics during transition A) on cardiopulmonary 
bypass (CPB) and B) off CPB. Figure shows a continuous measure of CPB-pump 
flowrate (FRCPB), mean arterial pressure (MAP), change in the cerebral blood flow 
index (ΔCBFi), cerebral tissue saturation (StO2), and changes in the oxidation state 
of cytochrome c oxidase (ΔoxCCO). ΔCBFi scales are adjusted across plots for data 
visualization. 
As each patient was transitioned onto CPB, as indicated by the increase in the FRCPB, and 
the heart was arrested using a potassium solution, blood flow changed from a pulsatile to 
non-pulsatile state. This is apparent in the standard deviation of CBFi; pulsatile flow 
produced a larger range of values (Fig. 5.2 A < 8 min) compared to on-pump flow. The 
reverse effect was evident during the transition off CPB (Fig. 5.2 B > 10 min) as the heart 
was restarted. Averaged values across all subjects during pre-, on-, and post-CPB periods 
are displayed in Table 5-2. Data represented as a change (Δ) were acquired for 5-minute 
intervals immediately surrounding the transition on CPB, 15 minutes into CPB, and 
immediately surrounding the transition off CPB. CPB transitions are represented in 
boxplots in Fig. 5.3. The average transition time on CPB was 202 ± 111 s, and off CPB 
was 230 ± 160 s. During the on-CPB transition, subjects showed a notable increase in CBFi 
and a statistically significant decrease in MAP and ΔoxCCO. No significant change 
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persisted 15 minutes into CPB. Following CPB, MAP increased, while CBFi and ΔoxCCO 
displayed no significant change. StO2 remained stable throughout the procedure. 
Table 5-2: Hemodynamic parameters throughout cardiopulmonary bypass (CPB). 
Parameter Pre-CPB On-CPB Post-CPB 
tHb (g/L) 112.6 ± 20.8 85.0 ± 13.0* 111.8 ± 42.8 
pH 7.41 ± 0.06 7.33 ± 0.02* 7.38 ± 0.03 
PaCO2 (mmHg) 41.1 ± 3.9 35.3 ± 6.2 38.8 ± 1.5 
Temperature (ºC) 35.6 ± 0.4 33.6 ± 2.4 36.3 ± 0.5 
Parameter Transition on CPB Mid-CPB Transition off CPB 
ΔMAP (mmHg) -18.8 ± 11.3* -6.0 ± 9.5 11.0 ± 21.8 
ΔCBFi (%) 88.5 ± 125.7 51.9 ± 91.4 -3.3 ± 17.2 
ΔStO2 (%) 1.2 ± 5.2 -2.8 ± 5.7 1.4 ± 3.1 
ΔoxCCO (µM) -0.5 ± 0.2* -0.3 ± 0.5 0.2 ± 0.3 
tHb: total Hemoglobin, PaCO2: partial pressure of carbon dioxide. ‘Transition on CPB’ 
data were acquired as a change immediately surrounding CPB onset; ‘Mid CPB’ data 
were acquired 15 min following CPB onset and compared to pre-CPB data; ‘Transition 
off CPB’ data were acquired as a change immediately surrounding the end of CPB. Data 




Figure 5.3: Box plots showing average change across subjects during transitions 
onto the CPB pump (ON CPB) and off of the pump (OFF CPB). Absolute StO2 
values are shown for periods immediately before and after each transition. Data 
were averaged for 5-minute durations immediately surrounding the transition 
period; + indicates statistical outliers and * indicates a statistically significant 
difference across the transition. Average transition time on CPB was 202 ± 111 s, 
and off CPB was 230 ± 160 s. 
CBFi data were also acquired at increased acquisition rate (20 Hz) prior to and following 
CPB. Fig. 5.4 depicts fast blood flow monitoring in an aortic valve replacement (AVR) 
patient before (Fig. 5.4 A) and following (Fig. 5.4 B) replacement of the defective valve. 
The increased sampling rate allowed for depiction of pulsatile waveforms within the CBFi 
measure. Following AVR, the range of CBFi values increased for each ejection and a 
change in the shape of the secondary peak – which represents a change in pressure due to 
vascular elastic recoil following AV closure – became apparent, indicating a potential 




Figure 5.4: Pulsatile waveforms observed in cerebral microcirculation measured at 
20 Hz A) pre and B) post aortic valve replacement. 
Across the seven patient data sets, 15 hypoperfusion events, defined as large decreases in 
FRCPB (mean change 2.8 ± 1.4 L/min, 70.6 ± 28.8%) and lasting a minimum of 30 seconds 
in duration (mean duration 93.9 ± 52.5 s), were observed. Fig. 5.5 displays data acquired 
in subject four during a stable period (Fig. 5.5 A) and when experiencing successive drops 
in FRCPB (Fig. 5.5 B). With a stable FRCPB, no significant changes were detected in the 
optical parameters. In Fig. 5.5 B, the drop in ΔCBFi (~2.5-minute mark) coincides with the 
onset of a significant bleed during surgery. This event prompted immediate reductions in 
FRCPB to allow for surgical correction. MAP and optical measures were found to mirror 





Figure 5.5: Cerebral hemodynamics in subject 4 during A) a stable period and B) 
successive FRCPB-driven hypoperfusion events. Each graph includes a continuous 
measure of CPB-pump flow rate (FRCPB), mean arterial pressure (MAP), change in 
cerebral blood flow (ΔCBFi), cerebral tissue saturation (StO2), and changes in the 
oxidation state of cytochrome c oxidase (ΔoxCCO). Data were temporally averaged 
(7-s window) for visualization. 
Correlation plots of hypoperfusion events, showing changes in optical parameters as a 
function of MAP, are displayed in Fig. 5.6; statistical outliers are depicted by red crosses. 
Statistically significant changes in ΔCBFi occurred below MAP values of 30 mmHg, in 




Figure 5.6: Correlation boxplots of ΔCBF, StO2, and ΔoxCCO as a function of 
MAP; + indicates statistical outliers and * indicates a statistically significant 
difference from baseline values. 
The maximum changes in oxCCO during each hypoperfusion event were plotted against 
the maximum change in CBFi in Fig. 5.7. A temporal delay of 18.2 ± 15.0 s was found 
between nadirs of ΔCBFi and ΔoxCCO. A delayed metabolic response in relation to flow 
has been previously reported [16,17,33,34]. Changes in CBFi greater than 70% resulted in 
large decreases in oxCCO. 
 
Figure 5.7: Correlation plot showing the relationship between the maximum 
reductions in ΔCBFi and ΔoxCCO. On average, the ΔoxCCO nadir occurred 




For patients undergoing cardiac surgery with the use of CPB, current clinical standards are 
either completely absent of brain specific monitoring or reliant on commercial oximetry 
devices to provide regional cerebral oxygen saturation measurements. While oximetry has 
advanced to provide robust continuous measures, saturation alone has proven insufficient 
in describing metabolism and predicting neurological outcome [15,35]. The goal of this 
study was to test the feasibility of a newly developed optical brain monitor to provide 
intraoperative measurements of cerebral hemodynamics and metabolism during CPB. 
In seven patients undergoing cardiac surgery with CPB, the hybrid optical device provided 
continuous monitoring of cerebral blood flow based on the DCS blood flow index (CBFi) 
and metabolism using B-NIRS to measure changes in the oxidation state of cytochrome c 
oxidase (ΔoxCCO). During transitions onto CPB (Fig. 5.2 A), the FRCPB was increased to 
provide adequate perfusion as the heart was arrested. The CPB pump was initially filled 
with a crystalloid solution in its reserve; when the pump was started, the first cycle was 
devoid of blood. As it continued, the crystalloid solution and blood mixed, resulting in a 
hemodilution effect that gradually diminished. From the perspective of the B-NIRS 
acquisition, there was a sudden change in the optical properties which may have 
contributed to the observed change in oxCCO. While Fig. 5.3 shows a statistically 
significant drop in ΔoxCCO, implying inadequate oxygen utilization across the on-CPB 
transition, the influence of hemodilution during this transition phase must be considered. 
It is also noteworthy that a significant increase in MAP was observed across this period 
and that no significant change in oxCCO persisted 15 minutes into CPB. Studies by 
Lassnigg et al. and Talpahewa et al. both reported similar changes in oxCCO following 
CPB-onset while noting contributions from hemodilution effects [36,37]. While 
hemodilution also results in a reduced number of moving light scatterers (e.g., red blood 
cells), it did not appear to have the same impact on DCS, since the CBFi measure relies on 
the temporal correlation of dynamic light scatter. Instead, CBFi was influenced to a greater 
extent by the FRCPB. The clinically chosen FRCPB was generally within a limited range from 
2.0 to 2.5 L/min/m2, using an estimated surface area for each patient [38–40]. Fig. 5.3 
displays a large range of ΔCBFi following CPB onset, with an average increase of 
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88.5 ± 125.7%. This shows that pump-flow rates were consistently overestimated, in 
relation to baseline values. While this ensures sufficient perfusion, intraoperative blood 
flow monitoring has potential in allowing for patient specific flow rates. Following the 
procedure, no significant changes were observed coming off CPB, suggesting no loss of 
oxygen supply or utilization when restarting the heart. Similarly, no change in StO2 was 
observed across either transition. Patients also experienced significant drops in total 
hemoglobin and pH during CPB, while no significant changes in temperature and PaCO2 
were observed. 
Fig. 5.4 demonstrates the system’s ability to capture pulsatile waveforms in the cerebral 
microcirculation. A patient presented with a bicuspid aortic valve (Fig. 5.4 A), which was 
replaced with an artificial valve (Fig. 5.4 B). In the pulse pressure waveform, the first and 
largest peak represents the systolic phase, corresponding to the aortic valve opening and 
left ventricular ejection. The second peak visualized represents the vascular elastic recoil 
following aortic valve closure [32]. After valve replacement, alterations in the height of the 
curve and shape of the secondary peak were observed. These changes could represent 
improvements in stroke volume and aortic pressure from cardiac pathologies (e.g., the 
progressive decrease in aortic pressure due to aortic stenosis) or surgical repairs (e.g. valve 
integrity) and could provide more insight on the impact of cardiac output on CBF. CPB 
produces a non-pulsatile blood flow while the heart is arrested. Pulsatile flow has been 
shown to significantly enhance organ perfusion (i.e., in kidneys) prior to transplant [41], 
and recent studies investigating non-pulsatile versus pulsatile CPB in major cerebral 
arteries suggest the potential benefit of cerebral pulsatility [42]; however, there is currently 
insufficient evidence to necessitate the clinical implementation of pulsatile CPB. 
Continuous monitoring of CBF and oxCCO could be used to assess the effects of pulsatile 
versus non-pulsatile CPB on cerebral health. 
Throughout surgery, numerous hypoperfusion events caused by large and sustained drops 
in FRCPB were observed. While on CPB, oxygen supply is solely dependent on the CPB-
pump flow rate; reducing FRCPB therefore directly impacts cerebral perfusion and could 
lead to adverse neurological outcome. Fig. 5.5 displays an example dataset acquired from 
a patient during a stable period (Fig. 5.5 A, no notable changes in FRCPB) and during 
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multiple successive drops in FRCPB. Optical metrics during 15 hypoperfusion events (mean 
drop in FRCPB of 70.6 ± 28.8% for 93.9 ± 52.5 s) are summarized in Fig. 5.6 as a function 
of MAP. As MAP decreased with reduced FRCPB, correlation plots show a consistent 
decrease in cerebral perfusion, saturation, and metabolism. Statistically significant 
differences were found for MAP values below 30 mmHg. ΔCBFi showed the earliest 
response with delayed responses in StO2 and ΔoxCCO. For each event, the maximum 
change in oxCCO was plotted as a function of the corresponding largest change in CBFi 
(Fig. 5.7). Mild-to-moderate reductions in CBFi (< 70%) resulted in small decreases in 
oxCCO; similar reductions were reported in patients undergoing transaortic valve 
replacements [43], and in healthy volunteers undergoing hypoxia and hypocapnia 
challenges [44,45]. Reductions in CBFi > 70% instigated larger changes in metabolism 
comparable to reductions observed in infants with brain injury [46]. The adult brain is 
assumed to have a total CCO concentration of approximately 5.5 µM [18]. The largest 
observed drop (−1.5 µM) represents an approximate 27% change in oxCCO within the 
brain. Furthermore, an 18.2 ± 15.0-s delay was observed between metabolic and flow 
nadirs. Previous studies have shown similar delays in piglets [17,47] and infants [16,33]. 
Reductions in CBF are likely met by increases in oxygen extraction to maintain stable 
metabolic levels. Following large and sustained drops in CBF, this compensatory 
mechanism could become overwhelmed and metabolism impacted. The variability in 
oxCCO is therefore influenced by the duration of hypoperfusion events observed. While 
shorter events can elicit similar CBF responses, they may not last long enough to cause the 
maximum reduction in oxCCO. Further investigations are required to establish clinical 
thresholds for changes in CBFi and oxCCO in order to understand when values become 
clinically relevant. Previous work has utilized continuous CBF monitoring to determine a 
patient-specific lower limit of autoregulation (LLA) [11]. Future work will look to 
determine the relationship of the LLA with changes in cerebral metabolism.  
When translating the optical system to the cardiac operating room, the bright ambient light 
in the surgical suite was initially a significant source of signal contamination. In this 
environment, additional shielding in the form of an optical blackout cloth was essential. 
Further, frequent bed motion and patient repositioning/intervention (i.e., head-cooling with 
ice, manipulating the transesophageal echocardiography probe) during surgical procedures 
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necessitated strong contact between the optical probes and the surface of the skin. This was 
achieved by anchoring the optical fibers at a point above the patient, minimizing weight 
and providing leeway for motion. An additional challenge of the current set-up is the 
inherent depth sensitivity of the optical technology. The SDDs chosen for B-NIRS and 
DCS have proven sufficient to interrogate the brain in adult populations [43,48,49]; 
however, previous work has shown the large contribution from the scalp for NIRS 
measures [50–52]. While StO2 is susceptible to this effect, oxCCO is less impacted since 
CCO concentrations are considerably higher in the brain than in extracerebral tissues [18]. 
To further address depth sensitivity, future work will implement multi-distance 
measurements to simultaneously acquire scalp perfusion and metabolism and correct for 
their influence. Previous reports have elaborated on the benefits of measuring extracerebral 
layers in discerning this contribution [43,49,53,54]. Another future direction will be to 
modify the system to enable measurements from multiple vascular territories. A limitation 
with the current system was that the single probe only afforded monitoring in one brain 
region. In this study, a patient had an intraoperative ischemic stroke in the M1 branch of 
the right middle cerebral artery, which was not detected by the probes placed on the right 
side of the forehead. With advancements in lower-cost detector technology, implementing 
multiple source-detection pairs would enable monitoring across multiple vascular 
territories [12,55]. 
5.5 Conclusion 
This study presents the clinical translation and feasibility of an optical neuromonitor 
capable of continuous measurement of cerebral perfusion and metabolism during cardiac 
surgery with CPB. Temporal resolution was sufficient to capture physiological responses 
to transitions on and off the CPB pump and intraoperative hypoperfusion events. Increases 
in CBFi and significant decreases in MAP and oxCCO were noted during transitions on 
CPB, with no change during transitions off. Large reductions in CPB-pump flowrate 
resulted in significant drops in CBFi and oxCCO when MAP decreased below 30 mmHg. 
The findings regarding metabolic change are supported by previous literature using similar 
methodologies. The optical system described provides a safe and non-invasive approach 
for real-time assessment of cerebral hemodynamics and metabolism. More studies are 
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required to determine if direct intraoperative monitoring of CBFi and oxCCO could aid 
clinicians in patient management and possibly provide insight into the impact of CPB on 
postoperative cognitive decline and brain injury. 
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Chapter 6  
6 Conclusion and Future Directions 
This section revisits the overarching aims of this dissertation and summarizes findings from 
each chapter. Limitations are discussed to address notable drawbacks within this work 
along with potential solutions and future directions in this field. 
6.1 Research Objectives 
Infants born prematurely (i.e., a gestational period fewer than 37 weeks) have an increased 
risk of adverse neurological outcome. The shorter the gestation, and the less infants weigh 
at birth, the higher the risk of developing a brain injury. For example, 25-50% of very low 
birth weight infants (< 1500 g) experience cognitive/behaviour deficits, and 5-10% develop 
major disorders such as cerebral palsy [1]. A common brain injury among this population 
is intraventricular hemorrhaging (IVH), which describes bleeding in the germinal matrix 
and surrounding white matter. Due to an underdeveloped vascular bed in this region, 
infants are particularly susceptible to hemorrhaging, particularly within the first 48 hours 
after birth [2]. Severe bleeding can trigger an inflammatory response and subsequent 
fibrosis, which can prevent drainage of cerebrospinal fluid (CSF) from the brain’s 
ventricles. Significant build-up of CSF can cause increases in intracranial pressure and 
result in ventricle enlargement; this is referred to as post-hemorrhagic ventricle dilatation 
(PHVD) [3,4]. PHVD is a common complication in high-grade IVH, both of which place 
infants at a higher risk of developing brain damage and long-term cognitive deficits. 
Currently, diagnosis of IVH and PHVD is conducted using cranial ultrasound (cUS) to 
visually grade/assess hemorrhages and ventricular dilatation [4,5]. Ultrasound is limited in 
its ability to longitudinally monitor and acquired images can only be used to assess damage 
that has already occurred. Advancements in optical technologies have shown potential in 
providing non-invasive monitoring of physiological markers of brain injury. Broadband 
near-infrared spectroscopy (B-NIRS) exploits light absorption properties of tissue 
constituents, such as hemoglobin, to quantify their concentrations [6]. This technique can 
therefore provide continuous monitoring of cerebral tissue saturation (StO2). Due to the 
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wide range of wavelengths implemented using B-NIRS, a measure of cytochrome c oxidase 
(CCO) can also be acquired. CCO is an enzyme in the mitochondria vital to oxidative 
phosphorylation (i.e., cellular energy production). Through monitoring CCO’s oxidation 
state (oxCCO), B-NIRS can provide a direct measure of metabolism [7]. Diffuse 
correlation spectroscopy (DCS) is a relatively newer optical technique that can provide 
continuously monitoring of cerebral blood flow (CBF). Whereas B-NIRS can quantify 
StO2 through measuring light absorption, DCS can provide a measure of blood flow by 
analyzing light scattered off of red blood cells (RBC) [8,9]. As RBC are the primary 
moving scatterers in tissue, changes in light scatter reflect RBC motion [10]. Using a stable 
long-coherence laser, DCS can directly monitoring CBF in the microvasculature.  
The overarching goal of this dissertation was to develop an optical system combining B-
NIRS and DCS techniques to provide a simultaneous acquisition of CBF and oxCCO. 
Bedside monitoring of perfusion and metabolism could act as a prognostic tool to provide 
insight into physiological precursors of brain injury before significant damage occurs. This 
thesis sought to achieve this through the following aims:  
1. Develop and validate a hybrid B-NIRS and DCS neuromonitor to simultaneously 
acquire CBF and oxCCO at the bedside (Chapter 2). 
2. Assess system feasibility in PHVD infants in the neonatal intensive care unit 
(Chapter 3). 
3. Investigate cerebral perfusion and metabolic stability during early brain 
development in premature infants soon after birth (Chapter 4). 
4. Investigate the impact of significant changes in CBF on cerebral energy metabolism 
(Chapter 5). 
6.2 Summary of Individual Chapters 
6.2.1 Development of a hybrid broadband NIRS and DCS device 
for concurrent measurements of cerebral perfusion and 
cytochrome c oxidase 
Chapter 2 presented a novel optical system combining B-NIRS, to monitor cerebral tissue 
saturation and oxidative metabolism (via the marker cytochrome c oxidase), with DCS to 
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provide measures of blood flow in the cerebral microvasculature. Though implementing a 
multiplexing shuttering system, B-NIRS and DCS techniques were acquired in quick 
succession while avoiding system crosstalk as demonstrated in a phantom model. Dynamic 
measurements of StO2, CBF, and oxCCO were reported in a piglet model of neonatal 
hypoxia-ischemia, achieved through clamping carotid arteries and reducing oxygen 
content. StO2 and CBF were found to react immediately to the onset of injury, while a delay 
in metabolism was observed. The hybrid system presented showed potential for real-time 
bedside monitoring of hemodynamics and metabolism as a prognostic tool to indicate 
injury. 
6.2.2 Monitoring changes in cerebral blood flow and metabolism in 
infants with post-hemorrhagic ventricular dilatation during 
ventricular taps 
Chapter 3 describes the clinical translation of NNeMo (Neonatal NeuroMonitor), a hybrid 
B-NIRS/DCS device for bedside characterization of cerebral perfusion and metabolism. In 
this work, StO2, CBF, and oxCCO were monitored in term infants with post-hemorrhagic 
ventricular dilatation while receiving ventricular taps to drain excessive cerebrospinal fluid 
and alleviate intracranial pressure. The minimal optical fiber and probe holder design 
allowed for convenient longitudinal monitoring. Across 14 ventricular taps, an 
approximately 15% increase in CBF was reported following the procedure, which was 
supported by previous investigations. Much smaller changes in metabolism were noted 
over this same period. NNeMo’s ability to provide bedside monitoring of perfusion and 
metabolism showed potential for numerous neuromonitoring applications in the neonatal 
intensive care unit. 
6.2.3 Monitoring cerebral hemodynamic, oxygenation and 
metabolic stability in premature infants following birth using a 
hybrid broadband NIRS/DCS optical brain monitor 
Chapter 4 reports the clinical translation of NNeMo to monitor the brains of eight 
premature infants soon after birth. Perfusion and metabolic stability were demonstrated on 
the first and third days of life. No significant differences in measurement stability was 
reported between days. Continuous wavelet transforms were applied to perform frequency 
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analysis and characterize prevailing oscillations during these monitoring periods. Apparent 
oscillations were found in StO2 and CBF markers on day 1, which diminished by day 3. 
Coherence and semblance were calculated to determine the relationship between optical 
measures of StO2, CBF, and oxCCO. The semblance of CBF/StO2 was found to 
significantly differ from relationships with oxCCO, suggesting that persistent fluctuations 
in CBF and StO2 did not influence the metabolism. 
6.2.4 Changes in cerebral blood flow and metabolism in response 
to hypoperfusion events in adults during surgery with 
cardiopulmonary bypass 
Chapter 5 demonstrates similar perfusion and metabolic measures in seven adults during 
cardiac surgery with cardiopulmonary bypass. This patient population experiences large 
intraoperative fluctuations in perfusion, as dictated by the bypass pump, to allow for 
surgical intervention. During the transition on bypass CBF increased by an average of 
approximately 89%. During this same period, a statistically significant drop in oxCCO was 
noted (0.5 µM), which was in part due to a hemodilution effect as the pump was turned on. 
Across all subjects, fifteen hypoperfusion events characterized by large and sustained drops 
in CBF were identified. During these periods, significant reductions in CBF and oxCCO 
were reported when mean arterial pressure dropped below 30 mmHg. Changes in CBF 
were found to precede metabolic response during these events. Optical neuromonitoring 
showed strong potential to aid in assessing hemodynamics intraoperatively, determining 
the presence of autoregulation, and in guiding patient management. 
6.3 Limitations 
This section describes limitations with respect to each chapter. General limitations 
common to all of the work discussed in addition to study specific limitations. A more 
detailed discussion of limitations for each body of work is presented within each chapter. 
6.3.1 General Limitations  
In the work presented, NNeMo utilizes a single source-detector pair for both B-NIRS and 
DCS techniques. This geometry limits data acquired to represent local changes in 
hemodynamics and metabolism as a representation of the global environment. In neonatal 
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studies, this prevented characterizing hemispheric differences which are often prevalent. 
For example, in chapter 3, the one subject who experienced IVH was diagnosed with a 
Grade II on the right and Grade I on the left. While hemorrhaging will likely affect the 
brain globally, a single acquisition site prevents characterizing the differences between 
these bleeds. Similarly, in the cardiac operating room, a patient in our study experienced 
an intraoperative ischemic stroke away from the site of monitoring. Due to the single 
source-detector pair, any influence on perfusion/metabolism from this event would be 
indistinguishable from global changes. NNeMo also utilizes only a single source-detector 
distance for B-NIRS and DCS measures, which limits depth sensitivity. While, in neonatal 
studies, signal contamination from extracerebral layers is minimal, increased depth 
sensitivity could aid in capturing changes in deeper brain regions where IVH originates. 
6.3.2 Study Specific Limitations 
Chapter 2: The work in this section describes the first combination of B-NIRS and DCS 
using a multiplexing shuttering system to avoid signal cross talk. Shutters were 
implemented, opposed to optical filters, since the DCS emission source (785 nm) overlaps 
with HbO2’s (680-845 nm) and oxCCO’s (780-900 nm) broad absorption spectra. 
Therefore, this acquisition was not truly simultaneous with each technique acquired in 
quick succession. As such, the system was limited in its temporal resolution, only achieving 
a full data set once every 14 seconds. The piglet model of hypoxia-ischemia involved 
clamping carotid arteries and reducing oxygen content to produce injury. When piglets 
were initially occluded, sudden and extreme changes in CBF resulted. The temporal 
resolution of the system limited the ability to resolve changes during this initial drop and 
compare metabolic response to moderate changes in CBF, opposed to the large changes 
that the occluders ultimately produced.  
Chapter 3: Subjects in this study underwent ventricular taps to drain cerebrospinal fluid 
directly from the brain’s ventricles. Due to sterilization of the site of interest prior to the 
procedure, and patient repositioning following, motion artifacts were prevalent 
surrounding the immediate monitoring period. As a result, data analysis was limited to 2-
mintute windows before needle insertion and removal. Changes in hemodynamics and 
metabolism therefore only represented the immediate effects of the ventricular tap, while 
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further changes likely persisted in the hours or days following. Data in this work were also 
prone to signal contamination from ambient light sources due to the increased lighting to 
aid surgeons in inserting the needle and the proximity of the optical probes to the site of 
insertion. 
Chapter 4: This section describes optical neuromonitoring with NNeMo soon after 
premature birth and analyzed an average of approximately 4 hours of data from each 6-
hour period of data acquired. This discrepancy was largely due to the abundance of patient 
handling and medical intervention during this early time frame, leading to excessive motion 
artifacts. The relative nature of CBF and oxCCO measures, prevented direct comparison 
of perfusion and metabolism between the first and third day of life. Instead, analysis was 
limited to signal stability (i.e., standard deviation), frequency analysis, and comparison 
between optical measures acquired concurrently. The small number of subjects monitored 
in this investigation also prevented correlation of measurement stability/prevailing 
frequencies to the onset of IVH, as only a single subject experienced a bleed. 
Chapter 5: This study demonstrated the translation of NNeMo to monitor adults during 
cardiac surgery with cardiopulmonary bypass. The data presented in this work was also 
quite susceptible to ambient light and motion artifacts. The former produced by the 
extremely bright environment in the operating suite and the latter from frequent bed 
motion, patient repositioning, movement of the transesophageal echocardiography probe, 
etc. Data collected as patients were transitioned onto bypass was influenced by a 
hemodilution effect, caused by the ‘first pass’ of the bypass pump which was initially filled 
with a crystalloid solution. This apparent decrease in hemoglobin concentration 
contributed in part to the significant drop in metabolism reported. Compared to previous 
work in piglets and neonates, the data presented in this study was limited in terms of depth 
sensitivity and had a larger influenced by scalp contribution. This likely impacted StO2 to 
the greatest extent since oxCCO is naturally more abundant in cerebral tissue due to higher 




6.4 Future Work 
To address the limitations discussed, future work seeks to modify NNeMo to allow for both 
multi-distance and regional measurements. For the former, the addition of a shorter source-
detector separation for B-NIRS would provide an estimate of extracerebral tissue 
saturation. This approach is well established for commercial NIRS devices to control for 
scalp effects. For the B-NIRS measure of metabolism this similarly useful, although to a 
lesser extent. Work by Nguyen et al. utilizing multi-distance measures of oxCCO in cardiac 
arrest patients showed a discrepancy in oxCCO response over 1-cm and 3-cm SDDs, 
supporting oxCCO’s inherent depth sensitivity. Multi-distant DCS measures have shown 
strong potential in separating flow responses from the brain and scalp [12], and have been 
utilized to quantify optical properties, allowing for DCE measurements and quantitative 
measures of CBF [13]. 
Regional measurements can be achieved by bifurcating optical fibers for emission sources 
and employing additional detectors. Alternatively, by utilizing optical shutters, light 
interrogating different regions can be collected and sent to the same detector in succession. 
This will allow for analysis from both regions without additional components but with a 
trade-off in a decreased temporal resolution. For B-NIRS detection, a spectrometer’s 
detection plane can be digitally sectioned and light incident on different regions can be 
separately analyzed. This requires an optical fiber detection bundle which spatially 
separates light from different regions when entering the spectrometer. An area of dead 
space between different sources is needed to avoid signal crosstalk; this approach allows 
for simultaneous B-NIRS acquisition and analysis from different sites. In neonatal 
populations, regional measurements have reported significant differences in cerebral 
saturation, flow, and metabolism across hemispheres, with the right hemisphere 
consistently reporting greater values [14]. Monitoring regional changes has potential to 
indicate local hemorrhaging or stroke.  
The recent development of supercontinuum lasers has allowed for combined B-NIRS and 
TR-NIRS techniques using a single source [15]. This approach is able to collect time-of-
flight information, through a temporal point spread function, for photons across a wide 
wavelength range. This would allow for TR-NIRS acquisition of the broad oxCCO spectra. 
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By isolating later arriving photons, an increased depth sensitivity can also be achieved 
compared to traditional B-NIRS approaches. Similarly, time-resolved DCS technology has 
proven capable of acquiring time-of-flight information in addition to measuring the 
autocorrelation function [16]. This allows for CBF monitoring with increased depth 
sensitivity by differentiating between photon pathlengths. 
Chapter 2 describes the development of the hybrid B-NIRS/DCS system using optical 
shutters. This approach was chosen since the wavelength of the DCS laser implemented 
overlapped with the absorption spectra of HbO2 and oxCCO. Recent work by Carp et al. 
has demonstrated DCS acquisition using an emission source at 1064 nm [17]. Using this 
approach, high/low-pass optical filters could be implemented to shield detectors from 
opposing sources, allowing for a truly simultaneous acquisition, significantly improving 
temporal solution. A similar approach has been demonstrated when combining TR-NIRS 
and DCS techniques [18].  
Chapter 3 describes hemodynamics and metabolism during ventricular taps in PHVD 
infants. Future investigation seeks to monitor infants at risk of CSF accumulation in the 
days and weeks preceding potential intervention with the aim of assessing perfusion and 
metabolism as prognostic markers. This will be achieved through correlating fluctuations 
and longitudinal changes in CBF and oxCCO to changes in ventricle volume and 
intracranial pressure prior to and following CSF drainage. Current practice relies on 
measurements of head circumference, and in some centers ventricular volume, to dictate 
intervention. Optical monitoring could provide a clearer indication of the when to intervene 
and/or how much CSF to drain in order to maintain sufficient cerebral metabolism and 
avoid tissue damage.  
Chapter 4 similarly discusses fluctuations in perfusion and metabolism as potential 
prognostic markers of IVH in premature infants. Firstly, a larger patient cohort will allow 
for stratification of subjects without prevailing injury and those with mild to severe IVH. 
Infants with IVH upon birth, as diagnosed by a day-one cranial ultrasound scan, can be 
further separated from infants who initially present without a bleed and subsequently 
experience hemorrhaging. The goal of this work will be to establish clinical thresholds of 
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perfusion and metabolic change that are indicative of subsequent injury. This will be 
achieved by monitoring infants continuously over the first few days of life and correlating 
optical measures to clinical outcome.  
Chapter 5 demonstrates CBF and oxCCO measures in adults undergoing surgery with 
cardiopulmonary bypass. Numerous large reductions in CBF were noted within this small 
patient cohort and were found to impact cerebral metabolism at low mean arterial 
pressures. Similar to chapter 4, fluctuations in optical measures will be utilized to establish 
clinical thresholds of neurological injury. In this study, patient specific thresholds can be 
achieved by determining a real-time measure of cerebral autoregulation. This is possible 
with an accompanying measure of MAP, which is absent in most neonatal populations. In 
addition, regional measurements of optical parameters will allow for an increased spatial 
resolution which has potential to identify local hemodynamic events such as strokes. 
6.5 Conclusion 
In conclusion, this dissertation provides a fundamental understanding of optical techniques 
and their applications in neuromonitoring, with a particular focus on the neonatal brain. 
NNeMo, a novel optical brain monitor, is presented combining B-NIRS and DCS 
technology to simultaneously characterize cerebral perfusion and metabolism at the 
bedside. The studies described in this thesis show potential for optical measures of flow 
and metabolism to act as prognostic markers of brain injury in both the NICU and cardiac 
operating room. Real-time monitoring of cerebral hemodynamics and energy production 
has potential to aid clinicians in patient management, mitigate adverse neurological injury, 
and ultimately improve long-term clinical outcome. 
6.6 References 
1. J. J. Volpe, "Brain injury in premature infants: a complex amalgam of destructive 
and developmental disturbances," Lancet 8(1), 110–124 (2009). 
2. P. Ballabh, "Intraventricular hemorrhage in premature infants: Mechanism of 
disease," Pediatr. Res. 67(1), 1–8 (2010). 
170 
 
3. S. Cherian, A. Whitelaw, M. Thoresen, and S. Love, "The pathogenesis of 
neonatal post-hemorrhagic hydrocephalus," Brain Pathol. 14(3), 305–311 (2004). 
4. A. Whitelaw, "Intraventricular haemorrhage and posthaemorrhagic 
hydrocephalus: Pathogenesis, prevention and future interventions," Semin. 
Neonatol. 6(2), 135–146 (2001). 
5. M. Hinojosa-Rodríguez, T. Harmony, C. Carrillo-Prado, J. D. Van Horn, A. 
Irimia, C. Torgerson, and Z. Jacokes, "Clinical neuroimaging in the preterm 
infant: Diagnosis and prognosis," NeuroImage Clin. 16(August), 355–368 (2017). 
6. M. Diop, J. Kishimoto, V. Toronov, D. S. C. Lee, and K. S. Lawrence, 
"Development of a combined broadband near-infrared and diffusion correlation 
system for monitoring cerebral blood flow and oxidative metabolism in preterm 
infants," Biomed. Opt. Express 6(10), 3907–3918 (2015). 
7. G. Bale, C. E. Elwell, and I. Tachtsidis, "From Jöbsis to the present day : a review 
of clinical near-infrared spectroscopy measurements of cerebral cytochrome-c-
oxidase," J. Biomed. Opt. 21(9), (2016). 
8. D. A. Boas, L. E. Campbell, and A. G. Yodh, "Scattering and Imaging with 
Diffusing Temporal Field Correlations," Phys. Rev. Lett. 75(9), 1855–1859 
(1995). 
9. D. A. Boas and A. G. Yodh, "Spatially varying dynamical properties of turbid 
media probed with diffusing temporal light correlation," J. Opt. Soc. Am. A 
14(1), 192–215 (1997). 
10. R. Bonner and R. Nossal, "Model for laser Doppler measurements of blood flow 
in tissue," Appl. Opt. 20(12), 2097–2107 (1981). 
11. J. Selb, D. a. Boas, S.-T. Chan, K. C. Evans, E. M. Buckley, and S. a. Carp, 
"Sensitivity of near-infrared spectroscopy and diffuse correlation spectroscopy to 
brain hemodynamics: simulations and experimental findings during 
hypercapnia.," Neurophotonics 1(1), 015005 (2014). 
171 
 
12. D. Milej, A. Abdalmalak, A. Rajaram, and K. St. Lawrence, "Direct assessment of 
extracerebral signal contamination on optical measurements of cerebral blood 
flow, oxygenation, and metabolism," Neurophotonics 7(04), 1–17 (2020). 
13. M. Khalid, D. Milej, A. Rajaram, A. Abdalmalak, L. Morrison, M. Diop, and K. 
St. Lawrence, "Development of a stand-alone DCS system for monitoring 
absolute cerebral blood flow," Biomed. Opt. Express 10(9), 4607–4620 (2019). 
14. P. Y. Lin, N. Roche-Labarbe, M. Dehaes, A. Fenoglio, P. E. Grant, and M. A. 
Franceschini, "Regional and hemispheric asymmetries of cerebral hemodynamic 
and oxygen metabolism in newborns," Cereb. Cortex 23(2), 339–348 (2013). 
15. D. J. F. Cohen and M. Diop, "Late-photons hyperspectral near-infrared 
spectroscopy improves the sensitivity to cerebral oxygenation in adults," OSA 
2020 Proc. Opt. InfoBase Conf. Pap. BTh3C.2, (2020). 
16. J. Sutin, B. Zimmerman, D. Tyulmankov, D. Tamborini, K. C. Wu, J. Selb, A. 
Gulinatti, I. Rech, A. Tosi, D. A. Boas, and M. A. Franceschini, "Time-domain 
diffuse correlation spectroscopy," Optica 3(9), 1006 (2016). 
17. S. A. Carp, D. Tamborini, D. Mazumder, K.-C. (Tony) Wu, M. R. Robinson, K. 
A. Stephens, O. Shatrovoy, N. Lue, N. Ozana, M. H. Blackwell, and M. A. 
Franceschini, "Diffuse correlation spectroscopy measurements of blood flow 
using 1064 nm light," J. Biomed. Opt. 25(09), 1–15 (2020). 
18. D. Milej, M. Shahid, A. Abdalmalak, A. Rajaram, M. Diop, and K. St. Lawrence, 
"Characterizing dynamic cerebral vascular reactivity using a hybrid system 
combining time-resolved near-infrared and diffuse correlation spectroscopy," 






















Appendix B: Permission for Reproduction of Scientific Articles 
 
Copyright Agreement for the Journal of Biomedical Optics Express (Chapter 2 & 5) 
 
From: … 
Sent: Jan 22nd, 2021 
To: … 
Subject: RE: Permission to Use Copyrighted Material in a Doctoral Thesis 
 
Dear Ajay Rajaram, 
  
Thank you for contacting The Optical Society (OSA). 
  
For the use of material from Ajay Rajaram, Gemma Bale, Matthew Kewin, Laura B. 
Morrison, Ilias Tachtsidis, Keith St. Lawrence, and Mamadou Diop, "Simultaneous 
monitoring of cerebral perfusion and cytochrome c oxidase by combining broadband near-
infrared spectroscopy and diffuse correlation spectroscopy," Biomed. Opt. Express 9, 
2588-2603 (2018) and Ajay Rajaram, Daniel Milej, Marianne Suwalski, Lawrence C. M. 
Yip, Linrui R. Guo, Michael W. A. Chu, Jason Chui, Mamadou Diop, John M. Murkin, 
and Keith St. Lawrence, "Optical monitoring of cerebral perfusion and metabolism in 
adults during cardiac surgery with cardiopulmonary bypass," Biomed. Opt. Express 11, 
5967-5981 (2020) 
  
Because you are the author of the source paper from which you wish to reproduce 
material, OSA considers your requested use of its copyrighted materials to be 
permissible within the author rights granted in the Copyright Transfer Agreement 
submitted by the requester on acceptance for publication of his/her manuscript.  It 
is requested that a complete citation of the original material be included in any 
publication. This permission assumes that the material was not reproduced from 
another source when published in the original publication. 
  
If the entire article is being included, it is permissible to use the version of record. 
  
While your publisher should be able to provide additional guidance, OSA prefers the below 
citation formats: 
   
For citations in figure captions: 
 [Reprinted/Adapted] with permission from [ref #] © The Optical Society. (Please 
include the full citation in your reference list) 
  
For images without captions: 
 Journal Vol. #, first page (year published) An example: Opt. Express 19, 2720 
(2011) 
  






January 26, 2021 
Authorized Agent, The Optical Society 
  
The Optical Society (OSA) 
2010 Massachusetts Ave., NW 




Sent: Jan 19th, 2021 
To: … 




I am a University of Western Ontario graduate student completing my Doctoral thesis in 
Medical Biophysics. My thesis will be available in full-text on the internet for reference, 
study and/or copy. Except in situations where a thesis is under embargo or restriction, the 
electronic version will be accessible through the Western Libraries web pages, the 
Library’s web catalogue, and also through web search engines. I will also be granting 
Library and Archives Canada and ProQuest/UMI a non-exclusive license to reproduce, 
loan, distribute, or sell single copies of my thesis by any means and in any form or format. 
These rights will in no way restrict republication of the material in any other form by you 
or by others authorized by you. 
 
I would like permission to allow inclusion of the following material in my thesis: 
 
1. A. Rajaram, G. Bale, M. Kewin, L. B. Morrison, I. Tachtsidis, K. St. Lawrence, and M. 
Diop, "Simultaneous monitoring of cerebral perfusion and cytochrome c oxidase by 
combining broadband near-infrared spectroscopy and diffuse correlation spectroscopy," 
Biomed. Opt. Express 9(6), 2588–2603 (2018). https://doi.org/10.1364/BOE.9.002588 
 
2. A. Rajaram, D. Milej, M. Suwalski, L. C. M. Yip, L. R. Guo, M. W. A. Chu, J. Chui, M. 
Diop, J. M. Murkin, and K. St. Lawrence, "Optical monitoring of cerebral perfusion and 
metabolism in adults during cardiac surgery with cardiopulmonary bypass," Biomed. Opt. 
Express 11(10), 5967-5981 (2020). https://doi.org/10.1364/BOE.404101 
 
The material will be attributed through a citation. 




Ajay Rajaram  
178 
 
Copyright Agreement for the Journal of Biomedical Optics Express (Chapter 3) 
 
From: … 
Sent: Jan 19th, 2021 
To: … 
Subject: RE: Permission to Use Copyrighted Material in a Doctoral Thesis 
Dear Ajay Rajaram, 
Thank you for your message. Please feel free to use the published material in your paper 
with a proper citation. We are an open access journal, the copyright of the published 




Ms. Amanda Zhang 
Managing Editor 
Brain Sciences (http://www.mdpi.com/journal/brainsci/) 
Twitter: @BrainSci_MDPI 
MDPI 
Postfach, CH-4020 Basel, Switzerland 




Sent: Jan 19th, 2021 
To: … 




I am a University of Western Ontario graduate student completing my Doctoral thesis in 
Medical Biophysics. My thesis will be available in full-text on the internet for reference, 
study and/or copy. Except in situations where a thesis is under embargo or restriction, the 
electronic version will be accessible through the Western Libraries web pages, the 
Library’s web catalogue, and also through web search engines. I will also be granting 
Library and Archives Canada and ProQuest/UMI a non-exclusive license to reproduce, 
loan, distribute, or sell single copies of my thesis by any means and in any form or format. 
These rights will in no way restrict republication of the material in any other form by you 
or by others authorized by you. 
 
I would like permission to allow inclusion of the following material in my thesis: 
 
A. Rajaram, L. C. M. Yip, D. Milej, M. Suwalski, M. Kewin, M. Lo, J. J. L. Carson, V. 
Han, S. Bhattacharya, M. Diop, S. de Ribaupierre, and K. St. Lawrence, "Perfusion and 
179 
 
Metabolic Neuromonitoring during Ventricular Taps in Infants with Post-Hemorrhagic 
Ventricular Dilatation," Brain Sci. 10(7), 452 (2020). 
https://doi.org/10.3390/brainsci10070452   
 
The material will be attributed through a citation. 











2015-2021  Doctor of Philosophy in Medical Biophysics 
Department of Medical Biophysics 
Western University, London, Ontario, Canada 
Supervisors: Dr. Keith St. Lawrence & Dr. Mamadou Diop 
Thesis: Optical neuromonitoring to prevent brain injury 
 
2010-2015  Honours Bachelor of Science 
   Co-operative Medical and Health Physics 
   McMaster University, Hamilton, Ontario, Canada 
Thesis: Dosimetric measurements of an orthovoltage unit using 
radiochromic film 
 
HONOURS AND AWARDS    
 
2021   Debbie Comuzzi CHRI Trainee of the Year Award (2020)  
   Children’s Health Research Institute, London, Ontario 
Awarded for significant contributions to the field of children’s 
health research from 2018-2020 
Local ($1,000) 
 
2021   Alfred Jay Award for Translational Research  
   Department of Medical Biophysics, Western University 
Awarded for innovation in the development of a clinical diagnostic 
or therapeutic procedure, showing significant progress on bench 
to bedside translation 
Institutional ($2,000) 
 
2019-2021  Alexander Graham Bell Canadian Graduate Scholarship 
   Natural Sciences and Engineering Research Council (NSERC) 
Awarded to high-caliber doctoral students based on academic 
merit and research productivity 
National ($70,000) 
 
2020   Nellie Farthing Fellowship in Medical Sciences  
   Schulich School of Medicine and Dentistry, Western University 
Awarded to graduate students based on research excellence 
Institutional ($3,000) 
 
2020   1st place clinical talk – Child Health Research Day  
   London Health Sciences 




2020   Doctoral Excellence Research Award 
   Department of Medical Biophysics, Western University 
Recognized for having a tri-agency doctoral scholarship (NSERC)  
Institutional ($3,000) 
 
2020   Western Graduate Research Scholarship  
   Department of Medical Biophysics, Western University 




2019   Alan C Groom Seminar Award 
   Department of Medical Biophysics, Western University 
Awarded for the best departmental seminar presentation 
Institutional ($1,000) 
 
2019 Queen Elizabeth II Graduate Scholarship in Science and 
Technology 
   Government of Ontario 
Merit based scholarship awarded for academic achievement and 
research excellence 
Provincial ($15,000) declined 
 
2018   3rd place oral presentation – ImNO conference 
Imaging Network Ontario, London, Ontario 
Awarded for scientific presentation 
Provincial ($200) 
 
2019   Doctoral Excellence Research Award 
   Department of Medical Biophysics, Western University 
Recognized for having a tri-agency doctoral scholarship (NSERC)  
Institutional ($3,000) 
 
2019   Western Graduate Research Scholarship  
   Department of Medical Biophysics, Western University 




2018 Ontario Graduate Scholarship (OGS) 
   Government of Ontario 
Merit based scholarship awarded for academic achievement and 
research excellence 





2018   2nd place poster – Lawson Imaging Discovery Day  
London Health Sciences 
Awarded for scientific poster presentation 
Institutional 
 
2018   Western Graduate Research Scholarship  
   Department of Medical Biophysics, Western University 




2017 Ontario Graduate Scholarship (OGS) 
   Government of Ontario 
Merit based scholarship awarded for academic achievement and 
research excellence 
Provincial ($15,000)  
 
2017   CIHR Travel Award,  
Canadian Institutes of Health Research (CIHR) 
   Awarded based on research proposal and scientific merit 
National ($1,000) 
 
2017   MexNIRS Travel Award,  
Mexican Symposium on Neuroimaging, Mexico 
   Awarded based on research abstract 
International ($900) 
 
2017   1st place poster – Newborn Brain conference  
   Brain monitoring and Neuroprotection in the Newborn, Ireland 
Awarded based on scientific poster presentation 
International ($375) 
 
2017   Western Graduate Research Scholarship  
   Department of Medical Biophysics, Western University 




2016 Ontario Graduate Scholarship (OGS) 
   Government of Ontario 
Merit based scholarship awarded for academic achievement and 
research excellence 






2016   2nd place 3-Minute Thesis Competition  
   Western University 




2016   Western Graduate Research Scholarship  
   Department of Medical Biophysics, Western University 




2015   Western Graduate Research Scholarship  
   Department of Medical Biophysics, Western University 




2014   Harold E. John’s Medical Physics Studentship Award  
   Cancer Care Ontario 
   Cancer Center of Southeastern Ontario, Kingston, Ontario 
Awarded based on academic achievement, funding a co-operative 
placement at a cancer center in Ontario  
Institutional ($9,600) 
 
2014   Harold E. John’s Medical Physics Studentship Award  
   Cancer Care Ontario 
   Juravinski Cancer Center, Hamilton, Ontario 
Awarded based on academic achievement, funding a co-operative 
placement at a cancer center in Ontario  
Institutional ($9,600) 
 
2013-2015  Dean’s Honour List 
   McMaster University 
   Awarded for academic achievement 
   Institutional 
 
ACADEMIC AND RESEARCH POSITIONS 
 
2018-2020  Teaching Assistant Graduate Biophysics Communications 
(4 terms)  BIOPHYS 9513/9514, Western University, London, Ontario 
Lectured MSc and PhD candidates on scientific presentations and 
assessed student work 





2016-2017  Teaching Assistant Undergraduate Physics 
(2 terms)  PHYS 1028/1029, Western University, London, Ontario 
Led physics laboratory sessions for first year undergraduates and 
assessed student work 
Supervisor: Dr. Kanthi Kaluarachchi 
 
2015    Research Assistant 
Lawson Health Research Institute, London, Ontario 
Supervisors: Dr. Keith St. Lawrence & Dr. Mamadou Diop 
Project: Optical monitoring of hemodynamics and inflammation in 
an animal model of rheumatoid arthritis 
  
2014    Research Assistant 
Cancer Center of Southeastern Ontario, Kingston, Ontario 
Supervisors: Dr. John Schreiner  
Project: Development of a radiochromic film dosimetry imaging 
system 
 
2014    Research Assistant 
Juravinski Cancer Center, Hamilton, Ontario 
Supervisors: Dr. Gordon Chan  
Project: Orthovoltage dosimetric measurements using 
radiochromic film 
 
2013    Research Assistant 
Grand River Regional Cancer Center, Waterloo, Ontario 
Supervisors: Dr. Runqing Jiang 
Project: Linear accelerator quality assurance; Radiation deposition 





2020    National Scholarship Ranking Committee 
Western University 
Assessed scholarship for incoming undergraduate students 
 
2016-2020  Medical Biophysics Graduate Recruitment Committee 
   Department of Medical Biophysics, Western University 
   Presented at graduate fairs and recruitment nights 
 
2013-2015   President - McMaster Medical Physics Undergraduate Society 
McMaster University 







2021 AC Burton Day 
Department of Medical Biophysics, Western University 
Institutional 
 
2020 Fetal Neonatal Neuroimaging Developmental Science Center 
Lecture Series 
Harvard Medical School, Boston Children’s Hospital 
International 
 
2019 Talks on Friday 
Lawson Health Research Institute Lecture Series 
St Joseph Hospital, London, Ontario 
Institutional 
 
2019 AC Burton Day 
Department of Medical Biophysics, Western University 
Institutional 
 
2018 Illuminating Innovation – Children’s Hospital Philanthropic 
Event 
Victoria Hospital, London, Ontario 
Local 
 
2018   Neonatology Grand Rounds 
Victoria Hospital, London, Ontario 
Local 
 
2018 Talks on Friday 
Lawson Health Research Institute Lecture Series 
St Joseph Hospital, London, Ontario 
Institutional 
 
2017 Talks on Friday 
Lawson Health Research Institute Lecture Series 
St Joseph Hospital, London, Ontario 
Institutional 
 
2016 Neonatology Grand Rounds 
Victoria Hospital, London, Ontario 







ACADEMIC REVIEWING ACTIVITES 
 
   Scientific Reports 
 
   Biomedical Optics Express 
 
   Neurophotonics 
 
   Neuroscience Methods 
 




2019   Imaging Network Ontario (Platform & Posters) 
   London, Ontario 
 
2019   London Health Research Day (Posters) 
   London, Ontario 
 
2017-2019  Thames Valley Science and Engineering Fair (Posters) 
   London, Ontario 
 
 
PUBLICATIONS AND PRESENTATIONS 
 
Peer-reviewed Journal Manuscripts: 
(11 published/in-press; 1 in review; 4 first-author) 
 
1. A. Rajaram, D. Milej, M. Suwalski, L. Yip, L. Guo, M. Chu, J. Chui, M. Diop, J. 
Murkin, K. St. Lawrence. “Optical monitoring of cerebral perfusion and metabolism 
in adults during cardiac surgery with cardiopulmonary bypass” Biomed. Optics Exp., 
11(10), 5967-5981 (2020) DOI:10.1364/BOE.404101 
 
2. A. Mendleson, A. Rajaram, D. Bainbridge, K. St. Lawrence, T. Bentall, M. Sharpe, 
M. Diop, C. Ellis “Dynamic tracking of microvascular hemoglobin content for 
continuous perfusion monitoring in the intensive care unit: a pilot study.” Journal of 
Clinical Monitoring and Computing (2020) DOI:10.1007/s10877-020-00611-x 
 
3. D. Milej, A. Abdalmalak, A. Rajaram, K. St. Lawrence “Direct Assessment of 
Extracerebral Signal Contamination on Optical Measurements of Cerebral Blood 







4. A. Rajaram, L. Yip, D. Milej, M. Suwalski, M. Kewin, M. Lo, J. Carson, V. Han, S. 
Bhattacharya, M. Diop, S. de Ribaupierre, K. St. Lawrence “Perfusion and Metabolic 
Neuromonitoring during Ventricular Taps in Infants with Post-hemorrhagic 
Ventricular Dilatation” Brain Sci., 10(7) (2020) DOI:10.3390/brainsci10070452 
 
5. D. Milej, M. Shahid, A. Abdalmalak, A. Rajaram, M. Diop, K. St. Lawrence 
“Characterizing Dynamic Cerebral Vascular Reactivity using a Hybrid System 
Combining Time-Resolved Near-Infrared and Diffuse Correlation Spectroscopy” 
Biomed. Optics Exp. 11(8), 4571-4585 (2020) DOI:10.1364/BOE.392113 
 
6. G. Bale, A. Rajaram, M. Kewin, L. Morrison, A. Bainbridge, L. Liu, U. Anazodo, M. 
Diop, K. St. Lawrence, I. Tachtsidis. “Multimodal measurements of brain tissue 
metabolism and perfusion in a neonatal model of hypoxic-ischaemic injury” Accepted 
for publication in Oxygen Transport to Tissue XLII, Springer International Publishing 
(2020) 
 
7. M. Kewin, A. Rajaram, D. Milej, A. Abdalmalak, L. Morrison, M. Diop, K. St 
Lawrence “Evaluation of hyperspectral NIRS for quantitative measurements of tissue 
oxygen saturation by comparison to time-resolved NIRS” Biomed. Optics Exp., 10(9), 
4789-4802 (2019) DOI:10.1364/BOE.10.004789 
 
8. M. Khalid, D. Milej, A. Rajaram, A. Abdalmalak, L. Morrison, M. Diop, K. St. 
Lawrence “Development of a stand-alone DCS system for monitoring absolute 
cerebral blood flow” Biomed. Optics Exp., 10(9), 4607-4620 (2019) 
DOI:10.1364/BOE.10.004607 
 
9. A. Rajaram, G. Bale, M. Kewin, L. Morrison, I. Tachtsidis, K. St. Lawrence, M. Diop 
“Simultaneous monitoring of cerebral perfusion and cytochrome c oxidase by 
combining broadband near-infrared spectroscopy and diffuse correlation 
spectroscopy” Biomed. Optics Exp. 9(6), 2588-2603 (2018) 
DOI:10.1364/BOE.9.002588 
 
10. G. Bale, A. Rajaram, M. Kewin, L. Morrison, A. Bainbridge, M. Diop, K. St 
Lawrence, I. Tachtsidis “Broadband NIRS cerebral cytochrome-c-oxidase response 
to anoxia before and after neonatal hypoxic-ischemic injury in piglets.” Oxygen 
Transport to Tissue XL, O. Thews, J.C. LaManna, and D.K. Harrison, eds. Springer 
International Publishing, 151-156 (2018) DOI: 10.1007/978-3-319-91287-5_24 
 
11. A. Rajaram, S. Ioussoufovitch, L. Morrison, K. St Lawrence, T.Y. Lee, Y. Bureau, 
M. Diop “Joint blood flow is more sensitive to inflammatory arthritis than 
oxyhemoglobin, deoxyhemoglobin, and oxygen saturation.” Biomed. Optics Exp 







12. D. Milej, A. Abdalmalak, A. Rajaram, A. Jhajj, A. Owen, K. St. Lawrence “Using 
regression analysis to improve the reconstruction of cerebral hemodynamic responses 
acquired by time-resolved near-infrared spectroscopy” Submitted to Journal of 
Biomedical Optics (JBO 210070), Mar 2021  
 
In preparation: 
1. A. Rajaram, D. Milej, M. Suwalski, L. Kebaya, M. Kewin, L. C. M. Yip, , S. de 
Ribaupierre, S. Bhattacharya, M. Diop, and K. St. Lawrence “Monitoring cerebral 
hemodynamic, oxygenation and metabolic stability in premature infants following 
birth using a hybrid broadband NIRS/DCS optical brain monitor” 
 
Peer-reviewed Conference Proceedings & Published Abstracts: 
(12 published; 4 first-author) 
 
1. D. Milej*, A. Abdalmalak, A. Rajaram, K. St. Lawrence. “Assessing the ability to 
monitor cerebral blood flow and oxygen consumption by combining time-resolved 
near-infrared and diffuse correlation spectroscopy” SPIE Proceedings vol 11639 
Optical Tomography and Spectroscopy of Tissue XIV; 1163918 SPIE BiOS, (Online, 
2021) DOI:10.1117/12.2577933 
 
2. D. Milej*, A. Abdalmalak, A. Rajaram, M. Suwalski, K. St. Lawrence. “Combining 
time-resolved near-infrared spectroscopy with regression analysis to improve the 
reconstruction of cerebral hemodynamic responses” SPIE Proceedings vol 11639 
Optical Tomography and Spectroscopy of Tissue XIV; 116390R SPIE BiOS, (Online, 
2021) DOI:10.1117/12.2577237  
 
3. L. Mawdsley*, A. Rajaram, L. Yip, N. Abayomi, S. Milkovich, K. St. Lawrence, J. 
Carson, C. Ellis, M. Diop. “Using near infrared spectroscopy and diffuse correlation 
spectroscopy to determine the microvascular effects of phenylephrine in vivo” SPIE 
Proceedings vol 11639 Optical Tomography and Spectroscopy of Tissue XIV; 
116390Z SPIE BiOS, (Online, 2021) DOI:10.1117/12.2577237  
 
4. L. Mawdsley*, A. Rajaram, L. Yip, C. Ellis, M. Diop. “Using near infrared 
spectroscopy, diffuse correlation spectroscopy, and intravital video microscopy to 
monitor skeletomuscular and cerebral microcirculation” Experimental Biology 2020 
Proceedings FASEB Journal 34 (S1), 1-1 (San Diego, CA, 2020) 
DOI:10.1096/fasebj.2020.34.s1.02980  
 
5. A. Rajaram*, L. Yip, M. Kewin, L. Morrison, M. Diop, K. St. Lawrence. 
“Development of a neonatal neuromonitor for concurrent measurements of 
cytochrome c oxidase and CMRO2” Brain & Brain PET Proceedings PB01-D04 




6. G. Bale*, A. Rajaram, M. Kewin, L. Morrison, A. Bainbridge, M. Diop, K. St. 
Lawrence, I. Tachtsidis. “Multimodal measurements of brain tissue metabolism and 
perfusion in a neonatal model of hypoxic-ischaemic injury” European Conference on 
Biomedical Engineering Proceedings 11074_38 (Munich, Germany, 2019) 
DOI:10.1117/12.2526729 
 
7. D. Milej, A. Rajaram, A. Abdalmalak, M. Khalid, M. Shahid, M. Kewin, K. St. 
Lawrence*. “Assessing extracerebral signal contamination in optical measurements of 
cerebral blood flow and oxygenation” European Conference on Biomedical 
Engineering Proceedings 11074_90 (Munich, Germany, 2019) 
DOI:10.1117/12.2527150 
 
8. A. Rajaram, G. Bale, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop*. “Hybrid 
broadband NIRS/Diffuse correlation spectroscopy system for simultaneous monitoring 
of cerebral perfusion and cytochrome c oxidase.” Optical Society of America 
Proceedings JW3A.50 (Hollywood, FL, 2018) 
DOI:10.1364/TRANSLATIONAL.2018.JW3A.50 
 
9. M. Kewin*, D. F Milej, A. Abdalmalak, A. Rajaram, M. Diop, S. de Ribaupierre, K. 
St Lawrence. “Validation of a Hyperspectral NIRS Method for Measuring Oxygen 
Saturation by Comparison to Time-Resolved NIRS.” Optical Society of America 
Proceedings OW4C.4 (Hollywood, FL, 2018) DOI:10.1364/OTS.2018.OW4C.4 
 
10. M. Khalid*, D. F Milej, A. Rajaram, A. Abdalmalak, M. Diop, K. St Lawrence. “Self-
calibrated DCS for monitoring absolute cerebral blood flow.” Optical Society of 
America Proceedings JTu3A.63 (Hollywood, FL, 2018) 
DOI:10.1364/TRANSLATIONAL.2018.JTu3A.63 
 
11. A. Rajaram*, K. St. Lawrence, M. Diop. “Development of a hybrid broadband 
NIRS/diffusion correlation spectroscopy system for real-time monitoring of cerebral 
perfusion and oxygenation in preterm brain injury.” SPIE BiOS Photonics West 
Proceedings 100540T (San Francisco, CA, 2017) DOI:10.1117/12.2253358 
 
12. A. Rajaram, K. St. Lawrence, M. Diop*. “Monitoring vascular markers of joint 
inflammation in a rabbit model of rheumatoid arthritis with time-resolved near-
infrared spectroscopy.” Optical Society of America & Proceedings JTu3A.30 (Ft. 




Peer-reviewed Conference Abstracts/Presentations: 
(50 total; 20 first-author; 26 oral presentations; 24 international conferences) 
* indicates presenting author 
 
1. SPIE BiOS Photonics West: International/Online Oral presentation 
A. Rajaram*, L. Yip, M. Suwalski, D. Milej, L. Kebaya, M. Kewin, M. Diop, S. de 
Ribaupierre, S. Bhattacharya, K. St. Lawrence. “NNeMo (Neonatal NeuroMonitor): A 
non-invasive brain monitor for continuous acquisition of cerebral blood flow and 
cytochrome c oxidase in the premature brain” (Online, 2021) 
 
2. SPIE BiOS Photonics West: International/Online Oral presentation  
A. Rajaram*, M. Suwalski, D. Milej, L. Yip, L. Guo, M. Chu, J. Chui, M. Diop, J. 
Murkin, K. St. Lawrence. “Cerebral perfusion and metabolic neuromonitoring during 
cardiopulmonary bypass” (Online, 2021) 
 
3. SPIE BiOS Photonics West: International/Online Oral presentation  
D. Milej*, A. Abdalmalak, A. Rajaram, M. Suwalski, K. St. Lawrence. “Combining 
time-resolved near-infrared spectroscopy with regression analysis to improve the 
reconstruction of cerebral hemodynamic responses” (Online, 2021) 
4. SPIE BiOS Photonics West: International/Online Oral presentation  
D. Milej*, A. Abdalmalak, A. Rajaram, K. St. Lawrence. “Assessing the ability to 
monitor cerebral blood flow and oxygen consumption by combining time-resolved 
near-infrared and diffuse correlation spectroscopy” (Online, 2021) 
 
5. SPIE BiOS Photonics West: International/Online Oral presentation  
L. Mawdsley, N. Abayomi, A. Rajaram, L. Yip, S. Milkovich, C. Ellis, M. Diop. 
“Using Hyperspectral Near Infrared Spectroscopy and Diffuse Correlation 
Spectroscopy to Monitor the Microvascular Effects of Phenylephrine in vivo” (Online, 
2021) 
 
6. Experimental Biology: International/Online Oral presentation 
L. Mawdsley*, A. Rajaram, L. Yip, N. Adayomi, N. Li, S. Milkovich, J. Carson, K. 
St. Lawrence, C. Ellis, M. Diop. “Simultaneous Monitoring of the Cerebral and 
Skeletomuscular Microcirculation using Hyperspectral Near Infrared Spectroscopy 
and Intravital Video Microscopy” (Online, 2021) 
 
7. Children’s Health Research Day: Local/Online Oral Presentation  
A. Rajaram*, D. Milej, M. Kewin, L. Kebaya, L. Yip, M. Lo, M. Suwalski, M. Diop, 
S. De Ribaupierre, S. Bhattacharya, K. St. Lawrence. “Cerebral blood flow and 
metabolic neuromonitoring immediately following premature birth” (Online, 2020)  
 
8. Canadian Anesthesiologists’ Society: National/Online Poster Presentation 
J. Murkin*, J. Chui, A. Rajaram, D. Milej, M. Chu, R. Guo, J. Morriseau, M. Diop, 
K. St. Lawrence. “Non-invasive Monitoring of CBF and Brain Oxidative Metabolism 




9. Optical Society of America: International/Online Poster Presentation 
Z. Fang, M. O’Neil, A. Rajaram, A. Mendelson, K. St. Lawrence, C. Ellis, M. Diop*. 
“Real-Time Monitoring of Muscle Blood Flow Regulation in Cardiac Surgery Patients 
with Near-Infrared Spectroscopy” (Online, 2020) 
 
10. Experimental Biology 2020: International/Online Oral Presentation  
L. Mawdsley*, A. Rajaram, L. Yip, C. Ellis, M. Diop. “Using near infrared 
spectroscopy, diffuse correlation spectroscopy, and intravital video microscopy to 
monitor skeletomuscular and cerebral microcirculation” (Online, 2020) 
 
11. Brain & Brain PET: International/Oral Presentation 
A. Rajaram*, L. Yip, M. Kewin, L. Morrison, M. Diop, K. St. Lawrence. 
“Development of a neonatal neuromonitor for concurrent measurements of 
cytochrome c oxidase and CMRO2” (Yokohama, Japan, 2019) 
doi:10.1177/0271678X19851020 
 
12. Lawson Imaging Discovery Day: Local/Oral Presentation 
M. Shahid*, D. Milej, A. Abdalmalak, A. Rajaram, M. Khalid, M. Diop, K. St. 
Lawrence. “Developing an optical device for simultaneous monitoring of oxygenation 
and blood flow dynamics in the adult brain” (London, ON, 2019) 
 
13. London Health Research Day: Local/Oral Presentation 
A. Rajaram*, L. Yip, M. Kewin, L. Morrison, M. Diop, K. St. Lawrence. “Optical 
neuromonitoring for continuous quantification of cerebral blood flow and energy 
metabolism in the developing brain” (London, ON, 2019) 
 
14. London Health Research Day: Local/Poster Presentation  
M. Shahid*, D. Milej, A. Abdalmalak, A. Rajaram, M. Khalid, M. Diop, K. St. 
Lawrence. “Developing a non-invasive optical system for monitoring oxygenation and 
blood flow dynamics in the adult brain” (London, ON, 2019) 
 
15. London Health Research Day: Local/Poster Presentation 
L. Mawdsley*, A. Rajaram, M. Diop, C. Ellis “The effect of sepsis on skeletomuscular 
and cerebral microvascular blood flow” (London, ON, 2019) 
 
16. European Conference on Biomedical Engineering: International/Oral Presentation 
G. Bale*, A. Rajaram, M. Kewin, L. Morrison, A. Bainbridge, M. Diop, K. St. 
Lawrence, I. Tachtsidis. “Multimodal measurements of brain tissue metabolism and 
perfusion in a neonatal model of hypoxic-ischaemic injury” (Munich, Germany, 2019) 
 
17. European Conference on Biomedical Engineering: International/Poster Presentation  
D. Milej, A. Rajaram, A. Abdalmalak, M. Khalid, M. Shahid, M. Kewin, K. St. 
Lawrence*. “Assessing extracerebral signal contamination in optical measurements of 





18. Imaging Network Ontario: Provincial/Oral Presentation 
A. Rajaram*, L. Yip, M. Kewin, L. Kebaya, V. Han, S. Bhattacharya, M. Diop, K. St. 
Lawrence. “NNeMo (Neonatal NeuroMonitor): A non-invasive optical device for 
assessing the coupling of cerebral blood flow and energy metabolism in the developing 
brain” (London, ON, 2019) 
 
19. Imaging Network Ontario: Provincial/Poster Presentation 
M. Kewin*, A. Rajaram, D. Milej, M. Diop, S. de Ribaupierre, K. St. Lawrence 
“Confirmation of a Derivative Hyperspectral NIRS Method to Measure Oxygen 
Saturation” (London, ON, 2019) 
 
20. Imaging Network Ontario: Provincial/Poster Presentation 
D. Milej*, A. Rajaram, A. Abdalmalak, M. Khalid, M. Shahid, M. Kewin, K. St. 
Lawrence “Characterization of scalp signal contamination for noninvasive optical 
brain monitoring” (London, ON, 2019) 
 
21. Imaging Network Ontario: Provincial/Poster Presentation 
M. Shahid*, D. Milej, A. Abdalmalak, A. Rajaram, M. Khalid, M. Diop, K. St. 
Lawrence. “Developing a Time-Resolved Near-Infrared/Diffuse Correlation 
Spectroscopy System for Monitoring Oxygenation and Blood Flow Dynamics in the 
Adult Brain” (London, ON, 2019) 
 
22. SPIE BiOS Photonics West: International/Oral Presentation 
M. Shahid*, D. Milej, A. Abdalmalak, A. Rajaram, M. Khalid, M. Diop, K. St. 
Lawrence. “Development of a hybrid optical system to study dynamic blood 
flow/oxygenation regulation in the human brain.” (San Francisco, CA, 2019) 
 
23. Critical Care Canada Forum: National/Oral Presentation 
A. Mendelson*, A. Rajaram, D. Bainbridge, K. St. Lawrence, T. Bentall, M. Sharpe, 
M. Diop, C. Ellis. “Dynamic tracking of microvascular hemoglobin content in skeletal 
muscle of ICU patients with a custom near-infrared spectroscopy system,” (Toronto, 
ON, 2018)  
 
24. Critical Care Canada Forum: National/Poster Presentation 
L. Mawdsley*, A. Rajaram, M. Diop, C. Ellis “The effect of sepsis on skeletomuscular 
and cerebral microvascular blood flow” (London, ON, 2019) (Toronto, ON, 2018) 
 
25. Functional-NIRS Tokyo: International/Poster Presentation 
D. Milej*, A. Abdalmalak, M. Khalid, M. Shahid, A. Rajaram, M. Kewin, M. Diop, 
K. St. Lawrence. “Assessing extracerebral signal contamination in NIRS and DCS” 
(Toyko, Japan, 2018) 
 
26. Lawson Imaging Discovery Day: Local/Oral Presentation 
A. Rajaram*, G. Bale, M. Kewin, L. Morrison, I. Tachtsidis, K. St. Lawrence, M. 
Diop. “A bedside optical neuromonitor for quantification of cerebral perfusion and 
metabolism in preterm brain injury.” (London, ON, 2018) 
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27. Lawson Imaging Discovery Day: Local/Oral Presentation 
M. Shahid*, D. Milej, A. Rajaram, A. Abdalmalak, M. Diop, K. St. Lawrence. 
“Development of a hybrid optical system to study dynamic regulation of blood 
flow/metabolism in the human brain.” (London, ON, 2018) 
 
28. London Health Research Day: Local/Poster Presentation 
A. Rajaram*, G. Bale, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop. “A novel 
optical neuromonitor for simultaneous quantification of cerebral perfusion and 
metabolism in preterm brain injury.” (London, ON, 2018) 
 
29. London Health Research Day: Local/Oral Presentation 
M. Shahid*, A. Abdalmalak, A. Rajaram, M. Diop, K. St. Lawrence. “Development 
of a hybrid optical system for studying the dynamic regulation of blood 
flow/metabolism in the human brain.” (London, ON, 2018) 
 
30. London Health Research Day: Local/Poster Presentation 
M. Kewin*, D. Milej, A. Abdalmalak, A. Rajaram, M. Diop, S. de Ribaupierre, K. St 
Lawrence. “Confirmation of a Derivative Hyperspectral NIRS Method for Measuring 
Oxygen Saturation by Comparison to Time-Resolved NIRS.” (London, ON, 2018) 
 
31. London Health Research Day: Local/Poster Presentation  
M. Khalid*, D. F Milej, A. Rajaram, A. Abdalmalak, M. Diop, K. St Lawrence. 
“Monitoring absolute cerebral blood flow using a self-calibrated software-based DCS 
system.” (London, ON, 2018) 
 
32. London Health Research Day: Local/Poster Presentation 
K. Selvan*, A. Mendelson, A. Rajaram, K. St. Lawrence, C. Ellis, M. Diop. 
“Monitoring Tissue Oxygenation in ICY patients using Hyperspectral NIRS” (London, 
ON, 2018) 
 
33. Imaging Network Ontario: Provincial/Oral Presentation 
A. Rajaram*, G. Bale, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop. “A novel 
optical neuromonitor for simultaneous and real-time quantification of cerebral 
saturation, perfusion, and metabolism at the bedside.” (Toronto, ON, 2018) 
 
34. Imaging Network Ontario: Provincial/Poster Presentation 
M. Kewin*, D. F Milej, A. Abdalmalak, A. Rajaram, M. Diop, S. de Ribaupierre, K. 
St Lawrence. “Confirmation of a Derivative Hyperspectral NIRS Method for 
Measuring Oxygen Saturation by Comparison to Time-Resolved NIRS.” (Toronto, ON, 
2018) 
 
35. Imaging Network Ontario: Provincial/Poster Presentation  
M. Khalid*, D. Milej, A. Rajaram, A. Abdalmalak, M. Diop, K. St Lawrence. 
“Development of a self-calibrated DCS for tracking absolute cerebral blood flow.” 




36. Optical Society of America: International/Poster presentation  
A. Rajaram, G. Bale, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop*. “Hybrid 
broadband NIRS/Diffuse correlation spectroscopy system for simultaneous monitoring 
of cerebral perfusion and cytochrome c oxidase.” (Hollywood, FL, 2018)  
 
37. Optical Society of America: International/Oral presentation 
M. Kewin*, D. F Milej, A. Abdalmalak, A. Rajaram, M. Diop, S. de Ribaupierre, K. 
St Lawrence. “Validation of a Hyperspectral NIRS Method for Measuring Oxygen 
Saturation by Comparison to Time-Resolved NIRS.” (Hollywood, FL, 2018) 
 
38. Optical Society of America: International/Poster presentation 
M. Khalid*, D. F Milej, A. Rajaram, A. Abdalmalak, M. Diop, K. St Lawrence. “Self-
calibrated DCS for monitoring absolute cerebral blood flow.” (Hollywood, FL, 2018) 
 
39. Mexican Symposium on Neuroimaging: International/Oral presentation  
A. Rajaram*, G. Bale, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop. “A novel 
hybrid broadband near-infrared/diffuse correlation spectroscopy neuromonitor for 
simultaneous and real-time quantification of cerebral saturation, perfusion, and 
metabolism at the bedside.” (Puebla, Mexico, 2017) 
 
40. Brain Monitoring, Neuroprotection in the Newborn: International/Poster presentation  
A. Rajaram*, G. Bale, M. Kewin, I. Tachtsidis, M. Diop, K. St. Lawrence. “A bedside 
optical neuromonitor for real-time monitoring of cerebral perfusion/oxidative 
metabolism.” (Killarney, Ireland, 2017) 
 
41. Functional-NIRS UK: International/Poster presentation 
A. Rajaram, G. Bale*, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop. 
“Development of a hybrid broadband NIRS/diffuse correlation spectroscopy system for 
simultaneous monitoring of cytochrome c oxidase and cerebral perfusion.” (London, 
United Kingdom, 2017) 
 
42. Internat. Society on Oxygen Transport to Tissue: International/Poster Presentation 
A. Rajaram, G. Bale*, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop. “A novel 
bedside optical neuromonitor for real-time measurements of cerebral 
perfusion/metabolism.” (Halle, Germany, 2017) 
 
43. Internat. Society on Oxygen Transport to Tissue: International/Oral presentation 
G. Bale*, A. Rajaram, M. Kewin, L. Morrison, K. St. Lawrence, M. Diop, I. 
Tachtsidis. “Broadband NIRS cerebral cytochrome-c-oxidase response to anoxia 
before and after neonatal hypoxic-ischemic injury.” (Halle, Germany, 2017) 
 
44. SPIE BiOS Photonics West: International/Oral Presentation 
A. Rajaram*, K. St. Lawrence, M. Diop. “Development of a hybrid broadband 
NIRS/diffusion correlation spectroscopy system for real-time monitoring of cerebral 




45. London Health Research Day: Local/Poster Presentation 
A. Rajaram*, D. Lee, K. St. Lawrence, M. Diop. “Development of a hybrid broadband 
NIRS/diffusion correlation spectroscopy system for real-time monitoring of cerebral 
perfusion and oxygenation in preterm brain injury.” (London, ON, 2017) 
 
46. Imaging Network Ontario: Provincial/Poster presentation 
A. Rajaram*, D. Lee, K. St. Lawrence, M. Diop. “Development of a hybrid broadband 
NIRS/diffusion correlation spectroscopy system for real-time monitoring of cerebral 
perfusion and oxygenation in preterm brain injury.” (London, ON, 2017) 
 
47. Canadian Bone and Joint Conference: National/Oral Presentation 
A. Rajaram*, L. Morrison, K. St. Lawrence, T.Y. Lee, M. Diop. “Monitoring vascular 
markers of joint inflammation in a rabbit model of rheumatoid arthritis with time-
resolved NIRS.” (London, ON, 2016) 
48. Optical Society of America: International/Poster presentation 
A. Rajaram, K. St. Lawrence, M. Diop*. “Monitoring vascular markers of joint 
inflammation in a rabbit model of rheumatoid arthritis with time-resolved near-
infrared spectroscopy.” (Ft. Lauderdale, FL, 2016) 
 
49. London Health Research Day: Local/Oral Presentation 
A. Rajaram*, L. Morrison, K. St. Lawrence, T.Y. Lee, M. Diop. “Monitoring vascular 
markers of joint inflammation in a rabbit model of rheumatoid arthritis with time-
resolved near-infrared spectroscopy.” (London, ON, 2016) 
 
50. IUPESM World Congress: International/Oral Presentation 
K. Alexander*, A. Rajaram, J. Schreiner. “Development of a Radiochromic Film 
Dosimetry Imaging System” (Toronto, ON, 2015) 
